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Summary

A detailed understanding of the chronology of cellular events in apoptosis is requir
order to gain insight into the mechanisms involved and to identify the critical

components responsible for the execution of cell death. The results presented describ

detailed chronology of the cellular events that occur in HL60, U-937 and Jurkat cells

response to the apoptosis-inducing agents etoposide, staurosporine, anti-Fas antibody
and the combination of TNFa and cycloheximide. The chronology of apoptotic events

was found to be specific for the cell type and inducing agent. The role of permeabili

transition in apoptotic cell execution was investigated, the results suggesting that

permeability transition is not always a critical triggering event in apoptosis and i
always the mechanism for release of cytochrome c from mitochondria. The pinocytic
loading of cytochrome c into Jurkat and U-937 cells showed that the presence of

cytosolic cytochrome c is sufficient to trigger activation of caspases-3 and -9, exp
of phosphatidylserine, loss of mitochondrial transmembrane potential and DNA
degradation. Evidence for the existence of a caspase-dependent feedback loop which

would result in amplification of the apoptotic cascade is presented. It was demonstr

during etoposide-induced apoptosis of HL60 cells that rapid endocytosis occurred aft
cell shrinkage and prior to changes in membrane permeability, providing a possible

mechanism for the dramatic reduction in cell surface area that occurs during apoptosi
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Chapter l

Introduction
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l.A.l

Apoptosis

Apoptosis is a genetically programmed form of cell death that functions in immune
system modulated defence, tissue homeostasis, development and aging. Apoptosis is an
evolutionarily conserved process, occurring in some form across a wide range of
organisms from bacteria (which respond to viral infection by activating proteases and

preventing protein systhesis, leading to bacterial death) to unicellular organisms, wh
undergo apoptosis via unknown mechanisms. Higher organisms including plants,
primitive animals such as the nematode Caenorhabditis elegans and advanced animals

including mammals all utilise the mechanism of apoptosis to execute physiological cell
death.

Many types of cells are degraded by apoptosis. These include
(i) undesirable cells, eg. virally infected cells and self-reactive T-lymphocytes
(ii) redundant cells, eg. excess neutrophils produced by the bone and cells removed
during the tissue remodelling of morphogenesis and foetal development.

Alterations in both cell survival and cell death contribute to the pathogenesis of hum

diseases. Inappropriate cell survival due to either increased proliferation or the fai
cells to undergo apoptosis is implicated in cancer, viral infections and autoimmune

diseases. Inappropriate cell death is implicated in neurodegenerative disorders such a
Parkinson's and Alzeimer's diseases, in AIDS (Acquired Immunodeficiency Syndrome),

osteoporosis and alcohol-induced liver disease and in the aftermath of ischemic injury

induced by heart attack and stroke. A better understanding of the molecular mechanisms
of apoptosis would allow the development of agents that either enhance or inhibit
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apoptotic cell death, preferably in specific cell types, and thus form the basis of
treatment for a range of human diseases. As an example, conventional cancer therapies
such as radiotherapy and chemotherapy non-specifically induce apoptosis, whereas in
the specific cases of prostate and breast cancer, studies of the molecular pathways of
apoptosis have contributed to the development of androgen ablation therapy for

prostate cancer and estrogen receptor antagonist therapies for breast cancer. The study
of apoptosis has enormous therapeutic potential for the treatment of a wide range of
human diseases.

Apoptosis proceeds through a regulated series of biochemical and morphological

changes including skeletal disruption, cell shrinkage accompanied by blebbing of the c
membrane, exposure of phosphatidylserine (PS) at the cell surface, disruption of
mitochondria and condensation and fragmentation of DNA. The cell is reduced to a
number of organelle-containing, membrane-bound apoptotic bodies that are engulfed by
neighbouring cells or macrophages, enabling the recycling of cellular contents without
induction of an inflammatory response. In contrast, necrosis is a pathological form of
cell death that is not genetically controlled and occurs in response to acute cellular
injury, for example, as an immediate effect of heart attack or stroke. Necrotic cells

and burst the plasma membrane, releasing cellular contents into the intercellular space
and eliciting a damaging inflammatory response.

1.A.2 The Phases of Apoptosis
Apoptosis can be triggered by a wide variety of extrinsic and intrinsic signals, for
example, the physiologic activation of receptors of the TNFa family by Fas ligand and
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T N F a , the action of transforming growth factor (3 (TGF(3), nutrient deprivation and

variations in the intracellular levels of calcium and glucocorticoids. Apoptosis can al
result from the action of therapeutic agents such as gamma radiation and
chemotherapeutics (eg. cisplatin, doxorubicin, etoposide, methotrexate), infection by
viruses, bacterial toxins, the activation of oncogenes such as myc, rel and El A, the
inhibition of tumor suppressors such as p53 and the damaging effects of oxidising
agents, free radicals and UV radiation.

Although apoptosis can by induced by a diverse range of signals in a wide variety of ce
types, these signals are converted into common cell death pathways that are conserved
from primitive animals such as nematodes to humans. The process of apoptosis can be

divided into three functionally distinct phases, the initiation, execution and degradat
phases [Wilson, 1998; Susin, 1997a]. During the initiation phase a stimulus provokes

the apoptotic response. This stimulus which may be an external signal, delivered to cel
surface receptors or may originate inside the cell in response to the cytotoxic action

drug or toxin or radiation. These diverse initiation events are translated into a patte
biochemical changes during the execution phase in which the cell becomes committed to

die by apoptosis. Alterations to mitochondria and the actions of a family of 14 cystein

proteases (caspases) that cleave on the carboxyl side of aspartic acid residues have bo
been implicated as having critical roles in apoptotic execution. The final degradation

phase includes cellular changes that are associated with the disposal of the cell corps
including the internucleosomal degradation of nuclear DNA and the exposure of PS at
the cell surface.
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1.A.3

T h e Role of Caspases in the Execution Phase of Apoptosis

Some of the initial breakthroughs in identifying components of the execution phase of

apoptosis were achieved through molecular studies of the nematode, C. elegans. During
development of this worm, 131 cells die by genetically programmed cell death. Three
genes were identified as being critical to the control of developmental apoptosis in

elegans. These genes were designated ced-3, -4 and -9, (ced = cell death abnormal). C

3 and ced-4 were found to be required for apoptosis, while ced-9, which is homologous

to the mammalian Bcl-2 family genes (Section l.A.5.1) inhibits apoptosis [Ellis, 1991

The first mammalian homologue of the C. elegans ced-3 gene was identified as the gene
encoding Interleukin-1 p-Converting Enzyme (ICE) which was already known as the
protease which cleaves the pro-inflammatory cytokine pro-interleukin 1 [Yuan, 1993],
now known as caspase-1. Since the discovery of ICE, 13 other mammalian caspases
have been identified.

Caspases recognise their substrate cleavage sites on the basis of tetrapeptide motif

can be grouped into 3 subfamilies depending on their preferred substrate specificity.
Group 1, including caspases-1, -4, -5 and -13, prefer bulky, hydrophobic amino acids

the P4 position, which is consistent with their major role in cytokine processing, ra
than in apoptosis [Nicholson, 1999]. Group II caspases, including caspase -2, -3 and
require aspartate in the P4 position (ie. the 4th amino acid side chain within the

substrate active site, numbered from the sissile bond towards the N-terminal) and are

the major effectors of cell death. Group III caspases (-6, -8, -9, and -10) prefer b
chain aliphatic amino acids in the P4 position and function as upstream activators of
group II effector caspases [Nicholson, 1999]. Each caspase is synthesised as a large
inactive precursor (procaspase) which is itself activated by cleavage at aspartate
6

residues either by autoactivation or after being cleaved by other caspases. The cleaved
protein is assembled into a heterotetramer which constitutes the active caspase
molecule.

Caspases are thought to act in an amplifying cascade of activation and proteolysis

culminating in the cleavage of key cellular proteins, for example those that are invol
in the maintenance of genomic integrity such as poly (ADP-ribose) polymerase (PARP)
and the catalytic subunit of DNA-dependent protein kinase (DNA-PKCS) as well as
structural components of the cytoskeleton including lamins, fodrin and gelsolin. The
cellular consequences of caspase activation include the suspension of cell cycle
progression and the disabling of processes that maintain homeostasis and repair.
Inhibitors of apoptosis such as the inhibitor of caspase-activated DNase (ICAD)

(Section 1.A.12) are inactivated, allowing the structural and morphological changes of
apoptosis that mark the dying cell for disposal by phagocytosis to proceed.

Caspases can be activated by autocatalysis, by the action of other caspases or after
recruitment to a signalling complex of multiple homologous proteins. Examples of
recruitment activation include the high levels of caspase-8 that are activated at the
inducing signal complex (DISC) formed from the intracellular domain of the Fas
receptor, the Fas-associated death domain adapter protein (FADD) and the
cytotoxicity-dependent APO-1 -associated protein (CAP-3). A second example of
recruitment activation is the recruitment and activation of procaspase-9 which is
mediated via interactions with the common caspase-activated recruitment domain
(CARD) of Apaf-1, the mammalian homologue of the C. elegans pro-apoptotic protein
CED-4.
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The upstream (Group III) activator caspases (caspase-8 and -9) cleave and activate
downstream (Group II) effector caspases (caspase-3 and -7) followed by caspase-6.

Caspases -3 and -6 cleave the proteins that are involved in nuclear apoptosis [Sakahir
1998]. The activation of effector caspases can occur directly, for example following
activation of caspase-8 at the DISC complex, or via an indirect pathway involving
mitochondria [Scaffidi, 1998]. Activation of low levels of caspase-8 at the DISC
complex in Jurkat and CEM cells induced to undergo apoptosis by ligation of the Fas

receptor, is followed by cleavage of Bid, a pro-apoptotic member of the Bcl-2 family o
proteins (Section l.A.5.1), which translocates to mitochondria effecting release of
cytochome c, which in turn leads to activation of caspases-9 and -3 and subsequent
nuclear apoptosis [Sakahira, 1998].

1.A.4 Caspase Inhibitors
Caspases can be regulated either at the level of processing and activation or, once
activated, by inhibitors that interact directly with the protease. The former type of
regulators includes molecules such as FADD, Apaf-1, Bcl-2 family members and

inhibitor of apoptosis proteins (IAPs). Direct inhibitors of activated proteases inclu
viral and cellular gene products as well as synthetic peptide inhibitors.

Apoptosis may be induced as a host cell response to rid the body of virally infected

cells. Viral cell death inhibitors, some of which act by binding to activated caspases
have evolved to block this host cell response and allow viral replication. Cytokine
Response Modifier A (crm A) binds to activated caspases-1 and -8, inhibiting the
defensive inflammatory response triggered by IL-1 (3 and apoptosis triggered by TNF
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receptor family members, which is mediated by caspase-8 [Ekert, 1999]. p35 is a

baculoviral protein that inhibits the apoptotic response of insect cells to viral infe

p35 can inhibit several insect caspases, the mammalian caspases-1, -3, -6, -7, -8 and and the C. elegans CED-3 protein. Mammalian IAPs including XIAP, MIHD, MIHC,
and NAIP have been shown to bind to and inhibit Group II caspases [Takahashi, 1998].
XIAP has been shown to block apoptosis triggered either by ligation of Fas receptor,
dexamethasone or Bax overexpression, perhaps via the association of IAP's with
procaspase-9 [Deveraux, 1998].

Efforts to develop synthetic caspase inhibitors as pharmacological agents to counter th
inappropriate apoptosis that is implicated in neurodegenerative diseases such as
Alzheimer's and motor neurone disease, and in ischemic vascular diseases such as heart
attack and stroke, has led to the availability of specific tetrapeptide inhibitors of
caspase activation, based on the preferred substrate cleavage sites of the caspases.

zVAD.fmk, for example, is an irreversible competitive general caspase inhibitor whereas
peptides such as DEVD and LEHD linked to aldehyde (-CHO) groups are reversible

inhibitors of specific groups of caspases. The activity of the aldehyde caspase inhibi

in intact cells is limited by their low membrane permeability, although they are potent
inhibitors of in vitro assays [Ekert, 1999]. The specificity and binding efficiency of
tetrapeptide inhibitors varies markedly, however they cannot be used to specifically
inhibit individual caspases. DEVD.CHO, for example, most potently inhibits caspase-3,

but also inhibits caspase-7 and -8. Because of their lack of specificity the tetrapepti

inhibitors cannot be used to implicate the actions of individual caspases in whole cell
models of apoptosis [Garcia-Calvo, 1998].
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1.A.5

Regulation of Apoptosis

A great deal of effort in the early years of apoptosis research was dedicated to

understanding the initiation and regulation of apoptosis in order to develop new disea

therapies that acted by either enhancing or inhibiting apoptosis [Vaux, 1996b], whilst

relatively little was known of the biochemical pathways involved in the execution phas

of apoptosis. Apoptosis is regulated by both intracellular and extracellular controls,

including the Inhibitor of Apoptosis Proteins (IAPs), the Bcl-2 family of proteins and

extracellular survival factors which are secreted by cells. IAP's are proteins which b
to the catalytic domains of caspases and procaspases via their common caspase
recruitment (CARD) domains, preventing the processing and activation of caspases
including caspase-3, -7 and -9 and thereby causing inhibition of apoptosis [Hofmann,

1997; Hofmann, 1999]. Extracellular survival factors are involved in cell-cell signalli
and act to inhibit apoptosis in neighbouring cells. These survival factors appear to
activate production of the apoptosis promoters Bcl-2 and Bcl-xL and to block apoptosis
promoters such as Bad via phosphorylation [Zha, 1996; Tan, 2000]. Cell survival in
most tissues appears to be dependent on a constant supply of survival signals from
neighbouring cells and from the extracellular matrix.

l.A.5.1 The Bcl-2 Family of Proteins
Bcl-2 belongs to a family that numbers at least 15 in mammals and includes both antiapoptotic (Bcl-2, Bcl-xL, Mcl-1) and pro-apoptotic (Bax, Bad, Bak, Bik/Nbk) proteins.
The apoptosis suppressors are integral membrane proteins localised to membranes
including the outer mitochondrial membrane, the endoplasmic reticulum (ER) and the

nuclear envelope. These proteins are homologous to the anti-apoptotic ced-9 protein of

10

C. elegans. Bcl-2 and

BC1-XL

inhibit apoptosis of cells triggered by m a n y different

agents [Chinnaiyan, 1996; Hawkins, 1997] and are antagonised by pro-apoptotic family
members including Bax, Bak, Bid and Bad [Orth, 1997]. Bcl-2 family proteins act by a
range of different mechanisms including:
(i) inhibition of the release of the pro-apoptotic protein, cytochrome c, from
mitochondria. Overexpression of Bcl-2 and Bcl-xL prevents the release of cytochrome c
[Shimizu, 1999; Yang, 1997] while binding of Bax or Bid to mitochondrial membranes in
vitro facilitates the release of cytochrome c [Narita, 1998; Shimizu, 1999; BossyWetzel, 1999; Jurgensmeier, 1998].

(ii) indirect inhibition of the activation of caspases, by binding to and inhibiting the
function of apoptosis promoters. Cytochrome c, on release from mitochondria forms a
complex with the Ced-4-like adapter protein Apaf-1 and pro-caspase-9, which results in
the activation of caspase-9, followed by downstream degradation of DNA (Section
1.A.10). Bcl-2 family suppressors can bind Apaf-1, blocking activation of pro-caspase9 and protecting cells from apoptosis [Zhivotovsky, 1998; Rosse, 1998; Hu, 1998].
Pro-apoptotic family members may serve to release the suppressor-bound Apaf-1,
allowing the activation of caspase-9 [Song, 1999].
(iii) interactions with many proteins including other family members. Bcl-2 family
members can form homo- and heterodimers, possibly via interactions of the BH3
domain which is highly conserved among family members [Gross, 1999]. Heterodimer
formation between apoptosis suppressors and effectors antagonises protein
functionality, for example Bcl-2 is inhibitable by heterodimerisation with Bad, Bax or
Bak.

Pro- and anti-apoptotic family members localise to separate cellular compartments in
the absence of a death signal, anti-apoptotic members being integral membrane proteins
1 1
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whereas most of the pro-apoptotic members are localised to the cytosol or cytoskeleton
[Gross, 1999]. On receipt of a death signal, it appears that pro-apoptotic family
members (including Bid and Bax) translocate to mitochondria after removal of their
amino terminal domains and undergo conformational changes enabling them to
heterodimerize with anti-apoptotic family members in the outer mitochondrial
membrane. The ratio of pro- to anti-apoptotic family members contributes to the

susceptibility of cells to death signals and is therefore a major checkpoint in apopt
[Gross, 1999]. Bcl-2 family members are also regulated by expression levels and by

protein modifications including phosphorylation and proteolytic cleavage. The cleavag
of Bid, for example, by caspase-8 generates a truncated protein that translocates to
mitochondria and triggers cytochrome c release [Li, 1998].

As well as binding and inhibiting the function of anti-apoptotic family members, proapoptotic Bcl-2 family proteins may act by forming channels in mitochondrial
membranes or by regulating existing channels, for example the permeability transition

(PT) pore (Section 1.A.6). There is a high degree of structural similarity between Bcl
family members, each with 2 central hydrophobic cores surrounded by 4 amphipathic
helices, which share structural similarity with the pore-forming helices of bacterial
toxins. In support of a proposed pore-forming function, it has been shown that Bcl-xL,
Bcl-2 and Bax can form ion channels in artificial membranes [Schendel, 1997; Minn,
1997; Schlesinger, 1997]. Enhanced dimerisation or induced expression of Bax or Bak

results in altered mitochondrial transmembrane potential (AY^t), production of reactiv
oxygen species (ROS) and sometimes, release of cytochrome c [Gross, 1999]. The
mitochondrial effects of Bax have been shown to be countered by cyclosporin A (CsA)
and bongkrekic acid (BA), suggesting that Bax may function through regulation of PT
pore opening [Shimizu, 1998].

The widespread regulation of apoptosis by the Bcl-2 family is evidence for the

convergence of distinct signalling pathways activated by different stimuli into a com
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death effector mechanism, suggesting the existence of a central executioner of the
apoptotic process. The finding that Bcl-2 is localised in the outer mitochondrial
membrane (as well as in the membranes of the endoplasmic reticulum and the nuclear
envelope) [Nunez, 1994] suggested that mitochondria play a key role in apoptosis.
Interest in mitochondria was also stimulated by the widespread detection in m a n y
apoptotic systems of reactive oxygen species ( R O S ) which are primarily generated b y
respiration [Buttke, 1994]. Investigations of the role of mitochondria as executioners of
apoptosis was temporarily slowed w h e n it was found that cells mutated to lack
mitochondrial D N A

(and therefore a functional respiratory chain) still underwent

apoptosis, and that in this case apoptosis was still blocked by overexpression of Bcl-2
[Jacobson, 1993]. Interest in mitochondria as executioners of apoptosis was revived
after the demonstration, initially by Kroemer et al. [Kroemer, 1995; Kroemer, 1997b] ;
that cells undergoing apoptosis show a loss of mitochondrial transmembrane potential
(AYmit), referred to as mitochondrial depolarisation.

1.A.6 The Role of Mitochondria in the Execution Phase of Apoptosis.
Apoptosis, in a wide variety of cell types, is characterised by a loss of mitochondrial
function. Ay m it is a product of the asymmetric distribution of protons and other ions on
either side of the inner mitochondrial membrane, that results from the operation of the
respiratory electron transport chain. In a wide range of cell types and under a range of
inducing conditions, cells undergoing apoptosis show a loss of AYmit which precedes
apoptotic events such as chromatin condensation, D N A fragmentation and increased
plasma membrane permeability [Petit, 1995]. Kroemer's group has shown that
mitochondria isolated from apoptotic murine liver cells induced nuclear condensation
and D N A fragmentation in nuclei from normal H e L a cells, implicating mitochondria in
the execution phase of apoptosis [Zamzami, 1996a].
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The reduction of A\|/mit during apoptosis is thought to result from mitochondrial
permeability transition (PT) [Kroemer, 1997b]. PT involves a sudden increase in the

permeability of the inner mitochondrial membrane and is believed to be mediated by the
formation of large conductance pores at contact sites between the inner and outer
mitochondrial membranes [Marzo, 1998a]. The PT pore is formed from a complex of
proteins that includes the adenine nucleotide translocator (ANT) in the inner
mitochondrial membrane, the voltage dependent anion channel (VDAC) in the outer
mitochondrial membrane and the matrix protein cyclophilin-D, as well as the
benzodiazepine receptor, hexokinase and glycerol kinase [Crompton, 1999]. The exact
stoichiometry and sites of interaction of these proteins are not yet known [Green,
1998].

The PT pore can exist in two conformations. A low conductivity conformation which
allows molecules of 300 Da to pass, is selectively permeable and is believed to be
involved in calcium homeostasis [Bemardi, 1998]. Low conductivity permeability

transition (LCPT) operates transiently in normal functioning mitochondria, only a sma

fraction of PT pores being open at any one time, resulting in transient depolarisation
only [Crompton, 1999]. The opening of high conductivity PT pores allows equilibration
of ions and respiratory substrates (<1500 Da) between the cytosol and the
mitochondrial matrix, leading to a collapse of A\j/mit and subsequent uncoupling of
oxidative phosphorylation [Mignotte, 1998]. The higher osmotic pressure in the matrix

space relative to that in the cytosol causes an influx of water into the matrix, prod
mitochondrial swelling and eventual rupture of the outer mitochondrial membrane
[Skulachev, 1996; Bemardi, 1998]. Outer membrane rupture may release intermembrane
constituents including the pro-apoptotic proteins cytochrome c and apoptosis inducing
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factor (AIF) into the cytosol. High conductivity P T occurs in an all-or-nothing fashion
in individual mitochondria and spreads in a wave-like fashion through populations of
mitochondria in vitro [Crompton, 1999].

PT can be induced by many different agents including inorganic phosphate, oxidising
agents such as menadione, thiol reagents including disulphide cross linkers such as
diamide, ligands of the ANT such as atractlyoside. The fact that uncouplers of
transmembrane potential (FCCP, K+) induce PT implies that the loss of AYmit is both a
cause and a consequence of PT. Inhibitors of PT include ligands of the ANT (e.g.

bongkrekate), divalent cations, competitors for calcium binding, radical scavengers, t

reducing agents, adenine nucleotides and cyclosporin A (CsA) which binds to the matrix
component of the PT pore, cyclophilin, shifting the open/closed equilibrium to the

closed state [Crompton, 1999]. PT may be the target for regulation of apoptosis by the
Bcl-2 family of proteins. Overexpression of Bcl-2 has been shown to prevent induction

of PT in response to specific stimuli [Bemardi, 1998] while Bax and Bak induce changes
that suggest they may also function via modulation of PT [Gross, 1999].

The modulation of PT opening by so many different physiological effectors including
matrix pH, divalent cations (Ca2+, Mg2+) nucleotides (ADP, ATP, NAD, NADH2),
lipids (acyl-CoA, ceramide), protein thiols, and phosphokinases [Kroemer, 1995],
suggests that it may allow for the convergence of different metabolic and signal
transduction pathways into one common cell death pathway. The lethal effects that
result from high conductivity PT pore opening include the cessation of oxidative
phosphorylation, hyperproduction of ROS, oxidation of cardiolipin within the inner
mitochondrial membrane and depletion/oxidation of glutathione. These changes are
15

associated with disruption of the mitochondrial transmembrane potential and the
uncoupling of the respiratory electron chain.

The central role of mitochondria in the execution phase of apoptosis was first propose
by Kroemer et al. in 1995 and has been more recently supported by several independent
lines of evidence including:
1. Kinetic data indicating a disruption of Ay

it

prior to degradation phase events in

a variety of cell types and under a wide range of inducing conditions [Adachi, 1997;
Kim, 1997; Zamzami, 1995b; Castedo, 1996].
2. The demonstrations that inhibition of PT in cell-free systems by (i) members of

the Bcl-2 family [Kroemer, 1997a], and (ii) ligands of PT pore constituents (eg. BA an
CsA) [Zamzami, 1996b] result in inhibition of DNA degradation.
3. It has been demonstrated that in cell-free systems (i) substances released from

apoptotic mitochondria are rate limiting for the activation of caspases [Kuwana, 1998;

Liu, 1996; Susin, 1998] and (ii) a dense organelle fraction enriched in mitochondria i
required for the onset of apoptotic changes [Newmeyer, 1994],
4. The anti-apoptotic protein Bcl-2 is located on the outer mitochondrial membrane

and the Bcl-2 family of proteins act on mitochondria to regulate apoptosis [Yang, 1997
5. Mitochondria are one of the most important generators of reactive oxygen
species (ROS) in the cell. ROS, in turn, can act as mediators of apoptosis [Buttke,
1994].
6. Entry of the pro-apoptotic mitochondrial protein cytochrome c into the cytosol
of intact human cells by microinjection or electroporation results in a specific and
dependent induction of apoptosis [Li, 1997a].
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The mechanisms that trigger P T in cells undergoing apoptosis remain to be elucidated. In
vitro experiments have suggested that caspases may act directly on mitochondria to
induce PT [Marzo, 1998b]. Consistent with this hypothesis, it has been shown that

overexpression of crmA (a viral inhibitor of caspase-8) [Nicholson, 1997], or treatme
with the broad-spectrum caspase-inhibitor zVAD.fmk, prevented the onset of A¥mjt in
CEM-C7.H2 cells that were induced to undergo apoptosis by treatment with anti-Fas
antibody [Susin, 1996]. zVAD.fmk was also shown to inhibit loss of ATmit in CEM
cells induced to undergo apoptosis by exposure to UVB light [Bossy-Wetzel, 1998].

1.A.7 Inhibition of PT
Inhibition of PT by specific agents that act on mitochondria has been used to verify
involvement of PT in apoptosis. Bongkrekic acid (BA) is a ligand of the adenine

nucleotide translocator that inhibits PT via this specific interaction [Marchetti, 1
Zamzami, 1997; Zamzami, 1996b]. In cell-free systems, the inhibition of PT by BA has
been shown to inhibit chromatin condensation and DNA fragmentation [Zamzami,

1996b] and also to inhibit mitochondrial swelling and cytochrome c release in Bax- or
Bak-induced PT [Narita, 1998]. The inhibition of mitochondrial depolarisation and
subsequent manifestations of apoptosis by BA has also been shown in intact cells
(Table 1.1).
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Table 1.1: Downstream effects of the inhibition of P T b y bongkrekic acid

Cell type

Inducing agent

murine splenocyte

dexamethasone (dex) D N A degradation

murine thymocyte

dex

Events inhibited

Publication
[Zamzami, 1996b]

glutathione depletion [Marchetti, 1996a]
R O S generation
PS exposure
chromatin
condensation
D N A fragmentation

murine thymocyte

nitric oxide ( N O )

P S exposure

[Hortelano, 1997]

D N A degradation
murine pre-B

valinomycin

(BAF-3)
Jurkat T cell

cell acidification

[Furlong, 1998]

apoptosis

NO

leukemia

caspase-3 and -9

[Ushmorov, 1999]

activation
cytochrome c release

neutrophil

anti-Fas

caspase activation

[Watson, 1999]

apoptosis

Cyclosporin A (CsA) interacts with cyclophilin D, a matrix protein [Bemardi, 1998]

causing a potent but transient inhibition of PT pore opening [Broekemeier, 1995]. Cs

inhibition has been found to block the release of cytochrome c from human endothelia

cells [Walter, 1998], suggesting that in this system cytochrome c is released as a r
ofPT.

Hyper-expression of the anti-apoptotic protein Bcl-2 (which may function as an
endogenous inhibitor of PT [Shimizu, 1999]), has been found to prevent the release
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from mitochondria of the pro-apoptotic proteins AIF [Susin, 1998] and cytochrome c
[Yang, 1997] and the induction of apoptosis [Marzo, 1998a; Hirsch, 1997]. Opening of

the PT pore (reconstituted into liposomes) is inhibited by recombinant Bcl-2 or Bcl-X
two apoptosis-inhibitory proteins which also prevent PT pore opening in cells and
isolated mitochondria [Marzo, 1998a].

1.A.8 Release of Pro-apoptotic Proteins from Mitochondria
The release of at least two separate proteins from mitochondria has been associated
with apoptosis. Kroemer and co-workers have shown that PT in isolated mitochondria
and in murine hepatocytes [Susin, 1996; Zamzami, 1996a] resulted in the release of a
kDa apoptogenic protein called Apoptosis Inducing Factor (AIF) that was capable of
initiating DNA fragmentation in isolated nuclei. The release of AIF did not occur if
was inhibited [Susin, 1996]. AIF has recently been sequenced and has been shown to
induce chromatin condensation and cleavage of DNA into 50 kbp fragments [Lorenzo,
1999]. Procaspases-2 [Zhivotovsky, 1999] and -9 [Zhivotovsky, 1999; Krajewski,
1999] have also recently been shown to be released from mitochondria following PT
whilst pro-caspase-3 has been shown to have mitochondrial as well as cytosolic
distribution [Mancini, 1998].

Cytochrome c is normally present on the outer surface of the inner mitochondrial
membrane where it shuttles electrons between complexes III and IV as part of the
electron transport chain. Wang and co-workers first demonstrated that cytochrome c

was released from apoptotic mitochondria [Liu, 1996] and that it was required for the
activation of caspase-3. Caspase-3 in turn proteolytically activates a series of
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intermediates, finally resulting in the degradation of chromosomal D N A [Enari, 1998].

Since the early studies emerged, there have been a great many published reports rela
to a range of cell types and inducers of apoptosis, in which release of cytochrome c
from mitochondria has been demonstrated in both cell-free systems and intact cells
[Krajewski, 1999; Ito, 1999; Xiao, 2000].

1.A.9 The Mechanism of Release of Intermembrane Mitochondrial Proteins
The mechanism by which intermembrane proteins, in particular cytochrome c, are
released from mitochondria has not yet been elucidated, however, two possible
mechanisms have been proposed. The first relies on the osmotic swelling of

mitochondria, caused by PT, which (in vitro) results in rupture of the outer membrane
and release of pro-apoptotic proteins [Petit, 1998; Igbavboa, 1989]. Several studies
demonstrated that induction of PT in isolated mitochondria induces cytcohrome c

release [Cassarino, 1998; Kantrow, 1997; Scarlett, 1997]. The release was shown to be
dependent on opening of the PT pore, since depolarisation alone, as induced by the
uncoupling agent carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), did
not result in cytochrome c release [Kantrow, 1997].

Overexpression of the pro-apoptotic Bcl-2 family member, Bax, has been found to
mediate the opening of the mitochondrial PT pore, the extent of mitochondrial change
being concentration dependent. Low concentrations (125 nM) caused transient PT with

release of intermembrane proteins (cytochrome c and adenylate kinase) and calcein fr

the matrix but without depolarisation or mitochondrial swelling [Pastorino, 1999]. At
higher concentrations (250 nM - 1 uM) depolarisation and swelling resulted from
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sustained PT. The hypothesis that Bcl-2 family proteins function via modulation of P T

is supported by the demonstration that enforced dimerisation or induced expression of

Bax or Bak results in altered AY^t, increased ROS production and sometimes the releas
of cytochrome c. Furthermore, the mitochondrial effects of Bax can be countered by
CsA or BA [Gross, 1999]. A recent report by Kluck et al. suggests that Bid and Bax
cause a permeabilisation of the outer mitochondrial membrane which is enhanced by a

cytosolic factor termed PEF (permeability enhancing factor) and allows the nonspecif
release of intermembrane space proteins such as cytochrome c, adenylate kinase and
sulphite oxidase without causing swelling of the mitochondria, and therefore
independently of HCPT [Kluck, 1999].

The fact that in some systems cytochrome c release has been shown to occur
independently of AY^t may reflect a more specialised mechanism for its release than
simple PT-induced rupture of the outer mitochondrial membrane. A suggested
alternative mechanism requires the formation of a specific channel for cytochrome c
release, possibly by a proapoptotic pore-forming protein such as Bax [Vander Heiden,
1997; Susin, 1997a]. Bax has been shown to induce release of cytochrome c when

overexpressed in yeast [Manon,]. Both Bax [Jurgensmeier, 1998; Eskes, 1998; Finucane,
1999a] and truncated Bid [Li, 1998] have been shown to cause release of cytochrome c

from isolated mitochondria and this release can be prevented by overexpression of Bc

or Bcl-xL. A number of other studies have demonstrated the ability of Bcl-2 or Bcl-xL
prevent the release of cytochrome c from mitochondria [Adachi, 1997; Kharbanda,
1997; Kim, 1997; Kluck, 1997a; Yang, 1997; Bossy-Wetzel, 1998]. Therefore a variety

of independent studies suggest that Bcl-2 family proteins regulate cytochrome c rele
whether it occurs as a result of PT or independently of PT.
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A n additional protein which m a y enhance cytochrome c release from mitochondria has
been identified. Termed the "hinge protein", it forms part of the cytochrome bcj
complex on the inner mitochondrial membrane and is believed to contribute to the

localisation of cytochrome c. Following the induction of apoptosis, relative to contr
cells, cells overexpressing hinge protein cDNA showed an increased rate of apoptosis

and an increase in the rate of cytochrome c release into the cytosol [Okazaki, 1998].

1.A.10 The Action of Cytochrome c in the Cytosol
After release of cytochrome c to the cytosol, pro-caspase-9, cytochrome c and Apaf-1

form a complex which results in the proteolytic activation of caspase-9, which in tur
cleaves and activates caspase-3. This binding occurs in an ATP/dATP dependent
manner [Li, 1997b; Zou, 1997]. It was recently demonstrated that the addition of

cytochrome c to cell extracts obtained from caspase-9 deficient mice did not stimulat
caspase-3 cleavage and activation [Kuida, 1998]. This demonstrates the absolute
requirement for caspase-9 in the pathway from cytochrome c release to caspase-3
activation.

1.A.11 Exposure of PS at the Cell Surface
One of the earliest changes in apoptotic cells that appears to be common to many

different systems of apoptosis including those involving neutrophils, tumor cell line
smooth muscle vascular cells and Jurkat T cells, is the exposure of PS, a negatively
charged phospholipid, at the cell surface. Plasma membrane phospholipids in normal

cells are asymmetrically distributed, with PS being restricted exclusively to the in
leaflet in most cells. The loss of phospholipid asymmetry and the exposure of PS was
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first demonstrated for apoptotic lymphocytes [Fadok, 1992; M o w e r , 1994] and has

since been confirmed in so many different cell types that it has come to be recognise
a universal early marker for apoptotic cells [Zhang, 1997]. Phospholipid asymmetry is
normally generated and maintained by a membrane protein termed the
aminophospholipid translocase, which translocates PS from the outer to the inner
membrane. The rapid extemalisation of PS is believed to be mediated by a Ca2+activated scramblase [Fadok, 1998] that facilitates rapid bi-directional movement of
major phospholipid classes. During apoptosis, the activity of the aminophospholipid
translocase is impaired and the scramblase appears to be activated [Verhoven, 1995]

resulting in loss of lipid asymmetry and clustered PS exposure on membrane blebs at t

cell surface [Casciola-Rosen, 1996]. PS exposure appears to serve as a recognition sig
for phagocytosis, enabling apoptotic cells to be identified and rapidly removed by
neighbouring cells or macrophages.

1.A.12 Fragmentation of Nuclear DNA
DNA degradation in apoptosis occurs firstly as the collapse of chromatin into highly
condensed and fragmented masses that marginalise to the nuclear membrane and can be
visualised by electron microscopy or by the use of DNA-binding fluorescent dyes.
Concomitment with this condensation, cleavage of DNA occurs in two stages, the first

stage creates fragments of 300 kbp and 50 kbp that can be detected by pulsed field ge

electrophoresis. In most but not all cell systems, further internucleosomal degradati

generates fragments which are multiples of 180-200 bp in length and which are detecte
as a characteristic DNA ladder by conventional agarose gel electrophoresis. The two
stages of cleavage are mediated by independent pre-existing endonucleases, which can
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differentiated on the basis of divalent cation requirements and can be separated into
different nuclear fractions [Pandey, 1997].

Until recently, although it was known that caspase-3 is necessary for the chromatin
condensation and DNA fragmentation (and membrane blebbing) of apoptosis to occur

[Janicke, 1998], the substrates of activated caspase-3 cleavage that lead to cleavage
DNA were unknown. In 1997, Wang's group identified a heterodimeric protein
designated DNA fragmentation factor (DFF) [Liu, 1997]. Cleavage of the 45 kDa
subunit of DFF by activated caspase-3 was shown to lead to nuclear DNA. Enari's
group identified the murine counterpart of DFF as the inhibitor of caspase-activated
DNase (ICAD). ICAD is cleaved by caspase-3 to release the caspase-activated
endonuclease (CAD) that translocates to the nucleus and degrades chromosomal DNA
[Enari, 1998].

1.A.13 Models of the Execution Phase of Apoptosis.
The release of pro-apoptotic intermembrane proteins after osmotic swelling of
mitochondria and rupture of the outer mitochondrial membrane is compatible with a
model of apoptosis in which mitochondrial PT is a critical triggering event for the
execution phase of apoptosis, causing the release of pro-apoptotic proteins such as
and cytochrome c and the downtream activation of caspase-3 and DNA fragmentation
[Susin, 1997a} (Figure 1.1).
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activation of
caspase-3
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D N A fragmentation and other
degradation phase events
death inducing signal

Figure 1.1: A theoretical model (Model 1) that describes a PT-dependent mechanism
for the release of pro-apoptotic proteins (which m a y include AIF or cytochrome c).
Cytosolic presence of the pro-apoptotic protein/s results in activation of caspase-3
followed by the onset of D N A fragmentation. Modified from [Wilson, 1998].

Studies in a cell-free system and in intact H L 6 0 cells have reported the release of

cytochrome c prior to and therefore independently of mitochondrial depolarisation (an

thus independently of PT) [Kluck, 1997a; Yang, 1997 ]. Yang et al. (1997) reported tha
in etoposide- or staurosporine-induced apoptosis of HL60 cells, DNA fragmentation
followed the release of cytochrome c to the cytosol and preceded the loss of A\|/mit.
Release of cytochrome c to the cytosol prior to loss of Aymit in intact cells was also
reported by Vander Heiden et al. [Vander Heiden, 1997] in staurosporine or anti-Fas

treated Jurkat cells and in FL5.12 (pro-B) cells treated by withdrawal of IL-3. In bo
these reports Rhodamine 123 was used as a probe of mitochondrial transmembrane

potential. The distribution of this dye after mitochondrial staining has been shown to

not accurately reflect A\|/mit [Metivier, 1998]. However, the release of cytochrome c wa
shown to precede the loss of A\|/mit in Ara-C induced apoptosis of HL60 cells [Kim,
1997]. In this study, the loss of Aymjt was measured using DiOC6 staining of cells
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followed by flow cytometric analysis, a method that has been validated for the
measurement of mitochondrial transmembrane potential [Metivier, 1998; Korchak,
1982].

A study of apoptosis induced by UVB radiation or staurosporine in CEM and HeLa
cells [Bossy-Wetzel, 1998] suggested that cytochrome c was released from
mitochondria prior to loss of A\j/mit, and before or coincident with proteolysis of

caspase-3 and cleavage of PARP. However the loss of A\|/mit was detected in this study
using chloromethyltetramethlyrosamine (CMTM-Ros) staining of cells, followed by
washing, paraformaldehyde fixation and prolonged storage before flow cytometric
analysis. This method was subsequently shown to be unreliable for measuring loss of
mitochondrial transmembrane potential in apoptotic cells [Gilmore, 1999]. Thus, some
reports have used flawed techniques to measure changes in A\|/mit [Bemardi, 1999] and
therefore claims that mitochondria maintain a high A\|/mit despite having released
cytochrome c must be examined cautiously on a case by case basis.

Liu et al. showed in a cell-free system that cytochrome c released in the absence of
activated DFF/ICAD (the proteolytic substrate of caspase-3) to release CAD, which
enters the nucleus and cleaves chromosomal DNA [Enari, 1998]. The formation of a
tetramolecular complex including cytochrome c results in the activation of caspase-9

which in rum activates caspase-3 [Li, 1997b] and caspase-7 [Pan, 1998]. These finding
form the basis of a model of apoptosis based on PT-independent cytochrome c release
[Wilson, 1998] (Figure 1.2).
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death inducing signal

Figure 1.2: A theoretical model (Model 2) describing a PT-independent mechanism for
the release of cytochrome c. This release is followed by sequential activation of caspase9 and caspase-3. Active caspase-3 cleaves D N A fragmentation factor (DFF/ICAD)
which releases C A D allowing it to enter the nucleus and cleave D N A . (Modified from
[Wilson, 1998]).

1.A.14

A Feedback Mechanism Involving Cytochrome C

Cytochrome c m a y be part of a positive feedback mechanism, linking both models of

apoptotic execution. It has been demonstrated that caspase-3 activation and subseque
DNA fragmentation is induced by microinjection of cytochrome c into the cytosol,

confirming the prediction from studies of cell-free systems that cytosolic cytochro

leads to the activation of caspase-3 [Liu, 1996]. A hypothesis by Reed suggests that
cytochrome c may feedback after its release from mitochondria to cause PT, thereby

acting as an amplifier of the execution process [Reed, 1997]. A number of studies ha

already demonstrated the ability of caspases to cause PT [Susin, 1997b; Marzo, 1998b
thus providing a mechanism for cytochrome c amplification. Caspase-8 has been shown
to cleave cytosolic Bid which then translocates to mitochondria, causing cytochrome
release in the absence of loss of AM^it [Li, 1998]. However, changes in Aymit were
measured in this study using chloromethyltetramethlyrosamine (CMTM-Ros) staining
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of cells, followed by paraformaldehyde fixation, a method which, as previously stated,
was subsequently shown to be unreliable for measuring loss of mitochondrial
transmembrane potential in apoptotic cells [Gilmore, 1999].

Other examples of positive feedback loops that act during apoptosis are known. ROS
are known to cause apoptosis and have been shown to induce PT [Zamzami, 1995a].
During PT the production of ROS can occur, thereby causing a self amplification
feedback loop [Zamzami, 1996a]. A recent study implicated cytochrome c in the
production of superoxide during apoptosis. This was due to a loss of part of the
electron transport chain when cytochrome c was released from mitochondria to the
cytosol [Cai, 1998]. This data further supports the hypothesis that cytochrome c may
have a self-amplifying function in apoptotic execution.

1.A.15 Elucidation of the Molecular Mechanisms of Apoptosis

During recent years there has been an intense research effort focussed on elucidating

molecular basis of the execution phase of apoptosis, particularly since Kroemer's gro

was instrumental in reviving interest in the role of mitochondria in 1995. In order t

understand the mechanisms involved in regulating apoptosis, it is necessary to have a

detailed understanding of the step by step chronology of events occurring in apoptosi

At the time of initiation of this project, there were very few reports giving a detai
chronology of events, particularly with respect to recently implicated mitochondrial
changes. Kroemer's group had established the chronology of apoptotic events in

dexamethasone-induced thymocytes as being firstly a reduction in ATmit and generation
of ROS, followed by cell shrinkage and, finally, DNA fragmentation [Zamzami, 1995a].

They also showed that in apoptosis of the 2B4.11 T-cell hybridoma cell line, U-937 an
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W E H I - 1 2 3 pre-B cells, triggered by a variety of inducers, disruption of A T m i t and the
generation of ROS preceded DNA fragmentation. Petit et al. reported in dexamethasoneinduced apoptosis of murine thymocytes that a decrease in AYmjt preceded DNA

fragmentation and loss of integrity of the plasma membrane [Petit, 1995]. A decrease i
ATmit was shown by Vayssiere et al. to precede DNA fragmentation during heat-

induced apoptosis of a virally transformed rat embryo cell line [Vayssiere, 1994]. The

sequence of events in these reports can be accomodated by the model outlined in Figure
1.1.

Kroemer's group proposed that during apoptosis PT causes mitochondrial
depolarisation, the release of AIF and the subsequent triggering of DNA degradation
[Kroemer, 1995]. They later broadened this hypothesis to claim that PT is the

integration point for all apoptosis inducing signals and triggers all degradation pha
events [Kroemer, 1997b]. The general validity of this hypothesis had not been

established in intact cell systems and in fact there was one report in the literature
time that in heat shock and dexamethasone-induced apoptosis of rat thymocytes, DNA

fragmentation preceded mitochondrial depolarisation, changes in mitochondrial mass an
loss of membrane integrity [Cossarizza, 1994]. These findings suggested that in some
systems mitochondrial PT does not trigger degradation phase events and therefore that

PT may not comprise a critical component of the execution phase events in all systems.
The sequence of apoptotic events in these cell systems may support the second
proposed model of the execution phase of apoptosis (Figure 1.2).
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The aims of m y work were primarily to:
1. Use a variety of agents to induce apoptosis in HL60, U-937 and Jurkat cells and
to carry out time course experiments to establish whether mitochondrial
depolarisation precedes degradation phase events in these systems.
2. Establish the relative timing of mitochondrial depolarisation and cytochrome c
release in order to determine if either or both of the above two models (Section
1.1.13) applies to each cell system studied.
3. Determine if PT triggers degradation phase events and the release of cytochrome
c by measuring these changes in the presence and absence of a specific inhibitor
ofPT.
4. Introduce cytochrome c into the cytosol of cells in order to determine the
apoptotic events that result specifically from the presence of cytosolic
cytochrome c.

Chapter 3 describes the results obtained after induction of apoptosis in HL60 cells usin
either the topoisomerase II inhibitor etoposide or the protein kinase inhibitor

staurosporine. Jurkat cells were induced to undergo apoptosis using either staurosporin

or anti-Fas antibody and the results are described in Chapter 4 while Chapter 5 presents
results obtained with U-937 cells induced to undergo apoptosis by treatment with a
combination of TNFa and the protein synthesis inhibitor cycloheximide. The apoptotic
changes that were measured over time in each of the above systems included
mitochondrial depolarisation, PS exposure, activation of caspase-3 and release of
cytochrome c from mitochondria. The loss of and degradation of DNA was measured by

a range of techniques, including standard agarose gel electrophoresis (internucleosomal
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fragmentation), pulsed field gel electrophoresis (high molecular weight fragmentation)
and analysis of Pi-stained permeabilised cells by flow cytometry (DNA loss).

Chapter 6 describes the measurement of apoptotic events induced in Jurkat and U-937
cells after introduction of cytochrome c into the cytosol by the technique of pinocytic

loading, while Chapter 7 presents a critique of a published protocol for the staining of
apoptotic cells with the mitochondrial dye CMX-Ros, followed by fixation and flow
cytometric analysis.

The sudden and dramatic shrinkage of cells is a universal feature of cells undergoing
apoptosis, but has been a neglected area of apoptosis research. Chapter 8 presents the
results of a study of the role of endocytosis in apoptotic cell shrinkage.

3 1

Chapter Two:

Materials and Methods
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This chapter contains the materials and methods that are commonly used throughout the
work described in this thesis. Experimental details that are specific for the work
described in Chapters 3, 4, 5, 6, 7 and 8 are described in those chapters.

2.A MATERIALS

2.A.1 Cell Culture
Dulbecco's Modified Eagles Medium:Hams F-12 (DMEM:F12) and Foetal Bovine
Serum (FBS) were purchased from Trace Biosciences (Melbourne, Australia) and
Greiner Labortechnik plasticware from Interpath Services (Melbourne, Australia).
H E P E S was supplied by the United Stated Biochemical Company (OH, U S A ) .

2.A.2 Genomic DNA Purification and Electrophoresis
Phenol:chloroform:isoamyl alcohol (25:24:1) was purchased from Research Organics
Inc. (OH, U S A ) . Agarose, proteinase K and 100 bp D N A ladder were obtained from
Promega (WI, U S A ) . R N A s e cocktail was obtained from Ambion (TX, U S A ) . Ethidium
bromide, Bromophenol Blue and xylene cylanol were from Sigma (Sydney, Australia).

2.A.3 Protein Determination, SDS-PAGE and Western Blotting
of Proteins
Acrylamide, tris-(hydroxymethyl)aminomethane (Tris) and glycine were purchased
from I C N Biomedicals (Sydney, Australia). Bradford reagent, ammonium persulphate,
N,N,N',N'-tetramethylethylenediamine

(TEMED),
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casein, and

thimerosal

were

purchased from Sigma (Sydney, Australia). N,N'-methylene-bis-acrylamide and sodium
dodecyl sulphate (SDS) were purchased from BDH (Dorset, England). Benchmark
Prestained Protein Ladder was purchased from Gibco (Melbourne, Australia) and
nitrocellulose was purchased from Micron Separations Incorporated (MA, USA).

Enhanced chemiluminescence (ECL) detection utilised Pierce Supersignal Substrat
USA) and either Kodak X-Omat Blue XB-1 film (NY, USA) or Amersham Hyperfilm
ECL (Sydney, Australia). Either a Novex XCell II Minicell (CA, USA) or a Hoefer

Mighty Small Minicell (CA, USA) were used for electrophoresis of proteins whils

BioRad Minitransblot Cell (Sydney, Australia) was used for wet transfer of prot
from gel to membrane.

2.A.4 Antibodies
Monoclonal anti-CPP32 antibody was obtained from Transduction Laboratories (KY,
USA) and HRP-conjugated sheep anti-mouse IgG was purchased from Silenus (CA,
USA).

2.A.5 Fluorogenic Caspase Assays
The caspase inhibitors Ac-DEVD.CHO, Ac-LEHD.CHO and Ac-IETD.CHO and
caspase substrates Ac-DEVD.AMC, Ac-LEHD.AMC and Ac-IETD.AMC were
obtained from BIOMOL (PA, USA). The caspase inhibitor zVAD.fmk was purchased

from Calbiochem (Sydney, Australia). Piperazine-n,n'-bis-[2-ethane sulphonic aci
(PIPES), 3-[(3-cholamidopropyl)-dimethylammonio]-l-propane sulphonate (CHAPS),

dithiothreitol (DTT), ovalbumin and ethylene glycol-bis(b-aminoethylether)-N,N,N'

tetraacetid acid (EGTA) were from Sigma (Sydney, Australia) and Complete11 prote
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inhibitor cocktail was obtained from Boehringer Mannheim (Sydney, Australia). Costar
black fhioro-assay microtitre plates were obtained from Coming ( M A , U S A ) .

2.A.6 Flow Cytometry
3,3'-dihexyloxacarbocyanine iodide (DiOQ) and chloromethyl-X-rosamine (CMX-Ros)
were purchased from Molecular Probes Inc. (OR, U S A ) . Annexin V-FITC was obtained
from Boehringer Mannheim (Sydney, Australia) and propidium iodide (PI) was
obtained from Sigma (Sydney, Australia).

2.A.7 Miscellaneous

All other chemicals were of Analytical Reagent grade and were purchased from either
Ajax Chemicals (Sydney, Australia) or B D H Chemicals (Dorset, England). All solutions
and buffers were

prepared

using reverse osmosis

purified water, excepting

electrophoresis and transfer buffers which were prepared using glass distilled water.
Tissue culture media was prepared using water purified by a Millipore Milli-Q Reagent
Water System (Sydney, Australia).

2.B METHODS

2.B.1 Cell Culture
The human leukemic cell lines Jurkat (T-cell), U-937 (myelomonocytic) and HL60
(promyelocytic) were obtained from the American Type Culture Collection ( A T C C ,
M D , U S A ) . Cell lines were cultured in D M E M : H A M S F12 media supplemented with
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1 0 % (v/v) F C S (complete medium) at 37°C in a humidified atmosphere of 5 % C 0 2 Culture media was buffered using 2 g/L NaHC03 and 10 mM HEPES. Cells were
maintained in log phase by sub-culturing three times weekly and were harvested at a
density of not more than 5xl05 cells/mL. Frozen stocks of cells were kept in liquid
nitrogen, suspended in freeze media (50% (v/v) FCS, 10% (v/v) DMSO, 40% (v/v)
DMEM:F12). Prior to treatment, cells were counted using a Neubauer haemocytometer,

harvested by centrifugation (500g, 5 min) and resuspended in fresh medium at a densi
of l-2xl06 cells/mL for most experiments.

2.B.2 Flow Cytometry
Flow cytometric data was collected using a Becton Dickinson FACSort and analysed
using CellQuest (v3.1) software (Becton Dickinson, Sydney, Australia). Cell-sized

events were identified and gated using forward laser scatter (FSC) and side angle la

scatter (SSC) signals to enable exclusion of cellular debris and aggregates from ana

Typical gating of cells is shown in Figure 2.1. A generous gate was used to accomodat

the cell shrinkage that is characteristic of apoptosis. For each flow cytometric ana
data were acquired for 10,000 cells from each of 3 replicate samples.
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Figure 2.1: Typical gating of cells for flow cytometric analysis. Density plots showing
the results of flow cytometric analysis of untreated U-937 (A), untreated Jurkat cells
(B) or Jurkat cells treated for 3 h with 2 u M staurosporine (C). Aliquots of 4xl0 5 cells
were analysed using a FACSort flow cytometer equipped with CellQuest software.
Apoptotic cell shrinkage is illustrated in (C). Cells were gated according to their forward
and side scatter characteristics to exclude cellular debris and aggregates but to include
shrunken cells.

2.B.3 Data Analysis
Experimental measurements were performed in triplicate and each experiment repeated

at least twice. Unless otherwise indicated, all results are expressed as means ± standar
error of the mean (SE). The Student's t-test was employed to determine the statistical
significance of differences in measured characteristics between samples.

2.B.4

Staining Cells with Cationic, Lipophilic Dyes to Measure

Mitochondrial Membrane Potential (A\j/mit)
Membrane-permeable lipophilic cations are accumulated by mitochondria in response to
the negative inner membrane potential and are therefore useful tools for measuring
changes in Avmit [Cossarizza, 1994]. Cationic lipophilic dyes such as 3,3'dihexyloxacarbocyanine iodide (DiOC6) and the methyl ester of tetramethyl rhodamine
(TMRM) accumulate in the negatively charged matrix of mitochondria, resulting in a
high level of punctate fluorescence in normal cells. Upon depolarisation of the

37

mitochondrial membrane potential a decrease in the matrix accumulation of dye
[Kroemer, 1997b] results in a diffuse cytosolic fluorescence which can be observed by
fluorescence microscopy or detected by flow cytometry as decreased cell-associated
fluorescence.

2.B.4.1 Method for Staining Cells with DiOC6
Changes in mitochondrial membrane potential (A\j/mjt) were measured by flow
cytometry using DiOC6. A 1 mM stock solution of DiOC6 was prepared in ethanol and
stored at 4°C until required. To measure changes in A\j/mit, 4x105 cells were harvested
by centrifugation (5 mins, 500g), resuspended in 500 pL complete medium containing 40
nM DiOC6 and incubated at 37°C for 15 min in the dark. Cells were then counterstained

briefly with 1 jig/mL PI (to identify dead cells) and then immediately subjected to flo

cytometric analysis. A decrease in A\|/mit was detected as a decrease in cell-associat

green fluorescence (FL-1 signal) relative to control (fully polarised) cells (Figure 2
control experiments, cells were labelled with DiOC6 in the presence of 50 \iM CCCP, a
protonophore which causes the collapse of A\j/mit. Determination of the proportion of
cells that had reduced A\|/mit was carried out by setting markers on flow cytometry

histograms and using the statistical functions of CellQuest software (Becton Dickinson
Sydney, Australia) (Figure 2.2).
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Figure 2.2: Flow cytometry histograms of D i O C 6 stained Jurkat cells. Cells induced to
undergo apoptosis by treatment for 6 h with anti-Fas antibody at 100 ng/mL (B) s h o w
decreased FL-1 (green) fluorescence relative to that of control cells (A), indicating a
decrease in A\|%ut. Identical markers were used for both control and treated cells in order
to estimate the percentage of cells with reduced Ax/mjt.

2.B.5

Assay for Non-viable Cells.

The cell-impermeant nuclear stain propidium iodide (PI) w a s used as a counterstain to

detect non-viable cells that had lost plasma membrane integrity. PI is excluded from cell
with intact plasma membranes but brightly stains the nuclei of dead cells. PI was added
to the cell suspension at 1 ug/mL immediately before flow cytometric analysis. Loss of
membrane integrity was measured as a large increase in cell-associated red fluorescence
(FL-3) which w a s used to electronically exclude non-viable cells from further analysis.
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2.B.6

Assay for Exposure of Phosphatidylserine at the Cell

Surface
Phosphatidylserine (PS) is a phospholipid normally confined to the inner surface of
plasma membrane, however, during apoptosis PS becomes exposed on the outer surface

of the cell to function in the recognition of apoptotic cells by phagocytic cells [Ma
1996; Casciola-Rosen, 1996]. PS exposure appears to persist from the early execution

phase of apoptosis until the final stage at which the cell is broken up into apoptot

bodies [van Engeland, 1998]. Annexin V is part of a highly conserved family of cellul

proteins which bind specifically to the negatively charged PS in the presence of cal
FITC-labelled annexin V (annexin V-FITC) provides a useful tool for measuring PS
extemalisation in cells undergoing apoptosis [Zhang, 1997; van Engeland, 1998]. When

the integrity of the plasma membrane is lost (eg. in dead cells), annexin V has acces
phosphatidyserine present on the inner surface of the plasma membrane, and therefore

the binding of annexin V-FITC is no longer specific to externalised PS. Simultaneous

staining of cells with annexin V-FITC (green fluorescence) and with propidium iodide
(red fluorescence) allows the discrimination of normal (FITC~PI~), apoptotic (FITC+
PI") and dead cells (FITC+PI+) by flow cytometry [Vermes, 1995].

2.B.6.1 Method for Staining Cells with Annexin V-FITC
Annexin V-FITC reagent was prediluted to 20 pg/mL in annexin V buffer (10 mM
HEPES / NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl2). 4 x IO5 cells were harvested by

centrifugation (500g, 5 min), washed in PBS and re-pelleted. After draining well, cel

were resuspended in 50 uL of diluted annexin V reagent and incubated for 20 min at R
protected from light. The cell suspension was then diluted by the addition of 450 uL
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annexin V buffer and the cells analysed b y flow cytometry

immediately after

counterstaining with 1 ug/mL PI. An increase in exposure of PS at the cell surface was

measured as an increase in cell-associated green fluorescence (FL-1), relative to that of

healthy control cells. Dead cells were identified by the high level of cell-associated re
(PI) fluorescence and were electronically excluded from further analysis.
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Figure 2.3: T w o colour flow cytometry density plots of annexin V-FITC and PIstained U-937 cells. Cells induced to undergo apoptosis b y pinocytic loading of
cytochrome c (B) show increased green fluorescence relative to control cells ( A )
indicating extemalisation of P S at the cell surface. Dead cells in which the integrity of
the plasma membrane had been compromised show high intensity red fluorescence,
allowing them to be electronically excluded from analyses.

2.B.7

Fluorogenic Assay for Caspase Activation

Activation of caspase activity w a s measured by addition of the appropriate fluorogenic
peptide substrate (aminomethylcoumarin (AMC) derivative) to lysates of cells. The
fluorescence level was compared with that produced in the presence of a specific
tetrapeptide aldehyde inhibitor. The difference in fluorescence indicated the level of
substrate cleavage that was specifically due to caspase activity. However, the

specificity of the fluorogenic substrates and inhibitors is not absolute, as cleavage can
achieved by closely related caspases. Cleavage of each of the fluorogenic substrates was
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interpreted as indicating activation of the target caspase or of a closely related caspase.
DEVD.AMC was used as the fluorogenic substrate and DEVD.CHO the aldehyde
inhibitor to measure caspase-3-like activity. The "core" tetrapeptide used for
measurement of caspase-8-like activity was IETD and for caspase-9-like activity was

LEHD. Active caspases cleave the tetrapeptide substrate between the aspartic acid (D)
and the AMC group, liberating free AMC which fluoresces at 460 nm upon excitation at
390 nm. The aldehyde inhibitors bind strongly to the caspase active sites to block
substrate binding and cleavage.

2.B.7.1 Fluorescence Microplate Assay for Caspase Activation
The presence of cellular caspase-3, -8 and -9-like activity was measured using the
following microplate assay adapted from Enari et al. [Enari, 1996]. Samples of 2xl06

cells were pelleted by centrifugation (500g, 5 min) and frozen at -80°C until requir
Cells were lysed by repeated freeze-thawing in 150 uL of extraction buffer (50 mM
PIPES-NaOH, pH 7.0, 50 mM KC1, 5 mM EGTA, 2 mM MgCl2, 1 mM DTT,

CompleteR protease inhibitor cocktail) and pelleted by centrifugation at 8,000 g for
min at 4°C. The supernatant was diluted with 350 ^L of assay buffer (100 mM HEPESKOH, pH 7.5, 10% (w/v) sucrose, 0.1% (w/v) CHAPS, 10 mM DTT, 0.1 mg/mL
ovalbumin). 50 uL was aliquoted into each of 9 wells of a Costar black fluoro-assay

microtitre plate. Stock solutions (10 mM) of all caspase substrates and inhibitors w
prepared in DMSO, aliquoted and frozen at -80°C until required. The appropriate
caspase inhibitor (diluted in assay buffer) was added to triplicate wells to a final

concentration of 1 \iM (10 \iM for caspase-9 inhibitor) and pre-incubated at 37°C for
30 min. To triplicate wells containing the inhibitor and a further three wells, the
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appropriate caspase substrate was added to afinalconcentration of 10 u M (caspase-3

and -8) or 20 uM (caspase-9), whilst assay buffer only was added to the remaining thr
(background) wells. Plates were incubated for 1-2 h at 37°C. Contents of wells were
excited at 390 nm using a Biolumin 960 fluorescence plate reader operated by
Xperiment software (v. 1.1.0) from Molecular Dynamics (Sydney, Australia) and
fluorescence emission was measured at 460 nm. Data was analysed using Microsoft
Excel software (v6.0).

2.B.8 SDS-PAGE of Proteins
Gel preparation for SDS-PAGE mini-gels was based on the method developed by
[Laemmli, 1970]. All samples were denatured prior to loading onto 10-15%) (w/v)
polyacrylamide gels by boiling for 5 min with an equal volume of 2x non-reducing
sample buffer (Tris-HCl, pH 6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 0.005% (w/v)
bromophenol blue). Electrophoresis was performed at 125 V in either a Novex XCell II
Mini Cell or a Hoefer Tall Mighty Small minicell in Tris-glycine buffer (25 mM Tris,
250 mM glycine, pH 8.3, 0.1% SDS). Molecular masses of electrophoresed proteins

were estimated by comparison of their electrophoretic mobilities with those of prote
standards of known molecular mass (Gibco Benchmark Pre-stained Protein Ladder).

2.B.9 Immunoblot for Caspase-3
Separated proteins were transferred onto nitrocellulose membranes according to
standard methods [Towbin, 1979]. The 0.22 pan nitrocellulose membrane was preequilibrated in transfer buffer (25 mM Tris, 192 mM glycine, pH 8.3, 20% (v/v)

methanol) prior to wet transfer in a BioRad Mini Transblot Cell for one hour at 100 V
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(4°C). After transfer, the remaining protein binding sites on the membrane were blocked
by overnight incubation in 1% (w/v) heat denatured casein in PBS containing 0.01%
thimerosal as preservative (HDC/PBS). All subsequent procedures were conducted at
room temperature (RT). The membranes were incubated for one hour with HDC/PBS
containing monoclonal anti-caspase-3 antibody at 2.5 jig/mL. Membranes were washed
three times for 10 min in PBS, followed by incubation for 1 h with 0.56 ug/mL
horseradish peroxidase (HRP)-labelled sheep anti-mouse IgG (SAM-IgG). After
washing three times for 10 min in PBS containing 0.1% Triton-X 100, membranes were
rinsed well with RO water. Enhanced chemiluminescence (ECL) was then used to detect
anti-caspase-3-reactive protein bands.

2.B.10 Agarose Gel Electrophoresis of Genomic DNA

Cells undergoing apoptosis cleave their DNA into fragments that are multiples of 18

200 base pairs in length [Vaux, 1996a]. It is believed that the linker region between
nucleosomes are the targets for endonuclease attack. Conventional agarose gel

electrophoresis of DNA from cells undergoing apotosis detects this pattern of cleav
as a "ladder" of bands [Vaux, 1996a]. DNA "laddering" is accepted as a biochemical
hallmark of apoptosis [Gerschensen, 1992].

To detect oligonucleosomal DNA fragmentation, 2 x 106 cells were centifuged (10 min a
500g), washed once with PBS and resuspended in 400 uL of pre-heated (50°C) DNA
extraction buffer (0.5 M Tris, pH 9.0, 2 mM EDTA, 10 mM NaCl, 2% (w/v) SDS) to
which 0.3 mg/mL proteinase K had been added. This was incubated overnight at 50°C
before DNA was purified from denatured proteins by two successive
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phenolxhloroform extractions, followed by a single chloroform extraction. After
addition of 0.1 volumes of 3 M, sodium acetate (pH 5.5), 0.01 volumes of 2 M MgCl2
and 2.5 volumes of ice-cold ethanol, DNA was precipitated and pelleted by

centrifugation at 11,000 g (20 min at 4°C). The pelleted DNA was air-dried and then
redissolved in 20 jxL of TE buffer (10 mM Tris.HCl, pH 8.0, 1 mM EDTA) and stored
at 4°C. The purity of DNA was assessed by comparison of the absorbance of diluted
samples at 260 nm with that at 280 nm. Samples with A260A28O of 1.8-2.0 were

assumed to be pure. The yield of DNA was calculated from the extinction coefficien
DNA at 260 nm (0.02 ^g^mLcm-1) [Sambrook, 1989]. An aliquot of the sample (7-10
|j.g) was incubated with 1 uL of RNAse cocktail (1 mg/mL RNase A, 25 mg/mL RNAse

Tl) for 30 min at 37°C and mixed with a 1/6 volume of 6x sample buffer (0.25% (w/v)
bromophenol blue, 0.25% (w/v) xylene cyanol FF, 30% (w/v) glycerol in RO water)

before heating at 60°C for 5 min and holding on ice prior to loading onto a 1.6% (w

horizontal agarose gel. 7-10 pig of each sample and 5 ug of DNA standard (Promega 1
bp ladder) were electrophoresed in TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH

8.0) at 6-8 V/cm for 1.5-2 h, followed by staining with 0.05 ug/mL ethidium bromid
RO water. DNA was visualised and photographed using a Novaline Gel Documentation
system (Novex, CA, USA).

2.B.11 Protein Determination
Protein was assayed by the Bradford method [Bradford, 1976] using a modified

microtitre assay format. A set of BSA standards (50 ug/mL-1 mg/mL) was prepared and
10 uL aliquots of both standards and appropriately diluted protein solutions were
transferred to duplicate wells of a 96-well plate. 200 uL of Bradford Reagent was
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to wells and mixed. Absorbance was read at 596 n m using a Spectromax Plate Reader
(Molecular Devices, Sydney, Australia).

2.B.12 Scanning Laser Confocal Microscopy
A Leica DMIRBE inverted microscope coupled to a Leica TCS SP confocal system
using Windows NT TCS software (Leica Microsystems, Sydney, Australia) was used
to acquire images of fluorescently labelled cells.
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Chapter 3

Etoposide- and Staurosporineinduced Apoptosis ofl(L6o CeCCs
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3A

INTRODUCTION

Etoposide, also k n o w n as VP-16, is a D N A topoisomerase II (topoll) inhibitor that is
widely used as a cancer chemotherapeutic, particularly for the treatment of acute
myelogenous leukemia [Champlin, 1987]. D N A topoll induces transient enzymebridged D N A breaks on both D N A strands, allowing the unwinding and separation of
complimentary and daughter D N A strands during replication and transcription events.
Under physiological conditions the D N A - e n z y m e complexes are transient and reverse
rapidly after D N A strand passage, but the presence of topoll inhibitors such as
etoposide stabilises the topo II-DNA adducts, resulting in strand breaks at the rate of
several breaks per 100 bp. Formation of these strand breaks result in cell-cycle arrest in
either G 2 or S phase and/or cell death by apoptosis. H L 6 0 , a human promyelocytic
leukemia cell line, and other h u m a n leukemia cell lines have been found to be highly
sensitive to D N A damage and subsequent apoptosis induced by topoisomerase
inhibitors [Dubrez, 1995] with S-phase cells being selectively sensitive. This sensitivity
m a y be associated with overexpression of the c-myc oncogene which has been shown to
regulate cell-cycle progression and apoptosis in response to D N A damaging agents
[Bertrand, 1991].

Much of the early work done on the effect of topoisomerase inhibitors on HL60 cells
was focussed on understanding the processes involved in D N A degradation. Kaufman et
al. found that internucleosomal cleavage w a s not due to the direct action of the
topoisomerase on D N A , but rather w a s due to intermediate metabolic processes
culminating in activation of a pre-existing endonuclease [Kaufmann, 1989]. The
internucleosomal digestion of D N A was proposed to play a central role in apoptosis,
causing the chromatin condensation and fragmentation that is one of the earliest
morphological markers of apoptosis. Attempts at elucidation of the signal transduction
pathways leading to D N A fragmentation and cleavage of nuclear proteins such as P A R P

48

and lamin B revealed that multiple ICE-like proteases are involved in apoptosis

[Lazebnik, 1994] and that a serine protease is involved in the final step of induction o
internucleosomal DNA cleavage in etoposide-treated HL60 cells [Yoshida, 1996].

Studies of HL60 cell apoptosis established that when treated with etoposide or a range

of cytotoxic agents these cells exhibit the classical morphological changes of apoptosi
such as chromatin condensation and fragmentation, cell shrinkage and membrane
blebbing. Del Bino et al. [Del Bino, 1991] showed that DNA fragmentation and
proteolysis precede changes in cell membrane permeability and mitochondrial membrane
permeability, and that a functional lysosomal protein pump is maintained in apoptotic
camptothecin-treated HL60 cells. Bruno et al. [Bruno, 1992] showed that intracellular
proteases may play a significant role in camptothecin-induced apoptosis of HL60 cells
since DNA degradation, plasma membrane integrity and characteristic morphological
changes were inhibited by the protease inhibitors N-tosyl-L-phenylalanylchioromethyl
ketone (TPCK) and N-tosyl-L-lysylchloromethyl ketone (TCLK). However, at the
time of initiation of this project, there were no extensive investigations into the
chronology of apoptotic events in HL60 cells. The following are the results of my
investigation into the chronology of events in etoposide- and staurosporine-treated
HL60 cells.
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3.B

MATERIALS AND METHODS

This section describes experimental details of the related work presented in Chapter

4 and 5 excluding the details that were presented in Chapter 2 (Materials and Methods

3.B.1 Materials
Etoposide, staurosporine and 7-amino-actinomycin D were obtained from Sigma
(Sydney, Australia). Bongkrekic acid was a kind gift of Dr. J. A. Duine (Delft
University, Delft, the Netherlands). Chloromethyl-X-rosamine (CMX-Ros), and
Alexa488 goat anti-mouse IgG conjugate were obtained from Molecular Probes (OR,
USA). Anti-(native) cytochrome c monoclonal antibody (clone 6B2.H4) was obtained
from BD Pharmingen (Sydney, Australia) and an IgG! isotype control antibody was
obtained from Silenus (CA, USA). Pulsed Field Gel Electrophoresis Marker (X-DNA)
was purchased from Amrad Pharmacia Biotech (Castle Hill, Australia). Low melting
point agarose was obtained from Promega (WI, USA).

3.B.2 Methods

3.B.2.1 Induction of Apoptosis

Cells were counted using a haemocytometer, harvested by centrifugation (500g, 5 min)
and resuspended in fresh DMEM:F12 supplemented with 10% FCS at a density of 1-

2xl06 cells/mL before addition of the specific apoptosis inducing agent. HL60 cells w
induced by the addition of 20 ng/mL etoposide from a 40 mg/mL stock solution in
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D M S O which was stored at -20°C. After removal of initial samples, cells were returned
to standard culture conditions (37°C, 5% C02) and sampled hourly for assessment of
apoptotic changes.

3.B.2.2 Flow Cytometric Assay for Mitochondrial Depolarisation
Cationic lipophilic fluorochromes including 3,3' dihexyloxacarbocyanine iodide (DiOC6)
and chloromethyl-X-rosamine (CMX-Ros) passively diffuse across the plasma
membrane and accumulate in active mitochondria in response to the negatively charged
matrix. The specificity of CMX-Ros staining for mitochondria has been shown by the

co-localisation of the dye with an antibody specific for subunit I of cytochrome oxidase
[Poot, 1996]. The extent of dye uptake reflects the transmembrane potential such that

dissipation of ATmit results in a decrease in cell-associated fluorescence of stained cel
that can be detected by flow cytometry or by fluorescence microscopy [Korchak,
1982]. The ability of these dyes to discriminate normal cells with fully polarised
mitochondria from those with depolarised mitochondria can be confirmed using a range

of mitochondrial poisons that act on different parts of the respiratory chain, including
antimycin A, azide and carbonyl cyanide m-chlorophenylhydrazone (CCCP), an
uncoupling agent that dissipates the proton gradient across the inner mitochondrial
membrane. The fact that protonophores, such as CCCP cause a loss of mitochondriaassociated fluorescence (as observed by fluorescence microscopy) [Korchak, 1982] and

hence a loss of cell-associated fluorescence, is evidence that the maintenance of a pro
gradient, and therefore a mitochondrial transmembrane potential, is necessary for

accumulation of the dye by mitochondria. The decrease in cell-associated fluorescence o
Jurkat cells stained with DiOC6 in the presence of CCCP can be seen in Figure 3.1.
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Figure 3.1: Flow cytometry histogram overlay showing control (black line) and C C C P
-treated (red line) Jurkat cells. CCCP-treated cells were pre-incubated with 50 u M
C C C P before both cell samples were stained with 40 n M D i O C 6 in culture medium for
15 min at 37°C. A decrease in A\|/mjt is detected as a decrease in cell-associated
fluorescence.

3.B.2.2.1 Optimisation of Staining Conditions for DiOC6 and CMX-Ros
DiOC6 passively diffuses across the plasma membrane and stains mitochondria when
used at low concentrations (eg. 250 nM) [Korchak, 1982] whereas at higher
concentrations (5-50 uM) it also stains the endoplasmic reticulum [Sabnis, 1997]. In
order to ensure that a decrease in mitochondrial membrane potential is reflected
accurately by a decrease in cellular fluorescence, it is necessary to use the lowest
possible dye concentration to avoid problems of fluorescence saturation in fully
polarised mitochondria. The range of concentrations of both DiOC6 and CMX-Ros that

gave a linear increase in fluorescence for increasing dye concentrations in fully pola

Jurkat cells was initially determined by staining cells according to the standard prot
(section 2.B.4) but with a range of dye concentrations from 0.1-1000 nM. A linear
increase in fluorescence was obtained for DiOC6 in the range 10-100 nM and for CMXRos in the range 0.1-50 nM. Following this, the ranges of CMX-Ros and DiOC6
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concentrations that were optimal for detection of mitochondrial depolarisation were
determined by staining Jurkat cells with a range of dye concentrations in the presence or
absence of 50 u M C C C P , followed by flow cytometric determination of the mean
fluorescence channel for each staining condition. The optimum staining concentration
range for resolution of fully polarised from depolarised populations was found to be 3050 n M for C M X - R o s and 40-100 n M for D i O C 6 .

A recent report [Rottenberg, 1998] suggested that the use of 40 nM DiOC6 did not
allow detection of depolarisation of mitochondria due to fluorescence quenching in fully
polarised mitochondria, and suggested the use of concentrations as low as 0.2 n M . T o
determine the validity of this claim, both Jurkat and U-937 cells were induced to
undergo apoptosis by treatment with anti-Fas antibody

or with

TNFa/CHX

respectively, under standard conditions for 4 h, harvested and stained using 0.2 n M , 1.0
nM

and 40 n M

D i O C 6 under standard conditions (5x10 5 cells/ 500 uL staining

solution). It was found that 40 n M D i O C 6 allowed good resolution of depolarised cells
from fully polarised control cells. The use of 1 n M D i O C 6 allowed partial resolution of
these populations only, while the use of 0.2 n M

D i O C 6 did not resolve these

populations at all. It is clear that a loss of A ¥ m j t is reflected by a maximal decrease in
cell-associated fluorescence at the concentrations of 40 n M for D i O C 6 and 30 n M for
C M X - R o s and that fluorescence is linearly related to concentration at these staining
concentrations. The

optimised

concentrations

were

adopted

for

all further

measurements of mitochondrial depolarisation during apoptosis. Figure 3.2 shows that
the percentages of cells with depolarised mitochondria identified using D i O C 6 staining
are virtually identical to those identified using C M X - R o s staining.
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time (h)

Figure 3.2: Comparison of the use of C M X - R o s (red line) and D i O C 6 (green line) for
the detection of mitochondrial depolarisation in etoposide-treated Jurkat cells.
Statistically significant differences between the percentages of cells exhibiting a loss of
A^mjt in etoposide-treated cultures and in untreated control cultures (blue line) were
detected at 5 h w h e n cells were stained with C M X - R o s and at 6 h w h e n cells were
stained with D i O C 6 (p<0.02, Student's t-test). The percentages of these cells detected
using both dyes were essentially the same throughout the time courses.

3.B.2.2.2

M e t h o d for Staining Cells with D i O C 6 or C M X - R o s

Cells were stained with either 40 nM DiOC6 or 30 nM CMX-Ros using the protocol
described in section 2.B.4.1

3.B.2.3

Simultaneous Determination of P S Exposure and Loss of A^mjt

Phosphatidylserine (PS) is a phospholipid that is normally confined to the inner surface
of the plasma membrane, however, during apoptosis PS becomes exposed on the outer
surface of the cell. FITC-labelled annexin V (annV-FITC) binds specifically to PS
residues on the surface of viable cells that have maintained membrane integrity and
therefore provides a useful tool for measuring PS extemalisation in cells undergoing
apoptosis. Double-labelling of cells with annV-FITC and CMX-Ros enables
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simultaneous measurement of P S exposure and loss of A Y m i t on the same cells, thus
allowing the relative timing of these two apoptotic events to be determined.

3.B.2.3.1 Method for Dual Annexin V and CMX-Ros Staining of Cells
Annexin V labelling solution was prepared by diluting Annexin V-fluos reagent (1
mg/mL stock, Boehringer) to 20 ug/mL in Annexin V buffer (10 mM HEPES/ NaOH,
pH 7.4, 140 mM NaCl, 5 mM CaCl2). 4xl05 cells were harvested by centrifugation (500

g, 5 min), washed in PBS and re-pelleted. After draining well, cells were resuspend
50 ^L of Annexin V labelling solution and incubated for 15 min in the dark at room
temperature (RT). A CMX-Ros stock solution (1 mM in DMSO) was diluted 1/100
with PBS and 5 uL of this was added to 445 uL DMEM:F 12/10% FCS containing 5
mM CaCh- 450 uL of this diluted CMX-Ros/ DMEM was added to cells to give a final
CMX-Ros concentration of 30 nM. Cells were incubated for 15 min at 37°C and
immediately subjected to flow cytometry, recording green (FITC) and red (CMX-Ros)
fluorescence. Cells in which mitochondria have depolarised display a decreased red

(CMX-Ros) fluorescence, whereas cells that have exposed PS at the cell surface have

increased green fluorescence due to increased binding of annV-FITC (Figure 3.3). Pa

staining of cells from the same cultures with lug/mL PI as described in Section 2.B.
allowed an estimation of the percentages of non-viable cells present in cultures.
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Figure 3.3: Flow cytometric density plots of untreated (A) and etoposide-treated
H L 6 0 cells (B) that were stained with C M X - R o s and annV-FITC. A loss of
mitochondrial membrane potential is indicated by a reduction in red ( C M X - R o s )
fluorescence. Exposure of PS at the cell surface is indicated by an increase in cellassociated green fluorescence due to increased binding of annV-FITC.

3.B.2.4 Inhibition of PT by Bongkrekic Acid
Bongkrekic acid is a ligand of the adenine nucleotide translocator, a protein that is
located in the inner mitochondrial membrane and forms part of the PT pore complex.
Bongkrekic acid binds to and changes the conformation of the ANT, reducing the
probability of PT pore opening [Zamzami, 1996b; Zamzami, 1996a]. Attempts were
made to inhibit PT using other known inhibitors of PT including cyclosporin A (CsA),
however PT could not be reproducibly inhibited using CsA, which is known to offer a

transient inhibitory effect only [Zamzami, 1996b]. CsA has been recently shown to also
affect the multi-drug resistance pump (MDR) [Bemardi, 1999] and is therefore not a
specific inhibitor of PT. The thiol-reactive agent monochlorobimane, which has been
used by other researchers to inhibit PT [Marchetti, 1997], was tested on HL60 and
Jurkat cells and found to inhibit PT. This agent does not however act excusively on
mitochondria and further experiments to elucidate the effect of the presence of
monochlorobimane on the events of apoptosis were therefore not pursued.
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3.B.2.4.1

M e t h o d for Inhibition of P T

To determine the effect that inhibition of PT had on the induction of apoptosis, cells
were incubated in the appropriate inducing agent in the presence or absence of 100 uM
bongkrekic acid (BA). The conditions for obtaining maximum inhibition by bongkrekic

acid were initially optimised. Media containing cells was acidified by the addition of 5
mM HC1 immediately before the addition of 100 uM bongkrekic acid (which was
obtained as a solution in 2 N NH4OH). This maximised the uptake of BA due to its
protonation and thereby maximised its inhibitory effect. Neutrality of cell suspensions
had returned by approximately 30 min after initial treatment. The numbers of cells that
had depolarised mitochondria, after treatment with apoptosis inducing agents, was
significantly reduced in the presence of BA (Fig. 3.4) indicating inhibition of PT.
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Figure 3.4: Flow cytometry histogram overlays of cell-associated DiOC6 fluorescence
showing the inhibition of mitochondrial depolarisation in the presence of B A . Untreated
H L 6 0 cells (black line) showed a high level of D i O C 6fluorescence.In cultures treated b y
incubation for 10 h with 20 ug/mL etoposide (green line) 3 6 % of cells exhibited a
decrease in cell-associated fluorescence indicating mitochondrial depolarisation. In
cultures treated with etoposide and 100 u M B A (red line) the percentage of cells with
depolarised mitochondria was reduced to 1 4 % .
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3.B.2.5

Pulsed Gel Electrophoresis of D N A

DNA fragmentation in apoptosis proceeds through ordered stages, the first of whi
involves cleavage to 300 kbp and 50 kbp fragments, followed in most but not all

by internucleosomal fragmentation to produce fragments that are multiples of 180

bp in length. The detection of early DNA degradation into large fragments is nec

to define fully the pattern of DNA degradation in apoptosis, allowing more rigor

definition of the chronology of events, particularly in those systems where degr

does not proceed to internucleosomal fragmentation. Pulsed Field Gel Electrophor

(PFGE) utilises the application of an orthogonal potential that rapidly switches
directions, allowing resolution of high molecular weight DNA [Walker, 1993] The

problem of chemical or mechanical shearing of high molecular weight DNA is overc

by embedding intact cells in agarose blocks before lysing the cells to expose ge
DNA in a detergent and proteinase K containing buffer.

3.B.2.5.1 Method for PFGE of DNA

Cell samples were prepared by the method of Pandey et al. [Pandey, 1997] Briefly

2xl06 cells were harvested by centrifugation (500 g, 5 min) washed once with nucl
buffer (15 mM Tris-HCl, pH 7.4, 60 mM KC1, 15 mM NaCl, 2.0 mM EDTA, 1.0 mM

EGTA, 0.5 mM spermidine, 0.15 mM spermine) and pelleted at 700 g for 5 min at 4°

Cells were resuspended in 50 uL of nuclear buffer, held at 37°C and mixed with a
volume of molten (37°C) 1.5% low melting point (LMP) agarose in nuclear buffer

containing 20 ng of proteinase K. The cell suspensions were pipetted into a BioR

sample mould and allowed to set at 4°C. The agarose plugs were incubated overnig
37°C in 3 mL of TEN buffer (10 mM Tris-HCl, pH 9.5, 25 mM EDTA, 1 mM EGTA,
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10 m M N a C l ) containing 400 ug proteinase K and 1 % (v/v) laurylsarcosine with gentle
rocking. Agarose plugs were washed twice by rocking for 15 min in TE buffer (10 mM
Tris-HCl, pH 8.0) containing 1 mM EGTA and 1 mM EDTA, and then stored at 4°C
until loaded into the wells of a 1% agarose gel and sealed with molten (37°C) 1% low
melting point agarose in 0.5x TBE buffer (0.045 M Tris, 0.045 M boric acid, 12.5 mM
EDTA, pH 8-8.5). PFGE was carried out using a BIORAD Chef DRII PFGE system

(Sydney, Australia) under the following conditions: initial switch time: 0.1 sec; fin

switch time: 54.2 sec; gradient: 6 V/cm; phase angle: 120°, at 14°C for 7 h. The gels
were stained with 0.05 ug/mL ethidium bromide and photographed on a No vex No valine
UV transilluminator (Sydney, Australia). An a-DNA standard having bands at 50-730
kbp was electrophoresed alongside each set of samples for comparison.

3.B.2.6 Flow Cytometric Assay for Loss of DNA
DNA is degraded in several stages during apoptosis, culminating in the generation of
fragments that are multiples of 180-200 bp in length. Permeabilisation of cells in a

hypotonic fluorochrome solution, followed by overnight incubation, allows diffusion o
small DNA fragments out of the nuclei into the buffer. Staining of the remaining DNA

using propidium iodide (PI) allows identification of apoptotic nuclei on the basis of
reduced DNA content (which can be detected by flow cyometry as a decrease in red
fluorescence). Apoptotic nuclei are identified in a broad hypodiploid DNA peak which

can be discriminated from the normal diploid DNA content [Nicoletti, 1991] The gating
strategy developed by Douglas et al. [Douglas, 1995]was used to exclude debris and
doublet nuclei from analysis. Only those events with detectable and linear FL-2 area

FL-2 width were included. Figure 3.5 allows comparison of the PI staining profiles of
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normal nuclei which exhibit the typical diploid D N A peak with that of apoptotic nuclei,
which show a reduction in red fluorescence resulting in a broad hypodiploid peak. This
method allows the assessment of the percentage of cells that have fragmented their

DNA.
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Figure 3.5: Flow cytometry histograms of PI stained nuclei from untreated Jurkat cells
(A) and cells induced to undergo apoptosis by incubation for 6 h with 2 u M
staurosporine (B). A reduction in PI fluorescence to a level below that present in
healthy diploid cells indicates a loss of nuclear D N A which results from D N A
fragmentation.

3.B.2.6.1

M e t h o d for PI Staining of Nuclei

Nuclei were stained by a modification of the method described by Nicoletti [Nicoletti,
1991] 4xl05 cells were centrifuged (500 g, 5 min) and resuspended in 500 uL of
hypotonic buffer solution (0.1% trisodium citrate, 9.7 mM NaCl, 0.03% NP-40)
containing 50 ug/mL PI. Samples were incubated overnight in the dark at 4°C and
subjected to flow cytometric analysis the following day. Data was collected using FL-2
AAV gating to define nuclei and gate out debris and aggregates (Fig. 3.6) according to
gating strategy developed by Douglas et al. [Douglas, 1995].
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Figure 3.6: Flow cytometry FL-2 area vs. FL-2 width density plots displaying the
gating strategy employed to exclude doublet nuclei and debris. Only those events with
detectable and linear FL-2 area vs. FL-2 width were included in analysis. Nuclei from
staurosporine treated Jurkat cells (B) exhibit a reduced Fl-2 area w h e n compared with
nuclei from untreated Jurkat cells (A). The wide range of PI fluorescence of nuclei from
staurosporine treated Jurkat cells that have been gated on the basis of FSC/SSC, rather
than on FL-2 A A V , indicates the presence of debris and doublet nuclei (C). Use of the
FSC/SSC gating strategy (red line) results in a m u c h broader range of hypodiploid PI
fluorescence than that observed with FL-2 A A V gating (black line) due to the presence
of low fluorescence debris (D).

3.B.2.7

Flow Cytometric Assay for Changes in M e m b r a n e Permeability

7-Amino-actinomycin D ( 7 A A D ) is a planar molecule that fluoresces on intercalation
between guanidine and cytosine bases in double stranded DNA [Philpott, 1996]. 7 A AD

is efficiently excluded by intact cells so that the degree of uptake and hence the inte

of cellular fluorescence is a reflection of the plasma membrane integrity of cells. Sta
of cells that have been induced to undergo apoptosis with 7AAD allows discrimination
of three cell populations on the basis of fluorescence intensity. 7AADbnght cells were
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identified b y S c h m i d et al [Schmid, 1994] b y morphologic examination to be late stage
apoptotic and dead cells without intact cell membranes. 7-AAD- cells were live cells
that had intact plasma membranes and 7-AADdim cells were shown to have reduced
forward scatter (FSC) characteristics and were classified as early apoptotic cells that
had not yet lost membrane integrity [Schmid, 1994]. The same cell populations can be
identified by incubation with 1 og/mL PI under the same conditions (Fig. 3.7).
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Figure 3.7: F l o w cytometry density plots of etoposide-treated H L 6 0 cells. Cells were
incubated with etoposide for 2 6 h, then stained with either 2 0 u g / m L 7 A A D ( A ) or with
1 ^ g / m L PI (B) under standard conditions. "Live" cells exclude both dyes and are
identified at l o w fluorescence intensities whereas "dead" cells have lost plasma
m e m b r a n e integrity and bind large amounts of dye. T h e intermediate cell populations
have an intermediate cell m e m b r a n e permeability and are identified as "apoptotic" cells.
T h e s a m e cell populations are identified b y both dyes.

3.B.2.7.1
Cells (5x105)

M e t h o d for Staining Cells with 7 A A D
were

harvested by centrifugation (500 g, 5 min) and resuspended in 100

uL PBS. 7AAD was added to a final concentration of 20 ug/mL from a stock solution (5
mg/mL in DMSO, 4°C) or PI added to a final concentration of 1 ug/mL from a stock
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solution (1 m g / m L in H 2 O , 4°C). Cells were incubated for 20 mins on ice and volume
was adjusted by the addition of 200 jxL P B S before analysing by flow cytometry.

3.B.2.8

Immunofluorescence Staining of Cytochrome c in Permeabilised
Cells Stained with an Anti-cytochrome c Antibody

Cytochrome c is a mitochondrial intermembrane protein that is loosely associated with
the outer surface of the inner mitochondrial membrane. Cytochrome c release from the
mitochondria to the cytosol has been reported for m a n y different systems of apoptosis
[Kluck, 1997a; Krippner, 1996; Zhuang, 1998; Martinou, 1999]. Immunofluorescence
staining of cells allows the release of cytochrome c from mitochondria to be visualised
by fluorescence microscopy as a change from punctate regions of intensely concentrated
fluorescence (corresponding to mitochondrial localisation), to a diffuse fluorescence that
is located throughout the cytosol of cells. In order to determine the relative timing of
mitochondrial depolarisation and cytochrome c release, replicate aliquots of cells were
removed at hourly intervals from a culture induced to undergo apoptosis, and either
stained with D i O C 6 (according to the method described in Section 2.B.4.1), or fixed and
permeabilised before staining with a mouse anti-cytochrome c antibody (clone 6B2.H4).
A n anti-mouse antibody that was labelled with the green fluorescent tag Alexa 488
(Molecular Probes) was used in conjunction with fluorescence microscopy or scanning
laser confocal microscopy to identify and quantify cells that had released cytochrome c
to the cytosol. Alexa 488 has the same excitation and emission characteristics as F I T C
but has the advantages of higher fluorescence yield, reduced photobleaching and a lack of
p H sensitivity. The specificity of staining was verified by comparison with cells in
which the primary anti-cytochrome c antibody was replaced by an isotype-matched
control antibody. Statistics for the proportion of control and etoposide-treated cells that
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had released cytochrome c to the cytosol were obtained by counting 5 fields of view,

each containing at least 200 cells, for each time point of two independent experiments
The mean percentages of cells with released cytochrome c were expressed ± the SE.

The percentages of cells with depolarised mitochondria were determined as described in
Section 2.B.4.1 and the chronology of these two apoptotic events was then determined.

3.B.2.8.1 Method for Immunofluorescence Staining of Cytochrome c in
Permeabilised Cells
2xl06 cells were centrifuged (500 g, 5 min) in a 15 mL polypropylene tube. The cell
pellet was resuspended in 0.4 mL of 4% freshly prepared paraformaldehyde in PBS.
Cells were fixed for 30 min at room temperature (RT) with shaking, then diluted to 15
mL with ice-cold PBS and centrifuged (900 g, 10 min). Cells were resuspended in 400

M-L PBS and stored at 4°C until required for staining. After centrifuging, the fixed c
were permeabilised by resuspending them in 400 uL of 0.5% (v/v) Triton x-100 (Tx-

100) in PBS and incubating on ice for 15 mins. Cells were diluted to 15 mL with ice-co

0.1%o (v/v) BSA/PBS to pre-block non-specific binding sites and to minimise cell losse

during centrifugation. Cells were centrifuged (900 g, 10 min), drained and resuspended
50 oL of 1% (w/v) BSA/PBS containing either 2.5 p.g/mL mouse anti-cytochrome c
primary antibody or 2.5 |ug/mL mouse IgGi isotype control antibody. Cell suspensions
were transferred to pre-chilled 1.5 mL tubes and incubated on ice for 1 h. Cells were
diluted to 1.5 mL with 0.1% BSA/PBS, centrifuged (900 g, 10 min) and thoroughly

drained. Cells were then resuspended in 50 \xh of goat-anti-mouse Ig-Alexa 488, dilute
to 40 ug/mL in 1% BSA/PBS and incubated in the dark, on ice, for 1 h. Cells were then

64

washed twice with P B S , resuspended in 1 % PF/PBS and stored at 4°C, protected from
light, until examined by fluorescence and/or scanning laser confocal microscopy.
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3.C

E X P E R I M E N T A L RESULTS

3.C.1

Etoposide-induced Apoptosis of HL60 Cells

In order to determine the chronology of apoptotic events (including mitochondrial

depolarisation, exposure of phosphatidylserine at the cell surface, activation of caspas
3 and degradation of DNA) that were induced in HL60 cells, time courses were set up in
which untreated cells and cells in the presence of 20 ug/mL etoposide were cultured in

parallel. Triplicate aliquots of cells were taken at 1, 2, 3, 4, 6, 8 and 10 h after in
of apoptosis. Time courses were repeated many times to ensure reproducibility, the
results shown being representative of the time courses performed.

3.C.1.1 Loss of Mitochondrial Transmembrane Potential (AYmit)
When HL60 cells were exposed to etoposide, the first cells showing a reduction in

ATmit appeared at approximately 4 h (Fig. 3.8). For the experiment represented, at this
time there were approximately 7.5% of cells with depolarised mitochondria. This
percentage increased rapidly after 6 h of etoposide treatment to reach 33% by 10 h.
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Figure 3.8: The percentage of etoposide-treated (red line) and untreated (blue line)
H L 6 0 cells with depolarised mitochondria as a function of time after induction of
apoptosis. Loss of A*¥mit was measured as a reduction in cell-associated D i O C 6
fluorescence (as described in section 2.B.4.1) and was first detected at 4 h. Dead cells
were identified by 7 A A D staining (as described in section 3.B.2.7.1) and excluded from
analysis. Data points represent the mean of triplicate measurements. Error bars
represent the SE. In m a n y cases the S E are too small to be visible. Results are
representative of m a n y independent experiments.

3.C.1.2

Extemalisation of phosphatidylserine (PS)

The exposure of phosphatidylserine at the cell surface was first detected at 4 h (Fig.
3.9). For the experiment represented, at this time 27%> of etoposide-treated cells
exhibited exposed PS. The percentage of cells with exposed PS increased with time,
reaching 64% by 10 h after induction of apoptosis. The time point for the appearance of
cells with depolarised mitochondria appeared to coincide with the first appearance of
cells with exposed PS, however the numbers of cells with exposed PS increased at a
faster rate. At 4 h, for example, 27% of cells had exposed PS but only 7.5% had
depolarised mitochondria.
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Figure 3.9: The percentage of HL60 cells with exposed PS at the cell surface as a
function of time after induction of apoptosis with 20 ug/mL etoposide. PS exposure was
measured as an increase in cell-associated annexin V-FITC fluorescence (as described in
section 2.B.6.1) and was first detected at 4 h. Dead cells were identified by 7 A A D
staining (as described in section 3.B.2.7.1) and excluded from analyses. Data points
represent the m e a n of triplicate measurements. Error bars representing the S E are in all
cases too small to be visible. Results are representative of m a n y independent
experiments.

3.C.1.3

Degradation of D N A

D N A degradation occurs in two stages in apoptosis. Initially, D N A is degraded into
large fragments of 300 kbp and 50 kbp which are then cleaved into internucleosomal
fragments that are multiples of 180-200 bp in length. Degradation of DNA into high
molecular weight fragments was detected by pulsed field gel electrophoresis (PFGE)
followed by ethidium bromide staining of gels and UV transillumination. DNA
laddering, characteristic of internucleosomal fragmentation, was detected by standard
agarose gel electrophoresis using 1.6% gels. In some cases, DNA loss was also measured
by flow cytometry using a published Pi-staining protocol [Nicoletti, 1991].

68

3.C.1.3.1

High Molecular Weight Fragmentation of D N A

The initial degradation of DNA was evidenced by a smear of high molecular weight
DNA on a pulsed field gel (Fig 3.10). This change was apparent by the time of first
sampling, 1 h after addition of etoposide to HL60 cells. Resolution of a faint 50 kbp

band was possible by 2 h after induction of apoptosis. This band increased in intensit

by 3 h, coinciding with the appearance of lower molecular weight bands, forming part of
a DNA ladder. The early high molecular weight stages of DNA degradation can only be
resolved by PFGE and occurs rapidly after treatment of HL60 cells with etoposide, well
before the detection of DNA ladders on a standard gel.

M 0 1 2 3 4h

50 kbp

Figure 3.10: Pulsed field gel electrophoresis showing high molecular weight
fragmentation of D N A in H L 6 0 cells induced to undergo apoposis by etoposide.
Cellular D N A was analysed at various times following exposure of cells to etoposide.
Purification and analysis of D N A was performed as described in Section 3.B.2.5.I. High
molecular weight degradation of D N A wasfirstdetected at 1 h. A faint 50 kbp band
observed at 2 h intensified by 3 h with concomitant extensive D N A degradation into
internucleosomal fragments. D N A from 2x10 6 cells was loaded in each lane. M =
molecular weight marker (X D N A ) .
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3.C.1.3.2

Internucleosomal Fragmentation of D N A

Using standard agarose gel electrophoresis, internucleosomal DNA fragmentation was

first detected (as a DNA "ladder") in etoposide-treated HL60 cells 3 h after induction
apoptosis. DNA fragmentation was not detected in untreated (control) cells (Fig. 3.11).

M con 2 3 4 6 con 6 h

800 bp

Figure 3.11: Standard agarose gel electrophoresis showing internucleosomal D N A
fragmentation in H L 6 0 cells as a function of time after addition of etoposide.
Degradation of D N A wasfirstdetected by 3 h in etoposide-treated cells and was not
observed in control cells at 0 or 6 h. Purification and analysis of D N A was performed as
described in Section 2.B.10. D N A from 2x10 6 cells was loaded in each lane. M =
molecular weight marker (100 bp ladder).

3.C.1.3.3

Flow Cytometric Assay for Loss of Nuclear D N A

The PI assay for loss of nuclear DNA was found to be an insensitive detection method
for reduction in nuclear DNA. Although internucleosomal fragmentation was observed

on agarose gels at 3 h after addition of etoposide to HL60 cells, nuclei with an inten

of fluorescence below that of the G0/G, peak of control cells were not detected until 1

h (Fig. 3.12). By 6 h there was a loss of the G2/S peak, indicating that actively divid
70

cells were selectively targeted by etoposide treatment. However the reduction in D N A

content of these cells was insufficient to reduce PI fluorescence intensity to the extent
that it was detected as a hypodiploid region. Therefore, although DNA degradation was
obviously taking place, the staining method was insensitive to the changes. This
insensitivity was not caused by the use of FL-2 AAV gating of nuclei. Without this
gating, there was no evidence of nuclei with less than Go/Gj levels of DNA until 10 h

after initiation of etoposide treatment, when events with very low levels of fluorescence
were detected (not shown). The low intensity of fluorescence of these events, as well as
their low FSC/SSC characteristics suggest that this population consisted of cellular
debris. The initial detection time for these low fluorescence events was again well after
DNA ladders were detected on agarose gels.
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Figure 3.12: Flow cytometry histogram overlays comparing the PIfluorescencelevel of
nuclei from etoposide-treated H L 6 0 cells (red line) with that of control nuclei (black
line). The loss of fluorescence corresponding to G 2 /S cells by 6 h after addition of
etoposide (A) indicates that cells in this stage of the cell cycle are selectively targetted
by etoposide. Nuclei with hypodiploid PI fluorescence were not observed until 14 h (B)
after addition of etoposide. Nuclei were stained as described in Section 3.B.2.6.I.
Results are representive of triplicate assays from 2 independent time courses.
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3.C.1.4

Activation of Caspase-3

The activation of caspase-3 was detected by two different methods. Firstly, SDSPAGE was used to separate proteins from cell lysates (section 2.B.8) and the presence
of the 32 kDa caspase-3 proenzyme was detected by immunoblot using an anti-caspase3 antibody (Section 2.B.9). The anti-caspase-3 antibody used did not detect the
presence of the p-17 and p-12 cleavage products and despite the testing of various
commercial antibodies purported to detect these fragments, a suitable antibody for
detection of the appearance of these fragments was not available for this work. A
decrease in the amount of procaspase-3 detected was taken as indicating activation of
caspase-3 via cleavage of the proenzyme. The second method employed a fluorogenic
assay based on the liberation of the fluorescent AMC molecule from DEVD-AMC by
active caspase-3-like enzymes (Section 2.B.7.1). The relative amount of fluorescence
generated in the presence and absence of a specific inhibitor, DEVD-CHO, gives an
indication of the degree of activation of caspase-3-like enzymes.

3.C.1.4.1 Immunoblot Detection of Caspase-3 Activation
Caspase-3 activation in etoposide-treated HL60 cells began by 3 h as evidenced by a
decrease in the amount of the inactive 32 kDa pro-caspase-3 detected (Fig 3.13). By 4 h
a substantial loss of the proenzyme indicated that most of the cellular caspase-3 had
been activated.
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Figure 3.13: Immunoblot showing activation of caspase-3 in HL60 cells induced to
undergo apoptosis with etoposide. The presence of inactive procaspase-3 was detected
as a function of time using an anti-caspase-3 antibody as described in Section 2.B.9.
Activation of caspase-3 occurs by 3 h as evidenced by a decrease in the amount of procaspase-3 detected. The result is representative of 3 independent experiments.

3.C.1.4.2 Fluorogenic Assay for Measurement of Activation of Caspase3-like Enzymes
Caspase-3-like activity was detected by fluorogenic assay 2 h after the initiation of
etoposide treatment (Fig. 3.14). The fluorescence levels of lysates assayed in the
presence of DEVD.CHO were reduced to backgound level. This indicates that the
observed fluorescence is caused by the presence of activated caspase-3-like enzymes.
The activation time detected by this assay is earlier than that indicated by
immunoblotting, suggesting that either (i) the fluorogenic assay is more sensitive than
the immunoblot assay or (ii) other caspase-3-like enzymes capable of cleaving DEVDAMC are activated prior to caspase-3.
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Figure 3.14: T i m e course for activation of caspase-3-like enzymes in etoposide-treated
H L 6 0 cells. Caspase-3-like activity was detected at 2 h after the addition of etoposide
(red line) as indicated b y the increase in fluorescence intensity. T h e fluorescence
intensity of lysates incubated in the presence of the specific caspase inhibitor
D E V D . C H O (green line) is reduced to background levels (blue), indicating that the
measured activity is specifically due to caspase-3-like enzymes. T h e assay w a s
performed as described in Section 2.B.7.I. Data points represent the m e a n of triplicate
assays. Error bars reresenting the S E are in all cases too small to be visible. Results are
representative of 3 independent experiments.

3.C.1.5

Immunofluorescence Detection of Cytochrome c Release
from Mitochondria

Release of cytochrome c from mitochondria to the cytosol w a s detected b y
immunofluorescence staining of fixed, permeabilised cells (described in 3.B.2.8.1).
Release of cytochrome c was observed as a shift from the punctate fluorescence typical
of mitochondrial staining, to a diffuse cellular fluorescence located throughout the
cytosol (Fig. 3.15). The specificity of staining was verified by the complete lack of
fluorescence observed in cells in which the anti-cytochrome c primary antibody was
replaced with an isotype-matched control antibody (results not shown).
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Figure 3.15: Scanning laser confocal images indicating the release of cytochrome c from
the mitochondria of etoposide-treated H L 6 0 cells to the cytosol. Immunofluorescent
staining of cytochrome c in healthy control H L 6 0 cells (a) shows the punctate
distribution typical of mitochondrial localisation. The release of mitochondrial
cytochrome c is indicated by a change to diffuse cytosolic fluorescence in cells treated
by etoposide for 2 h (b; white arrows). Cells were stained as described in section
3.b.2.8.1. Images are representative of m a n y obtained for each of 2 independent
experiments
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Data obtained from fluorescence microscopic observation of cells immunofluorescently
labelled to enable visualisation of cytochrome c is presented in Table 3.1. Cytochrome c

was initially released to the cytosol of etoposide-treated HL60 cells 2 h after initiatio
of treatment. The percentage of cells that showed released cytochrome c increased
dramatically by 3 h of treatment. A high percentage of cells at this time point were
observed by bright field microscopy to exhibit the characteristic morphological changes
of apoptosis, including cell shrinkage, membrane blebbing and apoptotic body
formation. The percentage of cells that had depolarised mitochondria was determined by
flow cytometric analysis after DiOCe staining (Section 2.B.4.1). Table 3.1 shows that
the percentage of cells with depolarised mitochondria remained at the control cell level

until 3 h after initiation of etoposide treatment. Significant numbers of cells exhibited
depolarised mitochondria by 4 h. Comparison of this data with that for release of
cytochrome c indicates that cytochrome c is released from etoposide-treated HL60 cells
before mitochondrial depolarisation is initiated.

Table 3.1: The percentages of etoposide-induced H L 6 0 cells with (i) depolarised
mitochondria and (ii) cytosolic cytochrome c as a function of time after induction.

Time (h)
% cells with
depolarised
mitochondria
% cells with
cytosolic
cytochrome c

0

1

2

7.52 ±0.16 6.96 ± 0.05 8.09 ± 0.23

3

4

10.64 ±0.97 28.06 ± 0.46

0.46 ±0.17 0.16±0.10 6,60 ± 0.98 41.0 ±4.96

NA

Data for the percentages of cells in which cytochrome c was released to the cytosol
were calculated from cell counts obtained from each of 5fieldscontaining at least 200
cells/field and expressed as the mean ± SE. Results for the percentages of cells with
depolarised mitochondria were derived from triplicate D i O C 6 assays (section 2.B.4.1)
from the same time course and were quantified using CellQuest software. Results are
representative of 2 independent time courses.
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3.C.2

The Inhibition of Apoptotic Changes by B A

Bongrekic acid ( B A ) is a ligand of the adenine nucleotide translocator that putatively
forms part of the mitochondrial PT pore complex. BA binding changes the conformation
of the ANT, reducing the probability of PT pore opening. The occurrence of
mitochondrial PT results in a loss of A^t which can be measured using lipophilic,
cationic dyes such as DiOC6. The ability of BA to inhibit mitochondrial depolarisation
in etoposide-induced HL60 cells was tested. The presence of BA was found to
substantially inhibit the loss of A^mit with the maximal effect being seen at 8 h after
induction of apoptosis, when BA inhibited the loss of A¥mit from 31% to 10% (Fig
3.16).
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Figure 3.16: The percentage of H L 6 0 cells with depolarised mitochondria as a function
of time after induction with etoposide. Cells were treated with etoposide (red bars), or
with etoposide and B A (green bars) or left untreated (white bars). Mitochondrial
depolarisation w a s measured as described in section 2.B.4.1 and wasfirstdetected at 4.5
h. The presence of B A substantially inhibited loss of AY m i t . Dead cells were identified
by 7 A A D staining (as described in section 3.B.2.7.1) and excluded from analysis. Data
points represent the mean of triplicate measurements. Error bars represent the SE.
Results are representative of 4 independent experiments.
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After establishing the efficacy of B A at inhibiting loss of A T m i t , the effect of this
inhibition on other apoptotic changes induced in HL60 cells by etoposide, including PS
exposure, DNA degradation and caspase-3 activation, was assessed.

3.C.2.1

Effect B A on P S Exposure

Exposure of P S was marginally inhibited by B A (Fig 3.17), with the effect being greater
in the early stages after induction of apoptosis. Only at 4.5 h was there a significant
level of inhibition, reaching 49% at this time (p<0.01).
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Figure 3.17: The percentage of H L 6 0 cells with externalised P S as a function of time
after induction with etoposide. Cells were treated with etoposide (red bars), with
etoposide and B A (green bars) or left untreated (white bars). Exposure of P S w a s
measured as described in section 2.B.6.1 and wasfirstdetected at 4.5 h. The presence of
B A partially inhibited P S exposure. Dead cells were identified by 7 A A D staining (as
described in section 3.B.2.7.1) and excluded from analysis. Data points represent the
m e a n of triplicate measurements. Error bars represent the SE. Results are representative
of 2 independent experiments.
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3.C.2.2

Effect of B A on Degradation of D N A

The effect of BA on the apoptotic degradation of DNA in etoposide-treated HL60 cells

was assessed by pulsed field and standard agarose gel electrophoresis. The presence of
BA had no effect on the timing or extent of either high molecular weight DNA
fragmentation (Fig 3.18) or internucleosomal DNA fragmentation (Fig 3.19). High
molecular weight DNA degradation was initiated 1 h after induction of apoptosis,
whereas internucleosomal fragmentation was evidenced by the appearance of a DNA
ladder 3 h after induction.
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Figure 3.18: Pulsed field gel electrophoresis showing high molecular weight
fragmentation of D N A in etoposide-induced H L 6 0 cells in the presence and absence of
B A . Genomic D N A was analysed at various times following exposure of cells. High
molecular weight cleavage of D N A wasfirstdetected at 1 h. The faint 50 kbp band
observed at 2 h intensified at 3 h and more extensive D N A degradation with resolution
of internucleosomal fragments was observed at 4 h. Purification and analysis of D N A
was performed as described in Section 3.B.2.5.I. D N A from 2xl0 6 cells was loaded into
each lane. M l = molecular weight marker (X D N A ) . M 2 = 100 bp D N A ladder. Results
are representative of 4 independent experiments.
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Figure 3.19: Standard agarose gel electrophoresis showing internucleosomal D N A
fragmentation in H L 6 0 cells as a function of time after addition of etoposide or
etoposide and B A . Degradation of D N A was first detected at 3 h in the presence or
absence of B A . Purification and analysis of D N A was performed as in Section 2.B.10.
D N A from 2x10 6 cells was loaded into each lane. M = molecular weight marker (100 b p
ladder). Results are representative of 3 independent experiments.

3.C.2.3 Effect of BA on Activation of Caspase-3
The effect of BA on the activation of caspase-3 in etoposide-treated HL60 cells was
assessed by SDS-PAGE-immunoblotting and by fluorogenic assay. Results from both
assays showed that caspase-3 activation was unaffected by the presence of BA.

Caspase-3 activation was detected 3 hours after etoposide treatment began and resulted
in almost complete loss of the proenzyme by 4 h of treatment, when assayed by

immunoblotting. There was no change in the apparent level of activation in the presenc
of BA (Fig. 3.20).
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Figure 3.20: Immunoblot showing activation of caspase-3 in H L 6 0 cells induced to
undergo apoptosis with etoposide with or without B A . Activation of caspase-3 occurs
by 3 h as evidenced by a decrease in the amount of pro-caspase-3 detected. T h e
activation of caspase-3 w a s unaffected by B A . The presence of the inactive procaspase3 was detected as a function of time using an anti-caspase-3 antibody as described in
Section 2.B.9. The result is representative of 3 independent experiments.

Fluorogenic assay for caspase-3 activation showed an increase influorescenceafter 2 h

of etoposide treatment. This is consistent with the immunoblot results, since it is likel
that the fluorogenic assay is more sensitive. In agreement with the immunoblot results,
the activation of caspase-3 was unaffected by the presence of BA (Fig. 3.21).
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Figure 3.21: Time course for activation of caspase-3-like enzymes in etoposide-treated
H L 6 0 cells. Caspase-3-like activity was defected after 2 h of etoposide treatment (red
line) as indicated by the increase in fluorescence intensity. The timing and extent of
caspase-3-like activation w a s unaffected by the presence of B A (blue line). T h e
fluorescence intensity of lysates incubated in the presence of the specific caspase
inhibitor D E V D . C H O (green line) is reduced almost to background levels (blue),
indicating that the measured activity is specifically that of caspase-3-like enzymes. T h e
assay was performed as described in Section 2.B.7.I. Data points represent the mean of
triplicate assays. Error bars reresenting the S E are in all cases too small to be visible.
Results are representative of 3 independent experiments.
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3.C.2.4

Effect of B A on Cytochrome c Release

BA had no effect on the timing or extent of releas#of cytochrome c from mitochondria
in etoposide-induced HL60 cells (data not shown^The fact that inhibition of A*vmit had

no effect on the release of cytochrome c, and thatedepolarisation of mitochondria occurs
after release of cytochrome c, indicate that?#T is not involved in the release of
cytochrome c in this system.

3.C.3 Induction of Apoptosis in HL60 cells using Staurosporine
In order to determine if the observed order of apoptotic events for etoposide-treated
HL60 cells was specific to the inducing agent, time courses were set up in which HL60
cells were induced to undergo apoptosis with staurosporine, a protein kinase inhibitor.

To determine if the order of events was cell-type specific, Jurkat cells were also induc
to undergo apoptosis by etoposide (Section 4.C.5). The chronology of high molecular
weight and internucleosomal DNA fragmentation, mitochondrial depolarisation and PS
exposure was determined for staurosporine-induced HL60 cells.

3.C.3.1 The Chronology of Loss of ATmJt and Exposure of PS
The timing of mitochondrial depolarisation in relation to PS exposure in staurosporineinduced HL60 cells was determined by 2-colour flow cytometric analysis of cells
stained with CMX-Ros and annexin V-FITC. The first time point at which cells

exhibited a loss of AH^t was 3 h, with very few cells affected until 4 h after inductio
of apoptosis (Fig. 3.22). Loss of A^m{t was preceded by the exposure of PS at the cell
surface, which was first detected in induced cells at 2 h.
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Figure 3.22: 3-D plots representing flow cytometric analyses of staurosporine-treated
H L 6 0 cells at different times following induction. Cells in untreated cultures (A) had
fully polarised mitochondria and no exposure of P S at the cell surface. Cells treated with
staurosporine for 3 h (B), 4 h (C) and 6 h (D) displayed a progressive increase in PS
exposure, followed by a loss of AT m it which wasfirstobserved at 3 h after induction of
apoptosis. Cells were stained with C M X - R o s and annexin V-FITC by the method
described in Section 3.B.2.3.I. Data was analysed using CellQuest software. Results are
representative of 2 independent time courses.

3.C.3.2 DNA Degradation
The degradation of DNA in staurosporine-treated HL60 cells was analysed by PFGE
and standard agarose gel electrophoresis and by flow cytometric analysis of isolated
nuclei after staining with PI. The degradation of DNA into high molecular weight
fragments was first detected 1 h after staurosporine treatment (Fig 3.23). At this time
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point a 50 kbp band was clearly resolved. B y 2 h, intemuclesomal D N A degradation
was visible on both pulsed field and standard gels (Fig 3.24) as a DNA ladder. Both high
molecular weight and internucleosomal DNA fragmentation occurred before
mitochondrial depolarisation, thus the sequence of these apoptotic events in
staurosporine-treated HL60 cells was the same as that for etoposide-treated HL60 cells,
indicating that the observed effects were not specific to the inducing agent.
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Figure 3.23: Pulsed field gel electrophoresis showing high molecular weight
fragmentation of D N A in staurosporine-induced H L 6 0 cells. D N A was analysed at
various times following induction. High molecular weight degradation of D N A was first
detected at 1 h with resolution of a 50 kbp band which intensified with time. B y 2 h,
more extensive D N A degradation was observed with resolution of internucleosomal
fragments. Purification and analysis of D N A was performed as described in Section
3.B.2.5.I. D N A from 2xl0 6 cells was loaded into each lane. M l = molecular weight
marker pi D N A ) . M 2 = 100 bp D N A ladder. Results are representative of 2
independent experiments.
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Figure 3.24: Standard agarose gel electrophoresis showing internucleosomal DNA
fragmentation in H L 6 0 cells as a function of time after the addition of staurosporine.
Degradation of D N A wasfirstdetected at 2 h. Purification and analysis of D N A was
performed as described in Section 2.B.10. D N A from 2x10 6 cells was loaded into each
lane. M = molecular weight marker (100 bp ladder). Results are representative of 3
independent experiments.

DNA loss was also assessed by flow cytometric analysis of Pi-stained nuclei. Again
this method proved to be an insensitive indicator of DNA degradation. The first time
point at which nuclei having hypodiploid levels of DNA were detected was 4 h after
induction of apoptosis. At this time point only 5% of nuclei had hypodiploid DNA
content (Fig. 3.25). This was 2 h after internucleosomal degradation was detected by
standard agarose gel electrophoresis.
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Figure 3.25: Flow cytometry histogram overlay of PI stained nuclei from untreated
H L 6 0 cells (black profile) and cells that had been induced to undergo apoptosis by 10 h
of treatment with 2 u M staurosporine (red profile). Nuclei with reduced D N A were
first detected 4 h after initiation of staurosporine treatment. Nuclei were stained as
described in Section 3.B.2.6.I. Results are representive of triplicate assays from 2
independent experiments.

3.C.3.3

Inhibition of Mitochondrial Depolarisation by B A

Mitochondrial depolarisation in staurosporine-treated H L 6 0 cells was inhibited by B A .
This inhibition is consistent with the loss of A^mit in this system being caused by PT
(Fig. 3.26).
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Figure 3.21: Flow cytometry histogram overlays showing inhibition of loss of AYmJt in
staurosporine-treated H L 6 0 cells by B A . Cells were left untreated (black line),
incubated for 11 h in the presence of staurosporine (red line) or in the presence of
staurosporine and B A (green line). The loss of A T m i t was measured as a reduction in
cell-associated D i O C 6 fluorescence (as described in section 2.B.4.1).
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3D

DISCUSSION

During the execution phase of apoptosis independent pathways initiated during the
induction phase by a range of physiological and toxic stimuli are translated into a
common pathway of biochemical changes and cells become committed to die. The
occurrence of mitochondrial PT has been proposed to constitute a critical triggering
event in the execution phase of apoptosis [Marchetti, 1996a]. Much of the data relating
to determination of execution phase events in apoptosis that have led to the
development of the two models presented in Section 1.A.13 were acquired from studies
of cell-free systems. The relevance of these models to physiological systems can be
tested by performing time course studies with intact cells. The relative timing of
apoptotic events allows determination of the validity of each of the two proposed
models of the execution phase of apoptosis in each cell system studied. The suggestion
by Kroemer et al. [Kroemer, 1997b] that PT is a critical execution phase event in all cell
systems, was assessed by inhibiting PT using BA and analysing changes induced in the
apoptotic program.

When HL60 cells are induced to undergo apoptosis by the topoisomerase II inhibitor,
etoposide, high molecular weight DNA fragmentation is the first detectable change in
cells, occurring by the time of first sampling at 1 h. This is followed 2 h later by
internucleosomal DNA fragmentation. The release of cytochrome c from mitochondria is
initiated by 2 h, well before the first mitochondrial depolarisation is detected at 4 h. The
activation of caspase-3, as detected by immunoblotting, occurs after release of
cytochrome c from mitochondria. The extemalisation of PS at the cell surface, a
characteristic degradation phase event, is initiated at about the same time as loss of
A^mit, but cells are affected at a faster rate, so many more cells have exposed PS than
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have depolarised mitochondria at each time point. The sequence of events in this system
is compatible with model 2 (Fig 1.2), in which cytochrome c is released from
mitochondria before the loss of AWm[U suggesting that PT is not responsible for the
release of cytochrome c in this system. Since mitochondrial depolarisation takes place
after the degradation phase events of DNA fragmentation and PS exposure, it appears
that PT does not trigger execution or degradation phase events of etoposide-induced
HL60 apoptosis. To confirm this, BA was used to inhibit PT, and the effect of this
inhibition on other apoptotic events was determined. The presence of BA substantially
inhibited loss of AYmit, indicating that BA inhibited PT, however, the presence of B A
did not inhibit DNA fragmentation or the activation of caspase 3 and did not result in
significant inhibition of PS exposure. These data suggest that the early collapse of AYmit
as a consequence of PT is not a universal early marker for apoptosis and that, at least in
this system, PT is not a critical element in the execution phase of apoptosis.
Furthermore, BA-mediated inhibition of PT did not inhibit release of cytochrome c from
mitochondria, confirming that PT is not involved in the release of cytochrome c in this
system.

In order to assess whether the sequence of events observed in etoposide-induced HL60
cell apoptosis is cell-type or inducer-specific, apoptosis was induced in Jurkat T-cell
leukemia cells using etoposide and in HL60 cells using staurosporine. Staurosporine is a
protein kinase inhibitor and therefore probably induces apoptosis by a different
mechanism from that initiated by etoposide. The treatment of HL60 cells with
staurosporine induced apoptotic changes at a faster rate than was the case with
etoposide but the order of events was the same with both inducing agents. DNA
degradation occurred rapidly and was followed by exposure of PS. Both of these events
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preceded loss of AYmit, which occurred 1 h after the initiation of P S exposure.
Therefore, the loss of Aymit late in the course of apoptotic events is not an inducingagent-specific phenomenon in HL60 cells.

The timing of apoptotic events found for HL60 cells is compatible with that reported
by Wang et al. who showed that (i) in staurosporine-induced HL60 cells, cleavage of
PARP coincided with release of cytochrome c to the cytosol, both events preceding
mitochondrial depolarisation [Yang, 1997], and (ii) in etoposide-induced HL60 cells,
DNA fragmentation coincided with cytochrome c release [Liu, 1996]. Doubt had been
cast on the validity of the findings reported in these publications due to the use of
Rhodamine 123 to determine the timing of onset of mitochondrial depolarisation
[Metivier, 1998]. The intensity of cell-associated Rhodamine 123 fluorescence is not
necessarily a reflection of the mitochondrial transmembrane potential, as indicated by
the anomolous effects of CCCP on cell-associated fluorescence levels. Using 40 nM
DiOC6 as a probe of mitochondrial membrane potential, Kim et al. [Kim, 1997] in Ara
C-induced HL60 cells and Finucane et al. [Finucane, 1999b] in staurosporine-induced
HL60 cells, demonstrated that cytochrome c release and caspase-3 activation preceded
loss of ATmit. In the current work, staining conditions to measure A^mit were optimised
and the decrease in fluorescence intensity of DiOC6-stained cells was shown to reflect a
loss of A^mit. Cells were analysed in the staining solution, without washing, allowing
the equilibrium concentration of dye (which directly reflects the electrochemical gradient
following the Nemst equation) to be maintained during analysis of b^m\\. The current
results confirm and extend those reported by Wang et al. [Yang, 1997], indicating that
loss of A^mit in HL60 cells does not play a role in controlling either the onset of
degradative events or the release of cytochrome c. Tang et al. [Tang, 1998] have shown
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that cytochrome c release precedes P A R P

cleavage and D N A fragmentation in

staurosporine-induced apoptosis of HL60 cells. The current results for HL60 cells are in
agreement with these published results. These findings support a model for apoptosis in
HL60 cells based on PT-independent cytochrome c release (Model 2, Fig. 1.2).

It has been reported in many intact cell systems including HeLa cells [Bossy-Wetzel,
1998; Li, 1998; Yang, 1997] THP.l cells [Zhuang, 1998] and in anti-Fas and
staurosporine-treated Jurkat cells [Vander Heiden, 1997] that induction of apoptosis
causes a reduction in A'Fmit considerably later than cytochrome c translocation and
DNA fragmentation. Cytochrome c released in the absence of PT was reported in other
systems to activate DFF and lead to DNA fragmentation [Liu, 1997; Kluck, 1997a].
Mitochondria have been reported to spontaneously release cytochrome c in a cell-free
system, independently of changes in A^mit and therefore of mitochondrial PT [Kluck,
1997a]. The validity of the methods used for detection of loss of AYmit in some of these
reports is questionable, for example Yang et al. and Vander Heiden et al. had used the
probe Rhodamine 123 as an indicator of mitochondrial membrane potential (see above).
In another report, in which loss of ATmit was reported to occur later than translocation
of cytochrome c to the cytosol, mitochondrial staining using the mitotracker reagent
CMX-Ros was followed by washing of cells, paraformaldehyde fixation and storage
from 1-7 days before analysis [Bossy-Wetzel, 1998]. This protocol has been shown to
be invalid when using the almost identical dye CMX-Ros for the determination of
changes in A*Fmit in a range of cell types undergoing apoptosis [Gilmore, 1999]. The
reported delayed onset of mitochondrial depoarisation in these cell systems may be an
artifact of the staining technique, and needs to be confirmed using validated techniques.
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The results obtained for detection of D N A fragmentation show that the method of PI
staining of nuclei, in which the appearance of hypodiploid nuclei is used as a marker for
DNA

loss, is a relatively insensitive detection method. In each time course, gel

electrophoresis showed high molecular weight D N A fragmentation and internucleosomal
fragmentation several hours before D N A loss was detected by the PI assay. Although
loss of D N A can be detected as a loss of stained nuclei in the G 2 /S regions, the reduction
in PI fluorescence is insufficient to resolve the loss as hypodiploid D N A . This is
supported by the findings of Douglas et al. that apoptotic nuclei showing fluorescence
in the region equivalent to Gi, which are detected by this assay as having normal D N A
content, have already fragmented their D N A [Douglas, 1995]. The delayed detection of
D N A fragmentation by PI assay relative to detection by agarose gel electrophoresis was
also observed by Cossariza et al. in studies of dexamethasone-induced thymocytes
[Cossarizza, 1994]. This calls into doubt conclusions drawn from experiments in which
D N A degradation assessed by PI assay, was judged to be a late event in apoptosis
[Castedo, 1996; Zamzami, 1996b]. It was noted by Petit et al. [Petit, 1995] that PI
staining of nuclei underestimates the population of apoptotic thymocytes, however, in
reference to work by Kroemer et al. [Zamzami, 1995b], Petit et al. stated that a
reduction in A Y m i t had been shown to precede both high and low molecular weight
D N A fragmentation. Kroemer et al. [Zamzami, 1995b] had assessed D N A loss by PI
staining of nuclei only (which does not allow high molecular weight fragmentation of
D N A to be detected) and did not show or refer to any data in which D N A fragmentation
was preceded by a loss of AY m i t . The results of P F G E of H L 6 0 cells confirmed that
D N A fragmentation in this system occurs in two stages, the early high molecular weight
fragmentation that is resolvable only by P F G E preceding the second stage of
internucleosomal fragmentation that is resolved by standard D N A gel electrophoresis.
These results are in accordance with those of B r o w n et al. w h o reported that high
molecular weight fragmentation in etoposide- and dexamethasone-treated thymocytes
preceded internucleosomal D N A fragmentation by several hours [Brown, 1993]. In the
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case o f H L 6 0 cell apoptosis, both stages of D N A fragmentation were found to precede
loss Of A^;,.

The findings that inhibition of PT had no effect on the release of cytochrome c, and that
depolarisation of mitochondria occurs after release of cytochrome c provide evidence
that PT is not involved in the release of cytochrome c in this system.
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Chapter 4

Anti-Fas Antibody and Staurosporineinduced Apoptosis of Jurkat CeCCs
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4.A

INTRODUCTION

The apoptotic signalling pathways initiated by C D 9 5 (Apo-1/Fas) receptor binding have
been extensively characterised. Binding of either the oligomerising CD95 ligand

(CD95L) or the agonistic anti-CD95 antibody to the CD95 receptor results in activation
of caspases leading to cleavage of multiple proteins that regulate internucleosomal
DNA degradation. The CD95 receptor is expressed on many cell types including

peripheral T, B, and natural killer (NK) cells and on cell lines of T, B, NK and myelo
lineages. It is strongly upregulated on activated T, B and NK cells and activated
thymocytes. The receptor belongs to the nerve growth factor receptor/tumor necrosis
(NGF/TNF) receptor superfamily and consists of an extracellular binding domain,

containing three cysteine-rich regions, a membrane-spanning region and an intracellula
death domain comprising about 80 amino acids. The death domain is common to all
death receptors and is comprised of a signal transduction domain and an inhibitory
domain.

Binding of anti-CD95 antibodies or CD95L to the CD95 receptor triggers apoptosis via
a series of biochemical changes initiated by the formation of a multimeric deathinducing signalling complex (DISC) consisting of trimerised CD95, the Fas-associated
death domain (FADD) adaptor protein, the two isoforms of procaspase-8 (procaspase 8a
or FLICE/Mach 1 and caspase8b or Mach 2) and the protein CAP3 (cytoxicitydependent APO-1-associated protein) [Ashkenazi, 1998; Nagata, 1995; Peter, 1996]
(Fig. 4.1). Recruitment of these intracellular components to the death complex is

followed by a 2-step autocatalytic cleavage causing activation of caspase-8 to form a
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heterotetramer consisting of two plO fragments and two pi8 fragments. Activated
caspase-8 then dissociates from the DISC, leading to initiation of a caspase cascade in
which caspase-3 and -7 are activated, followed by activation of caspase-6. Activated
caspase-3 and -6 then cleave the proteins involved in nuclear apoptosis. Caspase-3
cleaves DFF45/ICAD to release DFF40/CAD which then enters the nucleus and intiates
internucleosomal cleavage of DNA [Sakahira, 1998],
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Figure 4.1: A schematic representation of the pathways involved in the activation of
caspase-8 following binding of either Fas ligand or anti-Fas antibody to the C D 9 5 (Fas)
receptor. Binding of Fas ligand or anti-Fas antibody to the Fas receptor (A) leads to
trimerisation of the receptor and recruitment of procaspase-8, F A D D and C A P - 3 to
form the death inducing signal complex (DISC) (B). Procaspase-8 is activated at the
D I S C via a two-step autocatalytic cleavage (C) and after dissociation, initiates a cascade
of caspase activation and cleavage in which caspase-3, -7 and -6 are activated.
The role of mitochondria in C D 9 5 signalling pathways appears to vary depending on

the cell type involved. Scaffidi et al. [Scaffidi, 1998] have identified two types of cells
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in which the role of mitochondria varies markedly. In type I cells, ligation of C D 9 5
receptors is immediately followed by high level activation of caspase-8, followed by
rapid (30 min) direct activation of caspase-3 which appears to proceed via a
mitochondria-independent pathway since it is not blocked by Bcl-2 overexpression. In

contrast, in type II cells, initial activation of caspase-8 occurs at a much lower level

Further activation of caspase-8 and activation of caspase-3 are later events, occurring
after loss of A^Vi, and are inhibited by Bcl-2 and

BC1-XL,

implying the involvement of

a mitochondria-dependent pathway. In type II cells, the reduction in AYmit is followed
by release of cytochrome c to the cytosol, leading to activation of caspase-9 and
subsequent activation of caspase-3. These events do not appear to be involved in

apoptosis of type I cells. It appears that type I cells activate an apoptosis signallin

pathway that depends solely on caspases, whereas in Type II cells (such as Jurkat cells)
apoptosis proceeds via other, mitochondria-dependent, pathways [Peter, 1998].

At the time of initiation of this project, although much was known about the role of the
Fas antigen system in regulating the immune system, little was known about the
signalling pathways or mechanisms leading to Fas-mediated apoptosis. An early report
by Weis et al. [Weis, 1995] detailed the chronology of cellular events in anti-Fas
antibody-treated Jurkat cells, including morphological changes such as membrane
blebbing and apoptotic body formation as well as the early high molecular weight
fragmentation and internucleosomal cleavage of DNA. Mitochondria were shown by
TEM to swell markedly at about the same time as extensive internucleosomal
fragmentation was observed. Since that time many reports have emerged detailing the
apoptotic events involved in Fas-mediated apoptosis.
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The aim of this part of m y project was to induce apoptosis in Jurkat cells using three
different inducing agents: the protein kinase inhibitor staurosporine a monoclonal antiFas antibody, and the topoisomerase II inhibitor etoposide, and to carry out time course
experiments to establish the sequence of apoptotic events and determine the role of
mitochondria in the apoptotic progam in these cell systems. A specific objective was to
determine whether mitochondrial depolarisation precedes and triggers degradation
phase events in each of these two systems. As part of this investigation, the relative
timing of mitochondrial depolarisation and cytochrome c release was measured and the
impact of inhibition of PT on cytochrome c release was determined in order to assess if
PT was likely to be involved in the mechanism of cytochrome c release in each system.
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4.B

MATERIALS A N D M E T H O D S

4.B.1 Materials

Staurosporine and digitonin were purchased from Sigma (Sydney, Australia) and the
Immunotech monoclonal anti-CD95 (Fas) antibody was purchased from BeckmanCoulter (Castle Hill, Australia). HRP-labelled sheep anti-mouse IgG (SAM-IgG) was
obtained from Silenus (CA, USA). Boehringer Apoptotic DNA Ladder Kit was
purchased from Boehringer-Mannhein (Sydney, Australia). The antibody to denatured
cytochrome c (clone 7H8.2C12) was kindly provided by Dr. Ron Jemmerson
(University of Minnesota Medical School, Minneapolis, MI) as lyophilised ascites
fluid.

4.B.2 Methods

4.B.2.1 Induction of Apoptosis
Jurkat cells were induced to undergo apoptosis by the addition of either 2 uM
staurosporine from a 1 mg/mL stock solution in DMSO, stored at -20°C, or by addition
of 100 ng/mL anti-CD95 antibody. After removal of initial samples, cells were returned
to standard culture conditions (37°C, 5% C02) and sampled hourly for assessment of
apoptotic changes.

99

4.B.2.2

Purification of G e n o m i c D N A

Jurkat cell genomic DNA was purified using a Boehringer Apoptotic DNA Ladder Kit
according to the manufacturer's instructions except that the initial elution volume was
halved to 100 uL in order td increase the concentration of eluted DNA. The initial
elution was followed by 2 further elutions of 100 and 200 uL respectively. The yield
from 2 x IO6 cells in the first fraction was approximately 10 ug DNA using this
protocol.

4.B.2.3 Digitonin Lysis of Cells and Fractionation of Cytosol
Cells were selectively lysed in the presence of two different concentrations of digitonin
according to the method of Single et al. [Single, 1998]. The presence of 35 ug of digitonin
per 4x106 cells was reported to selectively lyse only the plasma membrane of cells,
leaving the mitochondrial membranes intact. Cell lysis in the presence of 250 ug of
digitonin was reported to lyse both plasma and mitochondrial membranes. This method
enabled cells to be collected during time courses after induction of apoptosis and the
cytosol fraction collected without damaging the mitochondria. Subsequent SDS-PAGE
of the cytosol fraction, followed by immunoblot for detection of cytochrome c enabled
determination of the time point at which cytochrome c was released to the cytosol.

4.B.2.3.1 Method for Digitonin Lysis of Cells and Fractionation of Cytosol
4x106 cells were harvested by centrifugation (500g, 5 min), washed twice in PBS and
transferred to a 1.5 mL microcentrifuge tube. Cell were resuspended in 100 uL of ice-
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cold lysis buffer (75 m M N a C L , 1 m M N a H 2 P 0 4 , 8 m M N a 2 H P 0 4 , 250 m M sucrose)
containing either 0.35 mg/mL of digitonin (for intact mitochondria) or 2.50 mg/mL of
digitonin (for complete cell lysis). Cells were incubated for 30 s, then centrifuged at
9,000 g for 1 min at 4°C. The supernatant was transferred to a fresh tube and held on
ice. Protein concentration was assayed using the Bradford assay (Section 2.B.11).

4.B.2.4 Immunoblot for Detection of the Release of Cytochrome c to the
Cytosol
50 ug samples of whole cell lysates and cytosol fractions were loaded onto an SDSPAGE gel and electrophoresed as described in Section 2.B.8, followed by Western
transfer and immunoblotting as described in Section 2.B.9. Membranes were probed
with a 1 in 500 dilution of ascites fluid containing anti-cytochrome c followed by 0.56
ug/mL of HRP conjugated SAM-IgG, and the position of cytochrome c bands was
detected by ECL.
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4.C

EXPERIMENTAL RESULTS

4.C.1

Induction of Apoptosis in Jurkat Cells using Anti-Fas

Antibody

In order to determine the chronology of apoptotic events induced in Jurkat cells by anti

Fas antibody, time courses were set up in which untreated cells and cells in the presenc
of 10 ng/mL anti-CD95 were cultured in parallel. Where appropriate, to inhibit PT,
cultures were incubated in the presence of anti-Fas antibody and 100 uM bongkrekic

acid (BA). Triplicate aliquots of cells were taken at 0.5, 1, 1.5, 2, 3, 4 and 6 h after
induction of apoptosis. Time courses were repeated many times to ensure
reproducibility, the results shown are representative of the time courses performed.

4.C.1.1 Loss of Mitochondrial Membrane Potential (A^mjt) and
Extemalisation of Phosphatidylserine (PS)
When Jurkat cells were exposed to an anti-Fas receptor (CD95) antibody, cells showing
a reduced A^mit first appeared after approximately 1 h (Fig. 4.2). For the experiment
represented, at this time there were approximately 9.3% of cells with depolarised
mitochondria compared with 5.1% in control cultures. This percentage increased rapidly
to about 20%o at 1.5 h and by 4 h after initation of anti-Fas treatment approximately
66%» of cells were affected. The exposure of phosphatidyserine at the cell surface was
first detected by 1.5 h. For the experiment represented, at this time 8.5%> of anti-Fas

treated cells exhibited an increased green fluorescence due to the binding of annexin V-

FITC to the cell surface compared with 3.1% in control cultures. The percentage of cells
with exposed PS increased rapidly with time, reaching 18%> by 2 h and 70%> by 4 h after
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induction of apoptosis. The exposure of P S at the cell surface was only detected on
those cells that had undergone a loss in A*Pmit (Fig 4.2), indicating that mitochondrial
depolarisation occurred before PS exposure.

Figure 4.2: 3-D plots representing flow cytometric analysis of anti-Fas antibodytreated Jurkat cells at various times after induction. Cells in untreated cultures (A) had
high levels of C M X - R o s fluorescence indicating fully polarised mitochondria and low
levels of annexin V-FITC fluorescence indicating no exposure of PS at the cell surface.
Cells treated with anti-Fas antibody for 1 h (B), 2 h (C) and 4 h (D) showed a
progressive loss of A T m i t followed by an increase in P S exposure. Cells were stained
with C M X - R o s and annexin V-FITC by the method described in Section 3.B.2.3.I.
Data w a s analysed using CellQuest software. Results are representative of triplicate
assays from 2 independent time courses.
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4.C.1.1.1

T h e Effect of B A on Depolarisation of Mitochondria

Bongkrekic acid, a known inhibitor of PT, was used to test whether PT was acting as a
trigger for DNA fragmentation and the other apoptotic events measured. Initially, the
effect of BA on mitochondrial depolarisation was measured, in order to validate it's use
as an inhibitor of PT in the Jurkat/anti-Fas antibody system. However, it was found
that rather than inhibiting the loss of ATmit, from 1-3 h after induction, the presence of
BA significantly enhanced the proportion of Jurkat cells with depolarised mitochondria
(p<0.05) (Fig. 4.3).

pr

r
"1

<
O

o
7

7
/
/

JJ ;:
CD
O

r£brf r£ r' n::;
0

0.5

1

1.5

2

3

4

time (hrs)
Figure 4.3: The percentage of Jurkat cells with depolarised mitochondria as a function
of time after induction with anti-Fas antibody. Cells were left untreated (white bars),
treated with anti-Fas antibody (red striped bars) or with anti-Fas antibody and B A
(green bars). Mitochondrial depolarisation was measured as described in Section 2.B.4.I.
In this cell system, B A did not inhibit loss of A^mit but, at 1-3 h after induction,
increased the proportion of cells with depolarised mitochondria (p<0.05). In m a n y cases
error bars representing the S E are too small to be visible. Results are representative of 3
independent experiments.
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4.C.1.1.2

T h e Effect of B A on the Extemalisation of P S

Because of the lack of inhibition of mitochondrial depolarisation by B A , it was not
anticipated that the other measured apoptotic events would be affected by the presence
of this PT inhibitor. The percentage of anti-Fas antibody-treated Jurkat cells with
exposed PS at the cell surface was not inhibited by BA. As was the case for
mitochondrial depolarisation, the presence of BA had a significant stimulatory effect on
PS exposure from 1 to 3 h (p<0.03) (Fig. 4.4).
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Figure 4.4: The percentage of Jurkat cells with bound annexin V-FITC as a function of
time after induction with anti-Fas antibody. Cells were left untreated (white bars),
treated with anti-Fas antibody (red striped bars) or with anti-Fas antibody and
bongkrekic acid (green bars). Exposure of phosphatidylserine was measured as described
in Section 2.B.6.I. In this cell system B A did not inhibit exposure of PS but, at 1-3 h
after induction, significantly increased the proportion of cells with exposed PS
(p<0.03). Error bars represent the SE, which in m a n y cases are too small to be visible.
Results are representative of 2 independent experiments.

4.C.1.2

Degradation of D N A

The initial degradation of D N A into high molecular weight fragments was analysed b y
pulsed field gel electrophoresis (PFGE) whereas standard agarose gel electrophoresis
was used to detect internucleosomal DNA fragmentation.
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4.C.1.2.1

High Molecular Weight Fragmentation of D N A

Resolution of a 50 kbp band was possible by 1 h after induction of apoptosis (Fig. 4.5)
This band increased in intensity by 1.5 h and by 2 h the appearance of lower molecular
weight fragmentation was apparent. The early high molecular weight stages of DNA

degradation occur rapidly after treatment of Jurkat cells with anti-Fas antibody and a
least 1 h before the appearance of DNA ladders on a standard gel. The presence of B A

had a slight stimulatory effect on the degradation of DNA in anti-Fas antibody-treated
Jurkat cells as detected by an increase in the amount of DNA less than 50 kbp at 2 h
(Fig. 4.5).
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Figure 4.5: Pulsed field gel electrophoresis showing high molecular weight
fragmentation of D N A from Jurkat cells induced to undergo apoposis by ligation of
anti-Fas antibody in the presence or absence of B A . Purification and analysis of D N A
was performed as described in Section 3.B.2.5.I. High molecular weight degradation of
D N A wasfirstdetected by 1 h with the appearance of a 50 kbp band in the presence or
absence of B A . D N A from 2xl0 6 cells was loaded into each lane. M = molecular weight
marker (k D N A ) . Result is representative of 2 independent experiments.
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4.C.1.2.2

Internucleosomal Fragmentation of D N A

Internucleosomal fragmentation of DNA was first detected 2 h after induction of
apoptosis by anti-Fas antibody with further DNA laddering visible by 3 and 4 h (Fig.
4.6). The presence of BA stimulated the degradation of DNA in anti-Fas antibody-

treated Jurkat cells as detected by the increase in intensity of DNA ladders at 2 and 3
indicating that more cells had undergone internucleosomal DNA fragmentation in the
presence of BA than in its absence.
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Figure 4.6: Standard agarose gel electrophoresis showing internucleosomal D N A
fragmentation after the addition of anti-Fas antibody in the presence or absence of B A .
Degradation of D N A wasfirstdetected by 2 h in anti-Fas antibody-treated cells but
was not observed in control cells. The presence of B A appeared to stimulate D N A
fragmentation. Purification and analysis of D N A was performed as in Section 2.B. 10. 10
ug of D N A was loaded into each lane. M = molecular weight marker (100 bp ladder).
Result is representative of 2 independent experiments.

4.C.1.3

Activation of Caspase-3

The activation of caspase-3 was detected by both immunoblot (Section 2.B.9) and b y
fluorogenic assay (Section 2.B.7.1).
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4.C.1.3.1

Immunoblot Detection of Caspase-3 Activation

The proteolytic activation of caspase-3, evidenced by disappearance of the 32 kDa proenzyme band measured by immunoblot analysis, was first detected 3 h after the
induction of apoptosis (Fig. 4.7). Activation was rapid with the almost complete
disappearance of the proenzyme band at this time. The presence of BA appeared to
slightly stimulate the activation of caspase-3. In the presence of anti-Fas only, the
almost complete loss of the inactive proenzyme at 3 h indicates the proteolytic
activation of the enzyme at this time. In the presence of BA, there appeared to be some
reduction in the amount of inactive proenzyme at 1.5 and 2 h, with complete
disappearance of the proenzyme at 3 h.
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Figure 4.7: Immunoblot showing activation of caspase-3 in Jurkat cells induced to
undergo apoptosis by ligation of anti-Fas antibody in the presence or absence of B A .
The presence of the inactive procaspase-3 was detected as a function of time using an
anti-caspase-3 antibody as described in Section 2.B.9. Activation of caspase-3 occurred
by 3 h as evidenced by the almost complete disappearance of procaspase-3 at this time.
The result is representative of 2 independent experiments.

4.C.1.3.2 Fluorogenic Assay for Activation of Caspase-3-Iike Enzymes
Caspase-3-like activity was detected by fluorogenic assay 2 h after the initiation of
treatment with anti-Fas antibody, the amount of activated enzyme increasing until 4 h
(Fig. 4.8). The fluorescence levels of lysates assayed in the presence of DEVD.CHO
were reduced to backgound level, indicating that the measured fluorescence was caused
by activated caspase-3-like enzymes. The activation time detected by this assay is
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earlier than that indicated by immunoblotting, suggesting that either (i) the fluorogenic
assay is more sensitive than the immunoblot assay or (ii) other caspase-3-like enzymes
capable of cleaving DEVD-AMC are activated prior to caspase-3. The effects of BA
were not tested in this assay.
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Figure 4.8: Time course for the activation of caspase-3-like activity in lysate prepared
from anti-Fas antibody-treated Jurkat cells. Caspase-3-like activity was detected 2 h
after the addition of anti-Fas antibody (red line) as indicated b y an increase in
fluorescence. T h e fluorescence of lysates incubated in the presence of the specific
caspase inhibitor D E V D . C H O (green line) was reduced, demonstating that the measured
activation w a s specifically due to the activation of caspase-3-like enzymes The assay
was performed as described in Section 2.B.7.I. Data points represent the mean of
triplicate assays. Error bars represent the SE. In m a n y cases, the S E are too small to be
visible. Results are representative of 4 independent experiments.

4.C.1.4

Activation of Caspase-8-like Activity

The activation of caspase-8 w a s detected by a microplate fluorogenic assay measuring
IETD.AMC cleavage activity (Section 2.B.7). This method measures the activation of
caspase-8-like enzymes by the relative amount of fluorescence generated in the presence
and absence of a specific inhibitor of caspase-8 (IETD-CHO). The background
fluorescence level is that generated by cell lysates in the absence of the fluorogenic
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substrate. Caspase-8-like activity w a s present in cell lysates b y the time of first
sampling at 30 min after addition of anti-Fas antibody to cells (Fig. 4.9). The activity
increased rapidly after 1 h and persisted at a high level until 6 h after induction of
apoptosis. The effects of BA were not tested in the assay.
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Figure 4.9: Time course for activation of caspase-8-like activity in anti-Fas treated
Jurkat cells. Caspase-8-like activity is activated within 30 m i n after the addition of antiFas antibody (red line), indicated b y an increase influorescence.T h efluorescenceof
lysates incubated in the presence of the specific caspase inhibitor I E T D . C H O (green
line) is reduced almost to background levels (blue line), indicating that the measured
activity is specifically that of caspase-8-like enzymes. The assay w a s performed as
described in Section 2.B.7.I. Data points represent the m e a n of triplicate assays. Error
bars reresenting the S E are too small to be seen. Results are representative of 3
independent experiments.
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4.C.1.5

Immunofluorescence Detection of Cytochrome c Release

from Mitochondria
Immunofluorescence labelling of cytochrome c enabled its release from mitochondria to
the cytosol to be monitored by fluorescence microscopy and scanning laser confocal
microscopy. Release of cytochrome c was observed as a shift from the punctate

fluorescence typical of mitochondrial staining, to a diffuse cellular fluorescence locate
throughout the cytosol (Fig. 4.10). The specificity of staining was verified by the
complete lack of fluorescence observed in cells in which the anti-cytochrome c primary
antibody was replaced by an isotype-matched control antibody (results not shown).

A B

Figure 4.10: Scanning laser confocal images which indicate the release of cytochrome c
from the mitochondria of anti-Fas treated Jurkat cells to the cytosol. Immunofluorescent
staining of cytochrome c in healthy control Jurkat cells (a) shows the punctate
distribution typical of mitochondrial localisation. The release of mitochondrial
cytochrome c is indicated by a change to diffuse cytosolic fluorescence in cells treated
by anti-Fas antibody for 2 h (b; white arrows). Cells were stained as described in
section 3.b.2.8.1. Images are representative of m a n y obtained for each of 2 independent
experiments
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Data obtained from fluorescence microscopic observation of cells immunofluorescently
labelled to enable visualisation of cytochrome c is presented in Table 4.1. Cytochrome c

was initially released to the cytosol of anti-Fas antibody-treated Jurkat cells by 1 h af
initiation of treatment, with 5% of cells being affected at this time. The percentage of
cells that showed released cytochrome c increased dramatically by 2 h of treatment to
36%o. A high percentage of cells at this time point were observed by bright field
microscopy to exhibit the characteristic morphological changes of apoptosis, including
cell shrinkage, membrane blebbing and apoptotic body formation. The percentage of
cells that had depolarised mitochondria in the same experiment was determined by
parallel flow cytometric analyses of DiOC6 stained cells. Table 4.1 shows that anti-Fas
antibody-treated Jurkat cells had begun to exhibit depolarised mitochondria 1 h after

initiation of etoposide treatment, with 13.5% of cells over and above control levels being
affected at this time. Cytochrome c release therefore occurs at the same time as
mitochondrial depolarisation in anti-Fas-treated Jurkat cells. The effects of BA were not
tested in this assay.
Table 4.1: Data for anti-Fas-treated Jurkat cells showing (i) the % of cells with
depolarised mitochondria and (ii) the % of cells with cytosolic cytochrome c, as a
function of time following induction.
Time (h)
% cells with
depolarised
mitochondria
% cells with
cytochrome c
released

0

1

2

3

4

3.8 ±0.32

17.3 ±0.72

27.6 ± 1.10

43.8 ±1.13

51.1±10.52

0.0±0.0

4.9±0.25

36±1.67

NA

NA

Data for the percentages of cells in which cytochrome c was released to the cytosol
were calculated from cell counts obtained from each of 5fieldscontaining at least 200
cells/field and expressed as the m e a n ± S E (Section 3.B.2.8.1). Results for the percentage
of cells with depolarised mitochondria were derived from triplicate D i O C 6 assays
(section 2.B.4.1) from the same time course and were quantified using CellQuest
software. Results are representative of 2 independent time courses.
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4.C.2

Induction of Apoptosis in Jurkat Cells using Staurosporine

The chronology of mitochondrial depolarisation, exposure of phosphatidylserine at the
cell surface, activation of caspase-3 and degradation of DNA induced in Jurkat cells by
staurosporine was determined from time courses that were set up with parallel cultures
of untreated cells, cells treated with 2 ]xM staurosporine and cells treated with 2 ^M

staurosporine and 100 uM bongkrekic acid. Triplicate aliquots of cells were taken at 0.5,
1, 1.5, 2, 3, 4 and 6 h after induction of apoptosis for flow cytometric analyses and
single samples for the remaining analyses. Time courses were repeated many times to
ensure reproducibility, the results shown are representative of the time courses
performed.

4.C.2.1 Loss of Mitochondrial Membrane Potential (A^mit)
When Jurkat cells were exposed to staurosporine, cells showing a reduced AYmit first
appeared after approximately 1 h (Fig. 4.11) with a significant difference from control

cultures first occurring by 2 h. At this time, for the experiment represented, there were
approximately 14.7% of cells with depolarised mitochondria compared with 7.8% in
control cultures. This percentage increased gradually to about 19%. at 3 h and then more
rapidly to reach 73% by 8 h after initiation of staurosporine treatment.
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time (h)

Figure 4.11: The percentage of Jurkat cells with depolarised mitochondria as a function
of time after initiation of treatment with staurosporine, estimated as described in Section
2.B.4.I. Jurkat cells were either left untreated (blue line) or treated with 2 u M
staurosporine (red line). Mitochondrial depolarisation wasfirstdetected by 2 h. Data
points represent the average of triplicate measurements taken at each time point. Error
bars representing the S E are too small to be visible. Results are representative of 7
independent experiments.

4.C.2.1.1

T h e Inhibition of Mitochondrial Depolarisation by B A

The effect of BA on mitochondrial depolarisation was measured by flow cytometric
analysis of DiOC6 stained cells. Fig. 4.12 shows the time course for loss of A*Pmit in
Jurkat cells induced to undergo apoptosis by staurosporine in the presence or absence
of BA. Bongkrekic acid was very effective at inhibiting the loss of A»Fmit, indicating
successful inhibition of PT. In the absence of BA, mitochondrial depolarisation was first
detected 1 h after induction of apoptosis. For the experiment represented, the
percentage of cells with depolarised mitochondria increased to 53%> by 4 h and to 83%
by 6 h. In the presence of BA, the onset of depolarisation was retarded so that the
percentage of affected cells did not increase significantly until 3 h after induction of
apoptosis, reaching 9.0 % at this time compared with 2.5% in control cultures. The

1 14

percentage of cells with depolarised mitochondria at 6 h was only 2 3 . 6 % in the presence
of BA compared to 83% in its absence, indicating a 74% inhibition of depolarisation.
The level of inhibition of A¥mit loss was significant at 2 h and at all later times after
induction of apoptosis (p<0.05, Student's t-test).
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Figure 4.12: The percentage of staurosporine-treated Jurkat cells with depolarised
mitochondria as a function of time after induction. Cells were left untreated (white bars),
treated with staurosporine (red striped bars) or with staurosporine and B A (green bars).
Mitochondrial depolarisation was measured as described in Section 2.B.4.I. B A
significantly inhibited the loss of AT m it from 2 h onwards after induction of apoptosis
(p<0.05, Student's t-test). Error bars representing the S E are too small to be visible.
Results are representative of 3 independent experiments.

4.C.2.2.

Exposure of P S at the Cell Surface

The exposure of phosphatidyserine at the cell surface was first detected by 1 h (Fig.
4.13). At this time, for the experiment represented, 10%> of staurosporine treated cells
exhibited an increased green fluorescence due to the binding of annexin V-FITC to the
cell surface compared with 5.7%> in control cultures. The percentage of cells with
exposed PS increased rapidly with time, reaching 61% by 4 h and 72% by 8 h after
induction of apoptosis. Cells with reduced A^mit and cells with exposed PS first
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appeared in samples taken at 1 h. Two-colour staining with C M X - R o s and annexin VFITC showed a population of cells that had depolarised mitochondria, but had not yet
exposed PS at the cell surface, suggesting that mitochondrial depolarisation occurs
marginally before PS exposure (data not shown).

time (h)

Figure 4.13: The percentage of Jurkat cells with exposed PS at the cell surface as a
function of time after initiation of treatment with staurosporine, estimated as described
in Section 2.B.6.I. Cells were either left untreated (blue line) or treated with 2 u M
staurosporine (red line). Exposure of P S was first detected by 1 h. Data points
represent the average of triplicate measurements taken at each time point. Error bars
representing the S E are too small to be seen. Results are representative of 5 independent
experiments.

4.C.2.2.1

T h e Effect of B A on P S Extemalisation

The exposure of phosphatidylserine at the cell surface was inhibited by B A (Fig. 4.14).
When Jurkat cells were induced with staurosporine , in the experiment represented, cells
with exposed PS were first detected at 1 h, increasing rapidly to reach 36% of cells by 3
h after induction and 82% by 6 h. In the presence of BA, the first cells exhibiting
exposed PS were detected at 1 h but the percentage of cells affected was reduced at each
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time point, reaching 2 9 % at 3 h and 6 5 % at 6 h. The level of inhibition of PS exposure

was significant at 2 h and at all later times after induction (p<0.05, Student's t-test).
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Figure 4.14: The percentage of Jurkat cells with bound annexin-V-FITC as a function
of time after imduction. Cells were left untreated (white bars), treated with
staurosporine (red striped bars) or with staurosporine and B A (green bars). Exposure of
phosphatidylserine was measured as described in Section 2.B.6.I. B A significantly
inhibited P S exposure at 2 h and at all later times (p<0.05, Student's t-test). Error bars
represent the SE, which in some cases are too small to be visible. Results are
representative of 3 independent experiments.

4.C.2.3 Degradation of DNA
High molecular weight fragmentation, internucleosomal fragmentation and loss of DNA
were detected in staurosporine-treated Jurkat cells.

4.C.2.3.1 High Molecular Weight Fragmentation of DNA
Resolution of a faint 50 kbp band was possible 1 h after induction of apoptosis (Fig.
4.15). This band increased in intensity by 1.5 h and by 2 h the appearance of lower
molecular weight fragmentation was apparent. The early high molecular weight stages of
DNA degradation occured rapidly after treatment of Jurkat cells with staurosporine and
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at least 1 h before the appearance of D N A ladders on a standard gel. The presence of
BA inhibited the early high molecular weight fragmentation of DNA. The inhibitory

effect of BA can be seen in the diminished intensity of the 50 kDa band observed by 1 h
and continuing through to 4 h (Fig 4.15), accompanied by the diminished intensity of
lower molecular weight fragmentation observed by PFGE from 2-4 h.

50 kbp

Figure 4.15: Pulsed field gel electrophoresis showing high molecular weight
fragmentation of D N A from Jurkat cells induced to undergo apoptosis by staurosporine
in the presence or absence of B A . Purification and analysis of D N A was performed as
described in Section 3.B.2.5.I. High molecular weight degradation of D N A was first
detected by 1 h with the appearance of a 50 kbp band. The presence of B A inhibited the
degradation of D N A to 50 kbp bands and to lower molecular weight fragments. D N A
from 2x10 6 cells was loaded into each lane. Result is representative of 4 independent
experiments.

4.C.2.3.2

Internucleosomal Fragmentation of D N A

Internucleosomal fragmentation of DNA was first detected 2 h after induction of
apoptosis by staurosporine (Fig. 4.16). The proportion of cells with fragmented DNA

increased at 3 and 4 h as evidenced by an increase in band intensity at these times. B
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inhibited internucleosomalfragmentationof D N A in staurosporine-induced Jurkat cells.
The onset of internucleosomal cleavage was delayed by BA, appearing at 3 h, rather

than at 2 h as it does in the absence of BA. The decreased intensity of DNA ladders at 3
h indicates that fewer cells had undergone internucleosomal fragmentation of DNA at
this time.
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Figure 4.16: Results of standard agarose gel electrophoresis showing internucleosomal
fragmentation of D N A extracted from Jurkat cells after induction of apoptosis by
staurosporine in the presence or absence of B A . The presence of B A inhibited
internucleosomalfragmentationof D N A . Degradation of D N A was first detected by 2 h
in staurosporine-treated cells but was not observed until 3 h in the presence of B A .
Purification and analysis of D N A was performed as in Section 2.B.10. 10 ug of D N A
was loaded into each lane. M = molecular weight marker (100 bp ladder). Result is
representative of 4 independent experiments.
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4.C.2.3.3

PI Assay for Loss of D N A

The flow cytometric PI assay for loss of DNA was tested with staurosporine-treated
Jurkat cells to confirm the findings obtained with etoposide-treated HL60 cells. For
etoposide-induced HL60 cells, the method was found to be insensitive to high molecular
weight fragmentation and to the initial stages of internucleosomal fragmentation of DNA

(section 3.C. 1.3.3). In the case of staurosporine-treated Jurkat cells, DNA loss did not
reach a detectable level until 6 h after induction of apoptosis (Fig. 4.17), whereas
internucleosomal DNA fragmentation was detected by standard agarose gel
electrophoresis 2 h after induction (Fig. 4.16). These results confirmed the lack of
sensitivity of the method for assessment of the time of onset of DNA degradation.
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Figure 4.17: Flow cytometry histogram overlays comparing the PI fluorescence level of
nuclei from staurosporine-treated Jurkat cells (red line) with that of control nuclei (black
line). Nuclei with fluorescence levels below that of normal diploid D N A were first
detected at 6 h (when FL-2 A A V gating was used to exclude cellular debris). Nuclei were
stained as described in Section 3.B.2.6.I. Results are representative of triplicate assays
from 2 independent time courses.

4.C.2.4

Activation of caspase-3

The activation of caspase-3 was detected by both immunoblotting (Section 2.B.9) and
by fluorogenic assay of DEVD.AMC cleavage activity (Section 2.B.7.1).
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4.C.2.4.1

Immunoblot Detection of Caspase-3 Activation

The proteolytic activation of caspase-3, as evidenced by partial disappearance of the 32
kDa pro-enzyme band, was first detected 3 h after induction of apoptosis (Fig. 4.18).
The activation of the enzyme was complete by 4 h, as evidenced by complete
disappearance of the proenzyme band at this time. The activation of caspase-3 in Jurkat
cells treated by staurosporine was inhibited by the presence of BA (Fig. 4.18).
Immunoblotting with anti-caspase-3 antibody to detect the disappearance of the
inactive proenzyme in cells treated with staurosporine only showed that caspase-3 was
activated by 3 h, whereas in the presence of BA the disappearance of the proenzyme
did not occur until 4 h.

32 k D a

Figure 4.18: Immunoblot showing the activation of caspase-3 in Jurkat cells induced to
undergo apoptosis by staurosporine. The presence of the inactive procaspase-3 was
detected as a function of time using an anti-caspase-3 antibody as described in Section
2.B.9. Activation of caspase-3 occurs by 3 h as evidenced by a reduction in intensity of
the procaspase-3 band at this time. The disappearance of the proenzyme was inhibited
by B A . The result is representative of 2 independent experiments.
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4.C.2.4.2

Fluorogenic Assay for Measurement of Activation of Caspase-

3-like Enzymes
Caspase-3-like activity was detected by fluorogenic assay 2 h after the initiation of

staurosporine treatment, the amount of activated enzyme increasing until 4 h (Fig. 4.19).
The fluorescence levels of lysates assayed in the presence of DEVD.CHO were reduced
to backgound level, indicating that the observed fluorescence was caused by the
presence of activated caspase-3-like enzymes. The activation time detected by this
assay is earlier than that detected by immunoblotting, indicating that either (i) the
fluorogenic assay is more sensitive than the immunoblot assay or (ii) other caspase-3like enzymes capable of cleaving DEVD-AMC are activated prior to caspase-3. The
effects of BA were not tested in this assay.
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Figure 4.19: Time course for activation of caspase-3-like enzymes in staurosporinetreated Jurkat cells. Caspase-3-like activity w a s detected 2 h after the addition of
staurosporine (red line) as indicated an the increase in fluorescence intensity. T h e
fluorescence intensity of lysates incubated in the presence of the specific caspase
inhibitor D E V D . C H O (green line) is reduced almost to background levels (blue line),
indicating that the measured activity is specifically that of caspase-3-like enzymes. T h e
assay was performed as described in Section 2.B.7.I. Error bars representing the S E are
in most cases too small to be visible. Results are representative of 5 independent
experiments.

4.C.2.5

Immunofluorescence

Detection of Cytochrome c Release

from

Mitochondria
The release of cytochrome c from mitochondria to the cytosol was quantified after
immunofluorescence labelling of cytochrome c using an anti-cytochrome c primary
antibody and a secondary antibody labelled with Alexa-488 (Section 3.B.2.8.1). Data
obtained from fluorescence microscopic observation of untreated cells and cells induced
to undergo apoptosis by staurosporine is presented in Table 4.2. Cytochrome c was

initially released to the cytosol of staurosporine-treated Jurkat cells 1 h after initiati
of treatment, with 0.8% of cells being affected at this time. The percentage of cells that
showed released cytochrome c increased rapidly with 14.3% of cells being affected by 2
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h of treatment and 4 3 % by 3 h. The percentage of cells that had depolarised
mitochondria was determined in the same experiment by parallel flow cytometric
analyses of DiOCg stained cells. (This data was obtained independently to that
presented in Section 4.C.2.1). Table 4.2 shows that staurosporine-treated Jurkat cells
had begun to exhibit depolarised mitochondria 1 h after induction, with 2% of cells over
and above control levels (0 h) being affected. Mitochondrial depolarisation is therefore
first detected at the same time as cytochrome c release, however a higher percentage of
cells have depolarised mitochondria at each time. This may indicate that staurosporinetreated Jurkat mitochondria depolarise prior to cytochrome c release and that PT could
trigger cytochrome c release.

Release of cytochrome c from staurosporine-treated Jurkat mitochondria was inhibited
by BA. In the presence or absence of BA, the first cells to exhibit cytochrome c release
from mitochondria were observed 1 h after initiation of staurosporine treatment.
However, in the period 1.5-3 h after induction, the percentage of affected cells was
significantly reduced in the presence of BA (p<0.05) (Table 4.2). This correlated with
an inhibition of mitochondrial depolarisation in BA-treated cells which was
demonstrated by a significant reduction in the percentage of cells exhibiting a loss of
A¥mit at 3 h (p<0.05). The inhibition of mitochondrial depolarisation and concurrent
inhibition of cytochrome c release from mitochondria is evidence that PT is responsible
for cytochrome c release.
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Table 4.2: Data for staurosporine-induced Jurkat cells showing the % of cells with (i)
depolarised mitochondria and (ii) cytosolic cytochrome, as a function of time after
induction.

Time (h)

0
0.5
1
1.5
2
3

% cells with depolarised
mitochondria
staurosporine
+BA

% cells with released cytochrome
c
staurosporine
+BA

NA
NA

3.710.37

4.610.28

0.210.19

3.910.18

5.410.29

NA

5.910.25

5.610.10

0.810.10

0.310.14

16.010.75

15.910.20

4.810.74

1.410.37

15.210.85

17.811.33

14.311.68

2.410.48

26.910.09

9.710.18

43.010.84

14.511.51

Data for the percentages of cells in which cytochrome c was released to the cytosol
were calculated from cell counts obtained from each of 5fieldscontaining at least 200
cells/field and expressed as the mean ± S E (Section 3.B.2.8.1). Results for the percentage
of cells with depolarised mitochondria were derived from triplicate D i O C 6 assays
(section 2.B.4.1) from the same time course and were quantified using CellQuest
software. Results are representative of 2 independent time courses.

4.C.2.6 Verification of the Timing of Release of Cytochrome c by
Immunoblot Analysis

The release of cytochrome c to the cytosol was also detected by immunoblotting using
an antibody to denatured cytochrome c (ascites fluid, clone 7H8.2C12). Lysates from
untreated whole cells were prepared after incubation of cells with 2.5 mg/mL of
digitonin. Lysis of cells in a buffer containing 0.35 mg/mL of digitonin allowed
separation of intact mitochondria from the cytosol fraction (Section 4.B.2.3.1).

Immunoblot analysis of the cytosol fractions of cells induced to undergo apoptosis b

staurosporine allowed determination of the time point at which cytochrome c was firs

released to the cytosol (Section 4.B.2.4). A faint 13 kDa band was detected in cytoso

fractions at 1 h indicating initial cytochrome c release at this time (Fig. 4.20). Th

intensity increased by 2 and 3 h, indicating a larger fraction of cells in which cyt
c had been released to the cytosol The results of immunoblot analysis thus confirmed

results obtained using immunofluorescence labelling of fixed cells (Section 4.C.2.5).
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Figure 4.20: Immunoblot showing the time course of release of cytochrome c into the
cytosol of staurosporine-treated Jurkat cells. A whole cell lysate showing the intensity
of detection of total cellular cytochrome c was prepared using 250 ug/100 uL digitonin
lysis of untreated cells (first 0 h lane)(Section 4.B.2.3.1). Time course samples of
cytosol were prepared following cell lysis using 35 ug/100 u L digitonin. Cytochrome c
release to the cytosol wasfirstdetected at 1 h. The amount of cytosolic cytochrome c
increased at 2 and 3 h. The cytochrome c standard was 20 ng of bovine cytochrome c.

4.C.3 Induction of Apoptosis in Jurkat Cells using Etoposide
Jurkat cells were induced to undergo apoptosis using 20 ug/mL etoposide in order to
confirm that the chronology of DNA fragmentation and loss of A^mit in Jurkat cells
was independent of the inducing agent. The use of the topoisomerase II inhibitor
etoposide with the Jurkat cell line also allowed comparison of the chronology of these
events in Jurkat cells with the same events induced in HL60 cells using etoposide. This
allowed assessment of whether the observed chronology of apoptotic events were
inducing agent-specific or cell-type-specific.

4.C.3.1 Loss of mitochondrial membrane potential (A^Fmjt)

When Jurkat cells were exposed to etoposide, cells showing a reduced A^Pmit first
appeared after 5 h (Fig. 4.21) when, for the experiment represented, 5.9% of cells had
depolarised mitochondria compared with 3.2% of untreated cells, a statistically

significant difference (pO.01, Student's t-test). The percentage of cells with depolarise
mitochondria increased gradually to about 11.3% at 7 h and then more rapidly to reach
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78.7%) by 20 h after initiation of staurosporine treatment (Fig. 4.21). Thus, the long lag
phase before initiation of depolarisation is common to cells treated with etoposide.
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Figure 4.21: The percentage of Jurkat cells with depolarised mitochondria (estimated as
in Section 2.B.4.1) as a function of time after initiation of treatment with etoposide.
Cells were either untreated (green line) or treated with 20 ug/mL etoposide (red line).
Mitochondrial depolarisation w a sfirstdetected at 5 h. Error bars representing the SE
are too small to be seen. Results are representative of 2 independent experiments.

4.C.3.2

Internucleosomal D N A Fragmentation

The internucleosomal degradation of DNA was first detected 5 h after induction of
apoptosis in Jurkat cells by etoposide (Fig. 4.22). The DNA ladder that was faintly

visible at this time increased in intensity by 6 h, indicating that greater numbers of ce
had fragmented DNA, and persisted until at least 8 h after induction of apoptosis.
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Figure 4.23: Standard agarose gel electrophoresis showing the time course for
internucleosomal D N A fragmentation in etoposide-treated Jurkat cells. Degradation of
D N A wasfirstdetected at 5 h by the appearance of a D N A ladder. Purification and
analysis of D N A was performed as described in Section 2.B.11. 10 ug of D N A was
loaded into each lane. M = molecular weight marker (100 bp ladder). Results are
representative of 2 independent experiments.
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4D

DISCUSSION

W h e n Jurkat cells were exposed to an anti-Fas receptor antibody, the first change
detected was caspase-8-like activity which was initiated by 30 min after induction of
apoptosis. Cells showing a reduced ATmit first appeared after approximately 1 h,
coinciding with onset of cytochrome c release to the cytosol. The early-stage cleavage of
nuclear DNA into 50-300 kbp fragments, as measured by PFGE, was also detected by 1
h and was followed 1 h later by internucleosomal cleavage. Thus, high molecular weight
DNA degradation occurred at the same time as the release of cytochrome c to the
cytosol, whereas internucleosomal cleavage occurred later. The exposure of PS at the cell
surface was first detected at 1.5 h and was only detected on those cells that had already
undergone a loss of ATmit.

Proteolytic cleavage of caspase-3 was first detected by immunoblotting 3 h after

induction whereas the fluorogenic assay first detected caspase-3-like activation 2 h afte
induction. Both of these detection methods suffer from limitations, the former method
with respect to sensitivity and the latter method with respect to selectivity. The
detection of activation of caspase-3 by immunoblotting relies on observation of the
disappearance of a 32 kDa band corresponding to the inactive proenzyme. The inability

to resolve subtle differences in density of these bands renders the technique potentially
insensitive to initial changes in the amount of the proenzyme in cell lysates. This
problem could be circumvented by the use of an antibody that detects the pl2 and/or
pl7 cleavage products of procaspase-3, which would potentially provide greater
sensitivity.
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Despite testing m a n y commercial antibodies that were reputed to detect the cleavage
products, these fragments were not detected. The available system for immunoblot

detection, although being specific for caspase-3, suffered from a lack of sensitivity that
hampered studies of the chronology of apoptotic events. The fluorogenic detection of
caspase-3-like activity, while not absolutely specific for caspase-3, was intrinsically a
more sensitive assay for the presence of activated enzyme. Caspase-2 is known to be a
particularly poor catalyst of tetrapeptide substrate hydrolysis and although caspase-7
has the same optimal substrate specificity profile as caspase-3, it hydrolyses the AcDEVD-AMC substrate at only one tenth the rate of caspase-3 [Garcia-Calvo, 1999].
Therefore, the contribution of caspase-2 and caspase-7 to the measured caspase-3-like
activity is unlikely to be large. The fluorogenic assay detected activation of caspase-3like enzymes 2 h after induction of apoptosis by anti-Fas antibody, which is later than
cytochrome c release and at about the same time as internucleosomal DNA
fragmentation. Very similar results for the chronology of apoptotic events were
obtained when Jurkat cells were exposed to staurosporine, with the timing of apoptotic
changes being virtually the same in this system as for anti-Fas antibody-mediated
apoptosis. The activation of caspase-8 was not measured in the Jurkat/staurosporine
system.

In the case of etoposide-treated Jurkat cells, the reduction in ATmit and the coincident
internucleosomal DNA fragmentation did not occur until 5 h after induction of
apoptosis. Therefore, in Jurkat cells, mitochondrial depolarisation occurs at or slightly
before DNA fragmentation, whether the inducing agent is etoposide, staurosporine or
anti-Fas antibody. The order in which mitochondrial depolarisation and
internucleosomal DNA fragmentation occur in apoptosis induced by etoposide is cell-
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type specific. In the case of H L 6 0 cells, internucleosomal D N A fragmentation occurs
well before depolarisation, whereas in Jurkat cells, there is a coincidence of these two
events.

Bongkrekic acid did not inhibit the reduction of AY^t in Jurkat cells induced to undergo
apoptosis with anti-Fas antibody and did not inhibit any of the degradation events
tested, including activation of caspase-3, DNA fragmentation and PS exposure. BA
appeared to transiently stimulate the loss of AYmit and PS exposure and to stimulate
activation of caspase-3 and degradation of DNA into internucleosomal fragments. In
contrast, when apoptosis of Jurkat cells was induced by staurosporine BA was found

to significantly inhibit the reduction of AYmit, the release of cytochome c to the cytosol
DNA fragmentation into both 50-300 kbp and internucleosomal fragments, the
activation of caspase-3 and the exposure of PS at the cell surface.

The pattern of apoptotic events in Jurkat cells treated by staurosporine is consistent
with a model in which apoptotic degradation phase events are downstream of and
triggered by PT (Model 1, Section 1.A.13). It appears that the loss of ATmit is
necessary for the onset of degradative events in this system. The release of cytochrome
c in this system occurs prior to the degradation-phase events and is inhibited by BA,
indicating that the release of cytochrome c may be triggered by PT. BA-mediated
inhibition of PT, cytochrome c release and all other degradation-phase events is
consistent with cytochrome c release being a critical component of the apoptotic
program in staurosporine-treated Jurkat cells. Although the model of PT-dependent
apoptosis (Model 1, Section 1.A.13) relies on the PT-dependent release of proapoptotic proteins to cause the downstream activation of caspase-3 which in turn leads
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to D N A fragmentation, there has been little previous evidence from studies of intact
cells that caspase-3 activation depends on PT. The BA-mediated inhibition of
depolarisation (and presumably PT) in staurosporine-treated Jurkat cells led to a
downstream inhibition of caspase-3 activation, as detected by immunoblotting. BAmediated inhibition of caspase activation has also been reported for dexamethasone and
etoposide-induced thymocytes [Hirsch, 1997] and anti-Fas antibody-induced
neutrophils [Watson, 1999]. These publications and the current study provide evidence
that PT is sufficient to provoke downstream activation of caspase-3-like proteases.

Although the chronology of events is very similar for Jurkat cells treated with anti-Fas
antibody or staurosporine, there are significant differences between these two systems.
In the case of anti-Fas antibody-induced apoptosis, BA is ineffective at inhibiting the
loss of AYmjt and degradative phase events, appearing to at least transiently stimulate
these events. This may mean that, although the loss of ATmit precedes degradationphase events in the Jurkat/anti-Fas system, it is not responsible for triggering those
events. The collapse of AY^t during apoptosis is thought to result from mitochondrial
PT. This hypothesis relies on the demonstration that BA, a specific inhibitor of PT,
inhibits the loss of AYmit. The fact that in the Jurkat/anti-Fas antibody system, BA is
ineffective at inhibiting the loss of A¥mit suggests that mitochondrial depolarisation in
this system is not caused by PT. An alternative explanation is that loss of A^mjt is
caused by PT in this system, but that the mechanism by which PT is induced is not
affected by BA and therefore differs from that in staurosporine-treated Jurkat cells and
in etoposide-treated HL60 cells.
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The immediate activation of caspase-8-like enzymes and delayed activation of caspase3-like enzymes defected by fluorogenic assay in anti-Fas antibody-mediated apoptosis
is consistent with current models of caspase activation in this system. Activation of
caspase-8 occurs soon after ligation of the Fas receptor and is followed by the
subsequent proteolytic activation of caspase-7, -3 and -9 [Sun, 1999]. Caspase-8 has
been shown in vitro to induce PT in isolated mitochondria [Marzo, 1998b] and to
indirectly induce release of cytochrome c [Bossy-Wetzel, 1999; Kuwana, 1998]. It has
been shown that neither overexpression of Bcl-2 nor BA inhibited caspase-triggered PT
[Susin, 1997a]. Anti-Fas-induced apoptosis in Jurkat cells may involve upstream

activation of caspase-8 which directly (or indirectly via the activation of other caspase
leads to PT. The inability of BA to inhibit PT induced by caspases may explain the
failure of BA to inhibit the loss of AYmit during anti-Fas antibody-induced apoptosis of
Jurkat cells. The Bcl-2 family member Bid was recently identified as a substrate for
activated caspase-8 which after cleavage translocates to mitochondria and induces
release of cytochrome c, caspase-dependent loss of AT^t and downstream apoptotic
events [Li, 1998].

The results obtained in the current study for the timing of cytochrome c release,
mitochondrial depolarisation and internucleosomal DNA fragmentation in anti-Fas
antibody- and staurosporine-treated Jurkat cells are in conflict with those reported by
Vander Heiden et al. [Vander Heiden, 1997] who showed that induction of apoptosis
causes a reduction in AYmit considerably later than cytochrome c translocation and
DNA fragmentation. This anomaly may be a result of their use of Rhodamine 123 to
determine the timing of onset of mitochondrial depolarisation. The intensity of
fluorescence caused by uptake of this dye is not necessarily a reflection of the
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mitochondrial transmembrane potential, as indicated by the effects of C C C P on cellassociated fluorescence levels [Metivier, 1998]. Rhodamine 123 is not a reliable
indicator of AYmit [Cossarizza, 1994].

The results obtained for the Jurkat/anti-Fas antibody system are consistent with the
sequence of apoptotic events reported in Fas-treated CEM-C7.H2 lymphoma cells by
Susin et al [Susin, 1997a], who reported that loss of A^mit precedes PS exposure and
causes the release of AIF, causing the downstream activation of caspase-3 and nuclear
apoptosis. The inability of BA to inhibit mitochondrial depolarisation was also
consistent with the work of this group who reported that PT was mediated by caspase1 in this system, and was not inhibited by Bcl-2, nor by BA in an in vitro system
consisting of isolated mitochondria, induced to undergo PT by the presence of
recombinant ICE. The induction of PT by activated caspases in Fas antibody-induced
apoptosis in CEM-C7.H2 lymphoma cells was verified by the inhibition of PT
(detected as a loss of AYmit) by zVAD.cmk or by transfection with ICE inhibitor crmA
[Susin, 1997a].

Weis etal. [Weis, 1995] have shown that high molecular weight DNA fragmentation is

one of the earliest detectable events in anti-Fas antibody-induced Jurkat cell apoptosi

and that mitochondria appear structurally intact (by electron microscopy) until the tim
of onset of internucleosomal DNA fragmentation, when mitochondria were observed to
swell (perhaps corresponding to the onset of HCPT). In the current work,
mitochondrial depolarisation occurred after the onset of high molecular weight DNA
fragmentation and coincident with internucleosomal DNA fragmentation. The fact that
BA inhibits the loss of AYmit and both stages of DNA fragmentation suggests that DNA
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fragmentation in this system is triggered by loss of AY m i t . The demonstration that high
molecular weight DNA fragmentation precedes internucleosomal fragmentation is in
agreement with the results of Weis et al. [Weis, 1995] in anti-Fas-treated Jurkat cells
and also the work of Brown et al. in spontaneous or dexamethasone- or etoposideinduced apoptosis of thymocytes [Brown, 1993]. Both of these groups showed that the
high molecular weight fragmentation corresponded in time with the condensation and
fragmentation of chromatin, one of the earliest detectable morphological changes in
apoptosis.

The level of involvement of mitochondria in triggering apoptosis in Jurkat cells is thus
dependent on the nature of the inducing signal. In staurosporine-induced apoptosis of

Jurkat cells, degradative phase events took place after the initial loss of AYmjt while the
onset of cytochrome c release was coincident with this event. In this system the loss of
A^mit and the ensuing degradative events were inhibited by treatment with B A, a specific
ligand of the ANT, which is believed to be an important component of the PT pore
complex. In this system, it appears that the loss of AYmit, which presumably arises from

PT, is necessary to trigger the onset of degradative changes. The failure of BA to inhibit

loss of A^mit in anti-Fas antibody-treated Jurkat cells meant that the role of the loss of
mitochondrial membrane potential in triggering degradative changes in this system could
not be assessed, although the loss of A^mit before degradation phase events is consistent
with some degree of involvement. In this system, PT may be triggered by the upstream
activation of caspases, against which B A offers no protection.
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apter 5

tfltfFce- and Cycloheximide-induced
Apoptosis of11-937 Cetts
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5.A INTRODUCTION

Tumour necrosis factor alpha (TNFa) is a cytokine, produced primarily by activated
macrophages and lymphocytes in response to infection, that induces necrotic death of
cancer cells in vivo and apoptosis of a variety of cell lines in vitro. T N F a belongs to the
tumour necrosis factor/nerve growth factor ( T N F / N G F ) family of ligands, which also
includes Fas ligand (FasL), and which function in the regulation of cell death and
survival, defence against intracellular pathogens and regulation of lymphoid tissue
development. T h e family is a group of type II membrane proteins (excepting alymphotoxin, a secretory protein) which consist of both extracellular and cytoplasmic
domains. 2 0 - 3 0 % similarity is found between family members in the extracellular
domain, whereas the cytoplasmic domain is more variable. T N F a acts via binding to
either of two cell-surface receptors ( T N F R 1 or T N F R 2 ) to induce cell proliferation or
differentiation as part of the inflammatory response, or to induce apoptotic cell death.
Each of the T N F receptors consist of an extracellular region containing 4 cysteine-rich
domains, that are highly conserved within the T N F / N G F receptor family, and a
cytoplasmic region which is not conserved except for similarity between T N F R 1 and
Fas receptor across a region of about 70 amino acids (corresponding to the intracellular
death domain (DD)). This death domain is both necessary and sufficient for
transduction of the apoptotic signal [Nagata, 1995].

Ligands of the TNF receptors exist as homotrimers which occur predominantly in a
cell-bound form but which can be proteolytically shed from the cell surface as a less
potent free form. Binding of trimeric T N F a causes clustering of the monomeric T N F R 1
receptor, initiating signals that m a y lead to activation of the transcription factors
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NF-KB

and AP-1, causing induction of proinflammatory and immunomodulatory genes
[Ashkenazi, 1998].

In some cell types, usually transformed cells, binding of TNFa in the absence of prot
synthesis may lead to induction of apoptosis. Binding of TNFa trimerises the TNFR1
receptor through association of the receptor's intracellular death domains (DD)
[Wallach, 1998]. The TNFR1 receptor then recruits at least 4 adapter molecules via
interaction with their respective death domains: TRADD, MORT/FADD, RIP and
RAIDD/CRADD, which bind sequentially to each other and recruit the inactive
precursor forms of caspases-8, -10 and -2. Procaspase-8 and -10 bind to MORT1/FADD
via their common death effector domains (DED) [Fernandesalnemri, 1996] forming the

death inducing signal complex (DISC) which leads to their autocatalytic cleavage and
activation, initiating the apoptotic death process [Ledgerwood, 1999]. Procaspase-2
binds to and is activated at the CARD domain of RAIDD/CRADD [Duan, 1997].

TNFa has been shown to be involved in regulation of activities involved in nonapoptotic processes such as inflammation. These non-cytotoxic activities may be
modulated via binding of TRADD and RIP to the TRAF-2 protein which is devoid of
death domains and which binds 3 different groups of proteins (A20, clAPl and 2, and
NIK) which inhibit the death function of TNFa via different mechanisms [Wallach,
1998]. Cells exposed to TNFa, under conditions which allow protein synthesis can be

resist to TNFa cytotoxicity, perhaps via these pathways [Wallach, 1997]. Cells induce
to undergo apoptosis with TNFa are treated in the presence of the protein synthesis

inhibitor cycloheximide (CHX) or actinomycin D (Act D) in order to inhibit activatio
of these alternative, resistance-conferring pathways.
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The mechanisms by which activation of the upstream caspases-8, -10 and -2 participate
in TNFa-induced apoptosis, and the role of mitochondria in this process, have not yet
been clarifed. It has been shown that mitochondrial morphology and function are
rapidly altered following induction of apoptosis by TNFa. This was evidenced in L-929
cells by swelling [Matthews, 1983] and ultrastructural changes to mitochondria and

damage to the respiratory chain resulting in inhibition of electron transport [Schulze
Osthoff, 1992]. It has been proposed that TNFa cytotoxicity is mediated through

reactive oxygen intermediates generated during mitochondrial respiration. Support for

this proposal comes from demonstrations that (i) antioxidants protect cells from TNFa-

induced apoptosis [Schulze-Osthoff, 1994; Cossarizza, 1996b] and (ii) L-929 subclones

lacking a functional respiratory chain are resistant to TNFa cytoxicity [Schulze-Osth
1993].

The active role of mitochondria in apoptosis was not recognised until the recent
observation by Kroemer et al. that sequential reduction of mitochondrial
transmembrane potential and generation of reactive oxygen species was common to
many different models of apoptosis, including the U-937/TNFa system. The loss of
A%iit was shown to precede generation of ROS and nuclear DNA loss in this system
[Zamzami, 1995a; Marchetti, 1996b]. Loss of AWmit was also shown to precede DNA
fragmentation in TNFa/CHX-treated U-937 cells by Cossarizza et al. [Cossarizza,
1996b].

Activation of caspase-3 was shown to occur before DNA fragmentation in TNFatreated U-937 cells [Erhardt, 1996]. The requirement of functional mitochondria for
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activation of caspase-3 and induction of apoptosis in TNFa-treated M L - l a
(myelogenous leukemia) cells underscores the essential role of mitochondria in this
system [Higuchi, 1997].

At the time of initiation of this work, although much was known about the initial sign
transduction events in the TNFa pathway, little was known about the role of
mitochondrial changes in the apoptosis of TNFa/CHX-treated U-937 cells. The timing
of loss of AYmit and the role of PT in triggering other apoptotic changes such as PS
exposure and DNA fragmentation had not been extensively studied. The aim of this
section of work was to induce apoptosis in U-937 cells using TNFa/CHX and by

carrying out time course experiments to establish the sequence of apoptotic events an

establish the role of mitochondria in this system. BA was used to inhibit loss of PT in

order to determine if PT triggers degradation phase events in this system. The relati

timing of cytochrome c release and mitochondrial depolarisation was measured in order

to determine if PT is likely to be involved in the mechanism of cytochrome c release in
this system. The results of this study would contribute to a better understanding of
role of mitochondrial changes in TNFa/CHX-induced apoptosis.
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5B

MATERIALS AND METHODS

5B.1

Materials

Tumour necrosis factor-alpha (TNFa) was a gift from Dr. Simon Easterbrook-Smith
(University of Sydney, Australia) and cycloheximide (CHX) was obtained from Sigma
(Sydney, Australia).

5B.2 Methods

5.B.2.1 Induction of Apoptosis

Human myelomonocytic U-937 cells were induced to undergo apoptosis by the addition
of 10 ng/mL TNFa and 10 ug/mL CHX to culture medium in which cells were
incubated. TNFa was diluted from a 500 ug/mL stock solution kept at -80°C and CHX
from a 10 mg/mL stock solution in DMSO, kept at 20°C. Cells were harvested by
centrifugation (500g, 5 min) and resuspended in fresh DMEM:F12 supplemented with
10% FCS at a density of l-2xl06 cells/mL before addition of TNFa/CHX. After

removal of initial samples, cells were returned to standard culture conditions (37°
C02) and sampled at regular intervals for assessment of apoptotic changes.
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5C

RESULTS

5C.1

Induction of Apoptosis in U-937 Cells using TNFa/CHX

To allow determination of the chronology of apoptotic events induced in U-937 cells by
TNFa/CHX, time courses were set up in which untreated cells and cells in the presence
of 10 ng/ml TNFa and 10 ug/mL CHX were cultured in parallel. Where appropriate, to
inhibit PT, cultures were incubated in the presence of TNFa/CHX and 100 uM

bongkrekic acid. Triplicate aliquots of cells were taken at 0.5, 1, 1.5, 2, 3,4 and 6 h
induction of apoptosis. Time courses were repeated many times to ensure
reproducibility; the results shown are representative of the time courses performed.

5.C.1.1 Loss of Mitochondrial Membrane Potential (AYmit) and
Extemalisation of Phosphatidylserine (PS)
When U-937 cells were exposed to TNFa/CHX, cells showing a reduced ATmit first

appeared after 1 h (Fig. 5.1). At this time, for the experiment represented, there were
approximately 20% of cells with depolarised mitochondria compared with 5% in control

cultures. This percentage increased rapidly to about 50%> at 1.5 h and 78% by 2 h after
initation of TNFa/CHX treatment. The exposure of phosphatidyserine at the cell
surface was first detected by 1.5 h. At this time approximately 20% of TNFa/CHX-

treated cells exhibited an increased green fluorescence due to the binding of annexin V
FITC to the cell surface compared with 5% in control cultures. The percentage of cells
with exposed PS increased with time, reaching 32%> by 2 h and 57%> by 4 h after
induction of apoptosis. At 2 h after induction of apoptosis and at later time points,
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degradation of significant numbers of cells into apoptotic bodies and debris meant that
these cells were excluded from analyses (statistics quoted for flow cytometric analyses
refer to cell-sized events only). Simultaneous measurement of changes in AVmit (using
CMX-Ros), and PS exposure (using annexin V-FITC), demonstrated that only those

cells that had undergone a loss of A¥mit exposed PS at the cell surface, and therefore tha
loss of A»Fmit precedes exposure of P S (Fig. 5.1).

Figure 5.1: Density plots representing flow cytometric analyses of T N F a / C H X treated U-937 cells at various times after induction. At the initiation of treatment (A)
cells had high levels of C M X - R o s fluorescence indicating fully polarised mitochondria,
and low levels of annexin V-FITC fluorescence indicating no exposure of PS at the cell
surface. Cells treated with T N F a / C H X for 1 h (B), 2 h (C) and 4 h (D) show a
progressive loss of A^Pmit followed by an increase in PS exposure. Cells were stained
with C M X - R o s and annexin V-FITC by the method described in section 3.B.2.3. Data
was analysed using CellQuest software. Results are representative of triplicate assays
from 3 independent time courses.
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5.C.1.2

T h e Inhibition of Apoptotic Changes by B A

Bongkrekic acid, a k n o w n inhibitor of PT, was used to test whether P T was acting as a
trigger for DNA fragmentation and the other apoptotic events measured. Initially, the
effect of BA on mitochondrial depolarisation was measured, in order to validate it's
effectiveness as an inhibitor of PT in the TNFa/CHX system.

5.C.1.2.1

Effect of B A on Depolarisation of Mitochondria

BA was found to poorly inhibit the loss of ATmit (Fig. 5.2), with significant inhibition
occurring at 1 h and again at 4 and 6 h (P<0.05, Student's t-test), while the level of
inhibition at 2 and 3 h was not statistically significant at the 95%> confidence level
(P>0.1, Student's t-test).
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Figure 5.2: The percentage of U-937 cells with depolarised mitochondria as a function
of time after induction with T N F a / C H X . Cells were left untreated (white bars), treated
with T N F a / C H X (red striped bars) or with T N F a / C H X and B A (green bars).
Mitochondrial depolarisation was measured as described in section 2.B.4.I. In this cell
system, B A partly inhibited loss of A^mit at 1 h and also at 4 and 6 h (p<0.05). In most
cases error bars representing the S E are too small to be visible. Results are
representative of 6 independent experiments.

144

5.B.1.2.2

The Effect of B A on the Extemalisation of P S

Because of the lack of inhibition of mitochondrial depolarisation by BA, it was not

anticipated that the other measured apoptotic events would be affected significantly b
this PT inhibitor. The percentage of TNFa/CHX-treated U-937 cells with exposed PS
at the cell surface was partially inhibited by BA, the level of inhibition being
statistically significant only at 2 h and at 6 h (PO.05, Student's t-test) (Fig. 5.3).

80

FL I

60O

II

<D

408

/-i

20.

s

0 -

•T D d
0

1

2
3
time (h)

4

6

Figure 5.3: The percentage of U-937 cells with bound annexin v-FITC as a function of
time after induction with T N F a / C H X . Cells were left untreated (white bars), treated
with T N F a / C H X (red striped bars) or with T N F a / C H X and B A (green bars). Exposure
of phosphatidylserine was measured as described in section 2.B 6.1. B A significantly
inhibited the exposure of PS at 2 h and again at 6 h (p<0.06, Student's t-test). Error bars
represent the SE, which in m a n y cases are too small to be visible Results are
representative of 4 independent experiments.

5.C.1.3

Degradation of D N A

The initial degradation of D N A into high molecular weight fragments was analysed by
pulsed field gel electrophoresis (PFGE) whereas standard agarose gel electrophoresis
was used to detect internucleosomal D N A fragmentation.
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5.C.1.3.1

High Molecular Weight Fragmentation of D N A

A 50 kbp band was resolved 1.5 h after induction of apoptosis (Fig. 5.4). This band
increased in intensity by 2 h and was accompanied by the appearance of lower
molecular weight fragmentation. The early high molecular weight stages of DNA

degradation occur at least 0.5 h before the appearance of DNA ladders on a standard g

(Fig. 5.5). The presence of BA inhibited the degradation of DNA into 50 kbp fragments

and into lower molecular weight fragments (compare +BA vs. -BA lanes for 1.5 and 2 h,
Fig. 5.4).

50 kbp

0 0.5

1

Figure 5.4: Pulsed field gel electrophoresis showing high molecular weight
fragmentation of D N A from U-937 cells induced to undergo apoptosis by treatment
with T N F a / C H X in the presence or absence of B A . Purification and analysis of D N A
was performed as described in section 3.B.2.5.I. High molecular weight degradation of
D N A wasfirstdetected at 1.5 h with the appearance of a 50 kbp band. The intensity of
this band was reduced in the presence of B A . D N A from 2xl0 6 cells was loaded into
each lane. Results are representative of 2 independent experiments. M = molecular
weight marker (X D N A ) .

146

5.C.1.3.2

Internucleosomal Fragmentation of D N A

Internucleosomal fragmentation of DNA was first detected 2 h after induction of
apoptosis by TNFa/CHX, with further DNA laddering visible by 3 and 4 h (Fig. 5.5).
The inhibition of DNA fragmentation in the presence of BA seen on pulsed field gels
(Fig. 5.5) was observed on standard agarose gels as a slight reduction of intensity of
DNA bands at 2 h after induction. However, at 3 h and 4 h after induction of apoptosis,
there was no discernible difference in band intensity, indicating that the inhibition
DNA fragmentation was a transient effect.

Figure 5.5: Agarose gel electrophoresis showing internucleosomal D N A fragmentation
after the addition of T N F a / C H X in the presence or absence of B A . Degradation of
D N A wasfirstdetected by 2 h in TNFa/CHX-treated cells but was not observed in
control cells. B A had no effect on D N A fragmentation after 2 h. Purification and
analysis of D N A was performed as in section 2.B.10. 10 ug of D N A was loaded into
each lane. Results are representative of 2 independent experiments. M = molecular
weight marker (100 bp ladder).

147

5.C.1.4

Activation of Caspase-3

The activation of caspase-3 was detected by both immunoblot (Section 2.B.9) and by
fluorogenic assay of DEVD.AMC cleavage activity (section 2.B.7.1).

5.C.1.4.1

Immunoblot Detection of Caspase-3 Activation

The proteolytic activation of caspase-3, as evidenced by the disappearance of the 32
kDa pro-enzyme band, was first detected 1.5 h after the induction of apoptosis (Fig.

5.6). BA appeared to slightly inhibit caspase-3 activation, delaying the disappearance o
the proenzyme band detected on immunoblots from 1.5 h to 2 h after induction (Fig.
5.6).
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Figure 5.6: Immunoblot showing activation of caspase-3 in U-937 cells induced to
undergo apoptosis by T N F a / C H X in the presence or absence of B A . The presence of
the inactive procaspase-3 was detected as a function of time using an anti-caspase-3
antibody (section 2.B.9). Activation of caspase-3 occurred by 1.5 h as evidenced by the
complete disappearance of procaspase-3 at this time. B A partially inhibited activation
of the proenzyme. The result is representative of 2 independent experiments.

5.C.1.4.2

Fluorogenic Assay for Activation of Caspase-3-like Enzymes

Caspase-3-like activity was detected by fluorogenic assay 2 h after the initiation of
treatment with TNFa/CHX (Fig. 5.7). The amount of activated enzyme was maximal at
this time. This is compatible with the timing of caspase-3 activation determined by
immunoblot, both assays detecting complete activation between 1 and 2 h after
induction of apoptosis. The effects of BA were not tested in this assay.
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Figure 5.7: Time course for the activation of caspase-3-like activity in lysates prepared
from T N F a / C H X treated U-937 cells. Caspase-3-like activity was detected 2 h after the
addition of T N F a / C H X (red line). The fluorescence of lysates incubated in the presence
of the specific caspase inhibitor D E V D . C H O (green line) was reduced to background
level (blue line) indicating that fluorescence w a s specifically due to the activity of
caspase-3-like enzymes. The assay was performed as described in section 2.B.7.I. Data
points represent the mean of triplicate assays. Error bars representing the S E are in all
cases too small to be visible. Results are representative of 3 independent experiments.

Thus, in the U - 9 3 7 / T N F a / C H X

system, B A

partially inhibits mitochondrial

depolarisation PS exposure, DNA degradation and caspase-3 activation. The inhibition
appears to be a transient effect as the extent of DNA fragmentation was not affected by
BA 3 h after induction of apoptosis. The activation of caspase 3 was also retarded in
the presence of BA (as detected by immunoblot analysis). The demonstration that
partial and transient inhibition of TNFa/CHX-induced A^™, loss by BA produced
partial inhibition of PS exposure, DNA degradation and caspase-3 activation is
consistent with a role for PT in the control of apoptotic degradation in this system.
However, this remains to be established.
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5.C.1.5

Immunofluorescence Detection of Cytochrome c Release from

Mitochondria
Immunofluorescence labelling of cytochrome c enabled release of cytochrome c from
mitochondria to the cytosol to be monitored by fluorescence microscopy and scanning
laser confocal microscopy. Release of cytochrome c was observed as a shift from the

punctate fluorescence typical of mitochondrial staining, to a diffuse cellular fluoresce

located throughout the cytosol (Fig. 5.8). The specificity of staining was verified by t
complete lack of fluorescence observed in cells in which the anti-cytochrome c primary
antibody was replaced by an isotype-matched control antibody (results not shown).

Figure 5.8: Scanning laser confocal images which indicate the release of cytochrome c
from the mitochondria of TNFa/CHX-treated U-937 cells to the cytosol.
Immunofluorescent staining of cytochrome c in healthy control U-937 cells (A) shows
the punctate distribution typical of mitochondrial localisation. The release of
mitochondrial cytochrome c is indicated by a change to diffuse cytosolicfluorescencein
cells treated by T N F a / C H X for 2 h (B; white arrows). Cells were stained as described
in section 3.B.2.8.I. Images are representative of m a n y obtained for each of 2
independent experiments.
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Data obtained from fluorescence microscopic observation of cells immunofluorescently
labelled to enable visualisation of cytochrome c is presented in table 5.1. Cytochrome c
was initially released to the cytosol of TNFa/CHX-treated U-937 cells by 1.5 h after

initiation of treatment, with 2.6%> of cells being affected at this time. The percentage of
cells that showed released cytochrome c increased by 2 h of treatment to 16.5%. A high
percentage of cells at this time point were observed by bright field microscopy to
exhibit the characteristic morphological changes of apoptosis, including cell shrinkage,
membrane blebbing and apoptotic body formation. The percentage of cells that had
depolarised mitochondria in the same experiment was determined by parallel flow
cytometric analyses of DiOC6 stained cells (Section 2.B.4.1). Table 5.1 shows that
TNFa/CHX-treated U-937 cells had begun to exhibit depolarised mitochondria 1 h after
initiation of etoposide treatment, with 8.5% of cells being affected at this time,
compared with untreated control cultures in which 5% of cells had depolarised
mitochondria. Cytochrome c release therefore occurs after mitochondrial depolarisation
in TNFa/CHX U-937 cells. The effects of BA were not tested in this assay.
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Table 5.1:
Data for the depolarisation of mitochondria and the release of
cytochrome c to the cytosol of T N F a / C H X -treated U-937 cells.
Time (h)

0

0.5

1

1.5

2

3

% cells with
depolarised
mitochondria

5.010.76

5.310.36

8.510.38

13.810.4

30.812.6

41.313.2

% cells with
cytochrome
c released

0.0210.01

0.0310.02 0.0410.02

2.610.24

16.511.5

60.612.5

Data for the percentages of cells in which cytochrome c was released to the cytosol
were calculated from cell counts obtained from each of 5fieldscontaining at least 200
cells/field and expressed as the m e a n ± S E (section 3.B.2.8.1). Results for the percentage
of cells with depolarised mitochondria were derived from triplicate D i O C 6 assays
(section 2.B.4.1) from the same time course and were quantified using CellQuest
software. Statistically significant numbers of cells had depolarised mitochondria at 1 h
(P<0.005, Student's t-test) and had released cytochrome c to the cytosol at 1.5 h
(PO.001) w h e n compared with untreated cells. Results are representative of 2
independent time courses.
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5D

DISCUSSION

W h e n U-937 cells were exposed to T N F a in the presence of the protein synthesis
inhibitor cycloheximide, the first change detected was the loss of mitochondrial
transmembrane potential which was initiated 1 h after induction. This was followed
rapidly by release of cytochrome c to the cytosol. The activation of caspase-3 was
detected at the same time as release of cytochrome c and also at the same time as the
early-stage cleavage of DNA into 50 kbp fragments. This was followed 30 min later by
internucleosomal DNA fragmentation, 2 h after induction of apoptosis. The appearance

of the first cells with exposed PS at the cell surface was detected at 1.5 h after induc
and occurred only in those with reduced AY^.

When U-937 cells expose to TNFa and cycloheximide were co-incubated with the PT
inhibitor BA, the loss of AY,^ detected at 1 h was partially inhibited. This inhibition
was transient, however, as the degree of inhibition was not significant at later time
points. The presence of BA resulted in partial inhibition of PS exposure and partial
inhibition of caspase-3 activation. BA also partly inhibited the fragmentation of DNA
into 50 kbp fragments and the initial fragmentation of DNA into internucleosomal
fragments.

The pattern of apoptotic events in U-937 cells treated with TNFa/CHX is compatible
with a model in which apoptotic degradation phase events are downstream of PT
(Model 1, Section LA. 13). The results of this study are therefore in agreement with the
published findings of Kroemer et al. [Zamzami, 1995b; Marchetti, 1996b] and of
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Cossarizza et al. [Cossarizza, 1996b] in which loss of &¥mit preceded the loss of D N A
in this system. The activation of caspase-3 prior to DNA fragmentation that was found
in this study is compatible with previous findings of parallel DNA fragmentation and
caspase-3 activation in TNFa-treated U-937 cells [Erhardt, 1996]. The loss of A"¥mit
prior to release of cytochrome c to the cytosol is compatible with PT being involved in
the mechanism of cytochrome c release, although the lack of complete inhibition of loss
of A^mit by BA made it impossible to definitively determine whether PT was the trigger
for cytochrome c release. Partial, BA-mediated inhibition of caspase-3 activation, high
molecular weight DNA fragmentation and PS exposure suggests (but does not establish)
that PT may be involved in triggering these degradation-phase events.

The fact that BA, a specific inhibitor of PT, only partially inhibited loss of A¥mit
suggests that either (i) mitochondrial depolarisation in this system may not be entirely
the result of PT, or (ii) that the mechanisms inducing PT in this system may be only
partially sensitive to BA-mediated inhibition. Therefore this system has similarities to
the Jurkat/aFas antibody system, in that although the loss of &¥mit precedes
degradation phase events, it may not be the sole trigger for these events. The loss of
ATmit occurs by a BA-independent mechanism in the Jurkat/aFas system (section
4.C.2.1) and is only partially inhibitable by BA in the U-937/TNFa/CHX system. In
accordance with these results, it has been reported that cyclosporin A (CsA) (a PT
inhibitor) only partially inhibited mitochondrial PT and apoptosis in TNFa/Act Dtreated L-929 cells [Pastorino, 1996]. The demonstration that CsA in the presence of
aristocholic acid (a phospholipase A2 inhibitor) confened complete inhibition, indicated
that other mechanisms (in addition to PT) may be involved in inducing mitochondrial
depolarisation in this system [Pastorino, 1996],
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The signal transduction pathway initiated by the binding of T N F a to the T N F R 1

receptor is known to involve the activation of caspases including caspase-8, -10 and -2
It has been shown in in vitro systems that caspase-8 can induce PT [Marzo, 1998b] and
indirectly induce cytochrome c release [Kuwana, 1998; Bossy-Wetzel, 1999] from
isolated mitochondria. Caspases-8 and -3 have been shown to cleave Bid, a proapoptotic Bcl-2 family member, which after cleavage translocates to mitochondria and
induces release of cytochrome c [Bossy-Wetzel, 1999]. TNFa may also act directly on
mitochondria, as it has been shown that exogenous TNFa is transported to
mitochondria where a TNFa binding protein is localised in the inner mitochondrial
membrane [Ledgerwood, 1999]. BA has been shown to be an ineffective inhibitor of
caspase-1-triggered loss of ATmit in isolated mouse hepatocyte mitochondria [Susin,
1997a]. As in the Jurkat/aFas antibody system, TNFa/CHX-induced apoptosis of U937 cells may proceed via the upstream activation of caspase-8 which directly or

indirectly leads to PT. Therefore the failure of BA to fully inhibit loss of AWmit in t
system may be a result of the inability of BA to inhibit caspase-induced PT.

The release of cytochrome c to the cytosol during apoptosis has been reported to be a
cell-type and inducer-dependent phenomenon. Cytochrome c release occurred in
puromycin-indueed U-937 cells [Ghibelli, 1999], in staurosporine-induced U-937 cells
and TNFa-induced PC3 cells [Tang, 1998], but not in BMD188-induced U-937 cells
[Tang, 1998]. The data provided here relating to the release of cytochrome c in
TNFa/CHX-treated U-937 cells provides a further example of a pathway of apoptosis
in which cytochrome c is released.
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The results presented here provide additional insight into the chronology of cellular
events in TNFa/CHX-induced apoptosis of U-937 cells. In this system, the loss of
AWmit precedes activation of caspase-3, exposure of PS and fragmentation of DNA.

Partial inhibition of PT leads to partial inhibition of all subsequent events. The result
are compatible with a model in which PT precedes degradation phase events (Model 1,
Section 1.A.13) but do not conclusively demonstrate that PT is the trigger for the onset
of apoptotic degradation in this system.
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Chapter 6

Pinocytic Loading of Cytochrome c
into Jurkat andli-937 CeCCs
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6.A

INTRODUCTION

6.A.1

The Role of Cytochrome c in Apoptosis

Cytochrome c is a mitochondrial protein which plays an important role in respiratory
electron transport. It is located in the intermembrane space and forms part of the

electron transport chain responsible for the generation of ATP. Cytochrome c is a sma
(-13 kDa) basic protein consisting of single polypeptide chain of 104 amino acids. It

encoded in the nucleus as apocytochrome c, combining covalently with a haem group t
become holocytochrome c after entering the mitochondria [Stryer, 1995],

A novel role for cytochrome c as a factor in apoptosis was first proposed by Wang a
co-workers in 1996 [Liu, 1996]. They demonstrated in a cell-free system, developed
using HeLa, 283 and U-937 cells, that cytochrome c was required for the activation of
caspase-3 and subsequent DNA fragmentation, and that the presence of cytochrome c in
the cytosol of apoptotic cells was the result of its release from mitochondria [Yang,
1997]. Similar results were obtained by Newmeyer and colleagues, using a cell-free
system based on Xenopus egg extracts, to show that other (unknown) cytosolic factors
were required for the mitochondrial release of cytochrome c and for subsequent
activation of caspase-3 [Kluck, 1997a; Kluck, 1997b]. The apoptotic effects of
cytochrome c release were found to be mediated via a caspase dependent pathway,
since they were inhibited by the caspase inhibitors zVADfmk, yVAD.CHO and

DEVD.CHO. The activation of caspase-3 has been shown to lead to activation of an 85
kDa heterodimeric protein named DNA fragmentation factor (DFF) [Liu, 1997] via
proteolytic cleavage of the inhibitory subunit (ICAD/DFF45). This cleavage releases
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the caspase-activated D N a s e ( C A D / D F F 4 0 ) that enters the nucleus and directly initiates
DNA fragmentation [Enari, 1998; Sakahira, 1998].

In these same reports, release of cytochrome c in intact HL60 cells was reported to be
unrelated to the occurrence of mitochondrial depolarisation [Kluck, 1997a; Yang,

1997]. The latter report showed that in etoposide- or staurosporine-induced apoptosis of
HL60 cells, DNA fragmentation preceded the loss of A\j/mit and coincided with the
release of cytochrome c to the cytosol. Vander Heiden et al. [Vander Heiden, 1997]
reported that release of cytochrome c to the cytosol prior to loss of A\j/mjt occurred
staurosporine and anti-Fas treated Jurkat cells and in FL5.12 (pro-B) cells treated by
withdrawal of IL-3. Detection of the loss of A\j/mitin both of these reports employed
Rhodamine 123 as a probe of mitochondrial transmembrane potential, the distribution
of which has been suggested not to accurately reflect A\|/mit. Release of cytochrome c
prior to the loss of A\ymit was shown in Ara-C induced apoptosis of HL60 cells [Kim,
1997] using 40 nM DiOC6 to measure A\j/mjt. Reports of cytochrome c release in other
cell types quickly followed, for example Bossy-Wetzel et al. [Bossy-Wetzel, 1998]
produced results suggesting that cytochrome c was released from mitochondria

independently of permeability transition (PT) and prior to or coincident with proteolys
of caspase-3 and cleavage of PARP in CEM or HeLa cells induced to undergo apoptosis
by UVB radiation or staurosporine. However, the technique of CMTM-Ros staining of
cells, followed by washing and paraformaldehyde fixation used in this report, has
recently been shown to be an invalid measure of loss of A \|/mit in apoptotic cells
[Gilmore, 1999; Bemardi, 1998]. Therefore, the use of inappropriate technique may
compromise the validity of results supporting claims that mitochondria maintain a high
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A\|/mit while releasing cytochrome c and such claims must therefore be carefully and
individually assessed.

Since the first reports by Wang's group [Yang, 1997] there have been a great many

published reports relating to a range of cell types and inducers of apoptosis, in which
release of cytochrome c from mitochondria was demonstrated in intact cells. These

include the recent reports of cyclosporin A-inhibitable cytochrome c release in cocaine
induced apoptosis of fetal myocardial cells [Xiao, 2000], in C2-ceramide-induced
apoptosis of the human neuroblastoma cell line SK-N-MC [Ito, 1999] and in rat
hippocampal CA1 neurons after transient global cerebral ischemia [Krajewski, 1999].
Although release of cytochrome c has not yet been shown to occur in primitive cells
such as those of Dictyostelium sp. or in invertebrate cells such as those of nematodes
and insects, there have been recent reports of cytochrome c release in plant cells
including tobacco protoplasts induced to undergo apoptosis by menadione [Sun, 1999]
and heat-treated cucumber cotyledons [Balk, 1999].

It has been demonstrated that in some cases cytochrome c does not accumulate in the
cytosol during apoptosis, for example in the apoptosis of multiple myeloma cells
induced by dexamethasone or anti-Fas antibody [Tang, 1998; Chauhan, 1997]. Ghibelli
et al. [Ghibelli, 1999] have recently shown, in puromycin-induced HepG2 and U937cells, that when apoptosis occurs in the absence of glutathione depletion, there is
translocation of cytochrome c to the cytosol. They have suggested that cytochrome c
release may be a consequence of cellular redox disequilibrium caused by depletion of

glutathione, the major intracellular antioxidant, which may or may not lead to inductio
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of apoptosis. Thus, multiple apoptotic pathways exist, some of which are independent
of cytochrome c release.

6.A.2 The Action of Cytochrome c in the Cytosol
It was shown that cytochrome c, together with Apaf-1 (apoptotic protease activating

factor 1; the first identified human homologue to the C. elegans cell death protein CE
4) [Zou, 1997] and dATP, is necessary to activate caspase-3 in vitro [Liu, 1996]. After
release of cytochrome c to the cytosol, pro-caspase-9, cytochrome c and Apaf-1 form a
tetramolecular complex with dATP which results in proteolytic activation of caspase-9

[Ellis, 1991; Wilson, 1998; Li, 1997b]. This in turn leads to cleavage and activation of
caspase-3 followed by DNA fragmentation and possibly other degradation phase events.

6.A.3 A Feedback Mechanism Involving Cytochrome c
The demonstration in intact cells that caspase-3 activation and subsequent DNA
fragmentation occur downstream of the release of cytochrome c to the cytosol, is
consistent with the prediction from studies of cell-free models that cytochrome c is
required for caspase-3 activation in vivo. The release of cytochrome c may form part of
a feedback mechanism as hypothesised by Reed [Reed, 1997]. He suggested that
following its release from mitochondria, cytochrome c may exert a feedback effect to

cause PT, thereby leading to further cytochrome c release which amplifies the apoptoti
cascade. A number of studies have demonstrated the ability of caspases to induce PT in
vitro [Susin, 1998; Marzo, 1998b], thus providing a mechanism for cytochrome c
amplification (Figure 6.1). A feedback loop involving cytochrome c and production of
reactive oxygen species (ROS) is also plausible. ROS are known to be generated during
apoptosis, and have been shown in p53-induced HeLa cells to induce PT [Li, 1999], as
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apoptosis, and have been shown in p53-induced H e L a cells to induce P T [Li, 1999], as
evidenced by the elimination of alterations in A^t in the presence of antioxidants.
During PT the production of ROS often occurs, potentially causing further
mitochondrial PT and cytochrome c release [Zamzami, 1996a]. A recent study

implicated release of cytochrome c to the cytosol in the production of superoxide duri
apoptosis [Cai, 1998]. This was due to a loss of part of the electron transport chain
when cytochrome c translocated from mitochondria to the cytosol. Taken together,

these data support the hypothesis that cytochrome c release may have a self-amplifying
function in the apoptotic execution process (Fig 6.1).
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Figure 6.1: Hypothesised role for cytochrome c as an amplifier in the execution phase
of apoptosis. Cytochrome c is released from mitochondria by an unknown mechanism
resulting in subsequent caspase activation. Caspases cause D N A fragmentation and P T
of mitochondria. P T in turn causes the release of proteins such as AIF and cytochrome
c, which results in further D N A fragmentation (adapted from [Reed, 1997]).
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6.A.4

Pinocytic Loading of Cytochrome c

Several techniques have been developed to introduce macromolecules into living cells.
These include electroporation, microinjection and fusion of macromolecule-containing
liposomes or red blood ceils with the plasma membrane. Each of these techniques has
limitations. Electroporation has been routinely used to introduce macromolecules
including nucleic acids into both prokaryotic and eukaryotic cells, however the
technique results in a significant loss of mammalian cell viability. Microinjection
[Diacumakos, 1970] allows direct presentation of macromolecules to the cellular
compartment of interest but is limited by the relatively small number of cells that can
injected in a reasonable period of time, the requirement for specialised equipment and
highly trained staff and the potential for disruption to cellular structures [Glogauer,
1992; Okada, 1982]. Fusion of liposomes [Poste, 1976] is limited by their small internal
volume and by the tendency of internalised liposomes to be endocytosed, causing
ambiguity in the interpretation of results. The technique of vortex-stirring in the
presence of high molecular weight polyacrylic acid has also been used to introduce
macromolecules into cultured cells [Shimizu, 1996], however, this technique is limited
to molecules of less than 4 kDa in mass.

The technique of introducting macromolecules into mammalian cells by osmotic lysis
of pinocytic vesicles was first published by Okada and Rechsteiner in 1982 [Okada,
1982]. The technique exploits the process of pinocytosis or "cellular drinking" which is
utilised by most eukaryotic cells continually to ingest fluids and small solutes via
vesicles less than 150 nm in diameter. Extracellular fluid is trapped in these vesicles
internalised by fusion of the vesicles with early endosomes, a process known as fluidphase endocytosis [Alberts, 1994]. The technique of pinocytic loading requires
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incubation of cells in a hypertonic culture m e d i u m containing 0.5 M sucrose, 1 0 %
polyethylene glycol 1000 (PEG) and the macromolecule to be transferred into the cell.
After incubation to allow uptake of pinocytic vesicles, the cells are transferred to a
mildly hypotonic medium. Most of the pinocytic vesicles burst in the hypotonic
medium due to osmotic uptake of water, releasing the enclosed macromolecule to the
cytoplasm. The technique is illustrated diagrammatically in Fig 6.2. The advantages of
this technique are the fact that most cell types remain fully viable after treatment
[Okada, 1982] and that the procedure allows transfer of macromolecules into large
numbers of cultured cells. The authors demonstrated introduction of a large variety of
macromolecules including the protein horseradish peroxidase (HRP), antibodies and
70,000 MW dextran into the cytosol of L929 cells while maintaining high viability.

10 min treatment with

2 min treatment with

hyper-osmotic buffer

hypo-osmotic medium

Pinocytic vesicles burst,
releasing contents

Figure 6.2: Schematic representation of the process of pinocytic loading. Cells are
incubated in a hyper-osmotic buffer containing the molecule to be loaded. This causes a
loss of water from the cells and the simultaneous uptake of pinocytic vesicles
containing the target molecule. During the subsequent incubation in a mildly hypoosmotic buffer, water re-enters the cells, and the hyper-osmolar pinocytic vesicles,
causing them to burst and release their contents into the cytosol.
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6.A.5

Introduction of Cytochrome c into Mammalian Cells

Cytochrome c is localised in healthy cells exclusively in the intermembrane space of

mitochondria but its release to the cytoplasm during apoptosis has been shown to be an
important event in apoptosis [Reed, 1997; Skulachev, 1998; Bossy-Wetzel, 1998]. The

introduction of cytochrome c into the cytosol of cells mimics the release of cytochrom
c from mitochondria and allows the observation of downstream effects specific to this
release. Cytochrome c has previously been introduced into a variety of mammalian cell
types by microinjection [Li, 1997a; Brustugun, 1998; Duckett, 1998; Zhivotovsky,
1998] and by electroporation [Garland, 1998]. The cell types tested and the apoptotic
events measured in each case are summarised in Table 6.1. Cytochrome c-induced
apoptosis in these cells was identified primarily by morphological changes. Garland et
al. also showed fragmentation and loss of DNA by using TUNEL (terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labelling) and propidium iodide
flow cytometric assays. They determined by 5,5',6,6'-tetrachloro-l,l',3,3'tetraethylbenzimidazol-carbocyanine iodide (JC-1) staining followed by fluorescence
microscopy, that mitochondrial membrane potential was unaffected by cytochrome c
release, although the finding appeared to be based on a qualitative single time point
assessment. These changes were specifically due to the presence of cytochrome c, as
inactivated cytochrome c and other heme-containing proteins did not cause apoptosis
when introduced into cells. Cytochrome c induced apoptosis was shown to be
dependent on caspase activity, since it was inhibited by co-injection [Li, 1997a],
preincubation [Zhivotovsky, 1998; Brustugun, 1998] or post-electroporation incubation
[Garland, 1998] with the caspase inhibitors DEVD.CHO and zVAD.fmk and was

absent in caspase-3 deficient MCF-7 cells unless they were transfected with procaspase3 cDNA [Li, 1997a]. Inhibition of apoptosis by Bcl-2 transfection showed that Bcl-2,
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which is k n o w n to block mitochondrial dismption and release of cytochrome c, can also
act downstream to inhibit caspase activation induced by the presence of exogenous
cytochrome c [Zhivotovsky, 1998].

A very recent paper [Chang, 2000] describes apoptosis induced in NRK-52E rat kidney
epithelial cells by microinjection of cytochrome c. Characteristic morphological
changes including cell shrinkage, rounding up and blebbing were reported as well as
swelling of the mitochondria and endoplasmic reticulum (ER). Apoptosis, including the
morphological changes exhibited by mitochondria, were prevented by pretreatment with
DEVD.CHO but not by overexpression of Bcl-2 [Chang, 2000]. Mitochondrial
transmembrane potential was measured by staining cells with Rhodamine 123 and
observing cells over a period of four hours by fluorescence microscopy, aided by

reincubation of cells periodically in fresh Rhodamine solution. As discussed previousl
Rhodamine 123 has been shown to be an unreliable indicator of loss of AVmit [Metivier,
1998], casting doubt on the finding that mitochondrial transmembrane potential was
retained in the presence of high amplitude mitochondrial swelling. A summary of

published data relating to apoptotic events induced in intact cells by introduction of
cytochrome c into the cytosol is presented in Table 6.1.
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Table 6.1: Summary of published data relating to apoptotic events induced in intact
cells by introduction of cytochrome c into the cytosol.
Cell type(s) tested
Apoptotic events detected Publication
human:

morphological changes:

embryonic kidney (293);

rounding up, shrinkage,

HeLa; M C F - 7

nuclear condensation

human embryonic kidney

morphological changes:

(293)

shrinkage, membrane

[Li, 1997a]

[Duckett, 1998]

blebbing;
nuclear condensation and
fragmentation
adrenocortical Y-l tumour; morphology;

[Zhivotovsky, 1998]

N R K (rat kidney epithelial) extemalisation of PS

[Bmstugun, 1998]

mouse embryonic
Swiss 3T3 fibroblasts;
rat promyelocytic IPC-81
H E K 2 9 3 (human kidney)
Clone 8 mouse fibroblasts
murine IL-3 dependent

morphology;

Pro-B (Bo);

D N A hypoploidy;

W E H I 3b lymphoma;

D N A fragmentation;

[Garland, 1998]

myelomonocytic C E M
NRK-52E (rat kidney

morphology: cellular,

epithelial)

mitochondrial, ER.
chromatin condensation
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[Chang, 2000]

Thus, at the time of initiation of this section of work there were a limited number of
publications that described the introducton of cytochrome c into intact cells by either
electroporation or microinjection. The resulting apoptotic events measured were limited
mainly to morphological changes. In cell-free systems, cytochrome c had been shown to

induce activation of caspases but this had not been measured in intact cells. The aims o
this section of work were to:
(1) introduce cytochrome c into the cytosol of cells using a mild, non-invasive
technique.
(2) determine whether introduction of cytochrome c into the cytosol:
(i) has any effect on mitochondrial membrane potential, or
(ii) induces activation of specific caspases, oligonucleosomal DNA fragmentation or
exposure of PS at the cell surface.
(3) determine whether the apoptotic changes induced by cytosolic cytochrome c are
caspase-dependent.
It was reasoned that the results obtained would expand the types of cells for which the
effects of introducing cytochrome c into the cytosol have been determined and provide
more complete measurements of cytochrome c-induced apoptotic changes than were
available from earlier studies. In particular, it was planned to measure the activation
individual caspases and perform a detailed study of changes in mitochondrial
polarisation.
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6.B

MATERIALS AND METHODS

This section describes experimental details of work presented in this chapter, excludi
details that were presented in Chapter 2.

6.B.1 Materials
Purified bovine cytochrome c, horse heart myoglobin, sucrose, polyethylene glycol
(MW = 1000) (PEG), fluorescein, FITC-dextran (4.4x103 Da), Sephadex G-25 and
Bradford reagent were all obtained from Sigma (Sydney, Australia). Calcein and TMRM
were purchased from Molecular Probes Inc. (OR, USA).

6.B.2 Methods

6.B.2.1 Pinocytic Uptake of Cytochrome c into Cells

Aliquots of lOxlO6 cells for each treatment were harvested by centrifugation (500 g, 5
min), resuspended in 1 mL of complete medium and transferred to a 1.5 mL
microcentrifuge tube. The cells were recentrifuged and each pellet thoroughly drained
before being resuspended in 200 uL of hyperosmotic buffer (10 mM HEPES, pH 7.4,
10%o (w/v) PEG, 0.5 M sucrose) containing 1 mg/mL of bovine cytochrome c, 1 mg/mL
myoglobin or no protein. After incubating for 10 min at 37°C, the cell suspension was
transferred to a 15 mL centrifuge tube, diluted to 10 mL with hypo-osmotic medium
(60% DMEM:F12: 40% RO water (v/v)) and incubated for 2 min at 37°C. The cells
were centrifuged (500g, 5 min) and resuspended at lxl06 cells/mL in complete medium.
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Bursting of pinocytic vesicles with release of contents into the cytosol was confirmed
by standard fluorescence microscopy and scanning laser confocal microscopy.

The efficacy of the technique was demonstrated by confirmation of cellular uptake of
FITC-labelled 4.4x103 Da dextran (FITC-dex) or of FITC-labelled cytochrome c (FITCcyt c). Cells were loaded with 1 mg/mL FITC-dex or FITC-cyt c by the pinocytic
loading technique and washed twice in DMEM:F12 before final resuspension. The
uptake of FITC-dex was measured by flow cytometry as an increase in cell-associated

green fluorescence (compared with control cells that had been subjected to the pinocyti
loading procedure in the absence of FITC-dex) (Fig 6.3).
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Figure 6.3: Flow cytometry overlay histograms showing an increase in green
fluorescence resulting from the uptake of FITC-cytochrome c into cells. U-937 cells
were pinocytically loaded from 1 m g / m L FITC-cyt c, washed and resuspended in
complete medium. The increase in greenfluorescenceof FITC-cyt c loaded cells (green
line) relative to that of control cells (black line) indicates uptake of FITC-cyt c.

6.B.2.2 Confirming the Specificity of the Effects of Pinocytic Loading of
Cytochrome c

In order to determine that the morphological and biochemical changes induced in cells b
pinocytic loading of cytochrome c were specifically due to cytochrome c, control

treatments were set up with cells that were subjected to either pinocytic loading in th
absence of cytochrome c, or to pinocytic loading from a solution containing 1 mg/mL of

171

myoglobin. Myoglobin is similar to cytochrome c in that it is also a heme-containing
protein of low mass (18 kDa). These controls enabled differentiation of apoptotic
changes that were caused by the loading technique itself, or by the presence of an

"irrevelant" exogenous protein. Initially three different cell lines were subjected to th
pinocytic loading procedure. These were HL60, U-937 and Jurkat cells. It was found
that HL60 cells were induced to undergo apoptotic changes by any one of the pinocytic
loading treatments tested. HL60 cells were therefore excluded from further
experimentation as their response to pinocytic loading was not specific to cytochrome
c.

6.B.2.3 Caspase Dependence of Cytochrome c-Induced Apoptotic Changes
The caspase-dependence of apoptotic changes induced as a result of the introduction of
cytochrome c into the cytosol of cells was assessed by measuring the effects of the
caspase inhibitors zVAD.fmk (50 uM) or Ac.DEVD.CHO (100 uM) when added to
the pinocytic loading medium.

6.B.2.4 Quantitation of Cytochrome c Loaded into Cells

In order to assess the significance of the effects obtained from loading cytochrome c int
cells by pinocytic uptake, it was desirable to confirm that the amounts being loaded
were physiologically relevant (i.e. were within the range obtainable in individual cells
release of endogenous cytochrome c from mitochondria). Quantitation of cytochrome c
uptake was achieved by loading cells with FITC-cyt c (using the same conditions as for
standard pinocytic uptake of unlabelled cytochrome c) and comparing the levels of
fluorescence in lysed cell fractions with that of a series of FITC-cyt c standards.
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6.B.2.4.1

M e t h o d for Quantitation of Cytochrome C Pinocytically Loaded

into Cells
A stock solution of FITC-cyt c in pinocytic uptake buffer (10 mM HEPES, 10% PEG,
0.5 M sucrose) was prepared and serially diluted to obtain solutions that were 750, 500
and 250 ug/mL. This range of uptake concentrations had previously been shown, by
fluorescence microplate assay, to give a linear fluorescence range when pinocytically
loaded into cells which were subsequently lysed. FITC-cyt c was pinocytically loaded
into triplicate samples of lOxlO6 Jurkat and U-937 cells under standard conditions
(section 6.B.2.1). After hypotonic lysis of vesicles, cells were resuspended in 1 mL of
complete medium, transferred to a 1.5 mL microcentrifuge tube, pelleted by
centrifugation (5 min, 500g), washed twice in PBS and resuspended in 200 \ih of 10 mM
HEPES, pH 7.4. Cells were lysed by repeated freeze-thawing and centrifuged (8,000 g,
15 min, 4°C). The supematants were transferred to triplicate wells of a Costar black
fluoro-assay microtitre plate. Cellular fluorescence was quantified by comparison with
set of FITC-cyt c standards. Serial dilutions yielding 10, 5, 4, 3, 2, 1, 0.5 and 0.25
ug/mL were prepared and duplicate 200 uL aliquots were transferred to the microtitre
plate along with duplicate 200 uL aliquots of 10 mM HEPES to allow for subtraction of
background fluorescence. Contents of the wells were excited at 485 nm using a Biolumin
960 fluorescence plate reader equipped with Xperiment software (v. 1.1.0, Molecular
Dynamics (Sydney, Australia) and fluorescence emission was measured at 520 nm. Data
was analysed using Microsoft Excel software (v 6.0).
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6.B.2.5

Fluorescein Labelling of Cytochrome c

Fluorescein isothiocyanate (FITC) was used to label proteins with fluorescein. The
target protein was dissolved in 0.1 M carbonate buffer, pH 9.0, at a concentration of 5
mg/ml and was labelled using 250 ug of FITC per mg protein. A FITC solution was
freshly prepared in DMSO at 40 mg/mL and protected from light. The FITC solution
was added dropwise to the protein solution whilst gently shaking and the reaction was
then allowed to proceed overnight at 4°C, protected from light. 0.01% hydroxylamine
was added and reacted with stirring for 30 min to inactivate any uncoupled dye.
Unreacted FITC was removed by gel filtration using a Sephadex G-25 column
equilibrated in 10 mM HEPES, pH 7.4. FITC-cyt c was stored at -20°C until required.

6.B.2.6 Quantitation of Protein Concentration and the Extent of FITC
Labelling
The Bradford dye-binding procedure [Bradford, 1976], which is based on an increase in
absorbance of Coomasie Brilliant Blue G at 595 nm upon binding to protein, was used
in microplate format to estimate protein concentrations. Column fractions were diluted
and 10 uL aliquots of diluted samples were dispensed into duplicate wells of a
microtitre plate. The concentration of protein in labelled fractions was estimated by
comparison with a set of cytochrome c standards serially diluted from a freshly
prepared 5 mg/mL stock solution in 10 mM HEPES. 200 uL of Bradford reagent was
added to 10 uL of sample in each well and thoroughly mixed before reading the
absorbance at 595 nm using a Spectramax 250 microplate reader (Molecular Devices,
CA, USA). Data was processed using the Softmax Pro software package. The protein
concentration in purified fractions was typically 1.8-4.2 mg/mL.
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The number of molecules of F I T C conjugated to each cytochrome c molecule was
calculated using the following formula:

molecules FITC per cytochrome c molecule = A495 x dilution factor x 13.000
68,000 x m g / m L cytochrome c

where A495 is the absorbance maximum of FITC, 68,000 is the molar extinction
coefficient of conjugated fluorescein and 13,000 is the molecular weight of cytochrome
c. Typically, two FITC molecules were bound to each cytochrome c molecule.

6.B.2.7 Detection of Permeability Transition and Loss of AYmjt
The disruption of AYmjt is a common feature of apoptosis and is thought to result from
permeability transition (PT), the opening of pores at points of contact between the
inner and outer mitochondrial membranes. It has been reported that there are two forms
of PT, a low conductivity form (LCPT) in which mitochondria become permeable to
molecules less than 300 Da in mass and a high conductivity (HCPT) form that allows
passage of molecules less than 1500 Da in mass and results in mitochondrial swelling
[Ichas, 1998]. The detection of PT in intact cells involves the demonstration of an
increase in the permeability of mitochondria [Wilson, 1998] which can be achieved by
tracing the movement of small fluorescent molecules (such as calcein, 642 Da) that are
normally excluded from mitochondria. In order to determine if the loss of A¥mit
specifically induced by cytochrome c loading was caused by PT, cells were
simultaneously loaded with calcein and cytochrome c from a solution containing 2.3
mg/mL calcein and 1 mg/mL cytochrome c, as described in Section 6.B.2.6.I. Cells were
incubated (after final resuspension in complete medium) for 2.5 h before staining with
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tetramethyl rhodamine (methyl ester) ( T M R M )

(Section 6.B.2.6.2) to identify

mitochondria. Loss of ATmit was measured by confocal microscopy as a decrease in
accumulation of TMRM in mitochondria, relative to that in untreated control cells.
HCPT was detected by the entry of calcein from the cytosol into mitochondria (calcein
would be excluded during LCPT).

6.B.2.7.1 Loading Cells with Calcein

Cells were loaded from either 2.3 mg/mL calcein alone, or from a solution containing 2.
mg/mL calcein and 1 mg/mL cytochrome c by the pinocytic loading technique detailed in
section 6.B.2.I. After loading and hypotonic lysis of vesicles, cells were centrifuged
min, 500g) and washed once in complete medium followed by resuspension at lxlO6
cells/mL in complete medium. Cells were then counter-stained with TMRM as
described in Section 6.B.2.6.2 and imaged by two colour scanning confocal microscopy.
Confocal images of green calcein fluorescence were collected using 488 nm excitation
(argon ion laser) and a 500-540 nm emission window. Images of red TMRM
fluorescence were collected using 543 nm excitation from a Helium-Neon laser and a
560-610 nm emission window.

6.B.2.7.2 Staining Mitochondria with TMRM
The cationic, lipophilic fluorophore TMRM accumulates in mitochondria in response to
the relatively negative matrix potential (section 2.B.4). A loss of mitochondrial
transmembrane potential (Avmit) causes a lower degree of accumulation of TMRM in
mitochondria. To load cells with TMRM, 2x106 cells were pelleted by centrifugation
(500g, 5 min) and resuspended in 500 uL of complete medium containing 100 nM
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T M R M . Cells were incubated for 15 min at 37°C in the dark and a small sample (9 uL)
was loaded onto a glass microscope slide for examination by confocal microscopy.
Images of red TMRM fluorescence were collected using 543 nm excitation from a
Helium-Neon laser and a 560-610 nm emission window.
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6.C

RESULTS

6.C.1

Confirmation of Efficacy of Pinocytic Loading

Initially, optimal conditions for uptake were determined using a range of different
uptake media and cell densities, with the aim of maximising uptake of the target
molecule whilst maintaining cell viability. Initially, pinocytic uptake of cytochrome c
was attempted in a hypertonic uptake medium composed of 0.5 M

sucrose and 10%o

P E G in H 2 0 . It w a s found that although high levels of macromolecules were taken u p
into cells from this medium, high levels of apoptosis were induced in cells treated in this
way, regardless of the cell type. For example, for U-937 cells, approximately 40%> of
viable cells had depolarised mitochondria and externalised P S at the cell surface by the
time of initial sampling, 15 min after the initiation of hyotonic lysis of pinocytic
vesicles (data not shown). A high level of small cellular debris was generated, as detected
by flow cytometric analysis and light microscopic examination of cultures which
showed a large proportion of shrunken cells, cells exhibiting membrane blebbing and
apoptotic body formation. H L 6 0 cells were also adversely affected by this pinocytic
loading technique, which caused apoptosis of cells to an even greater extent than was the
case with U-937 cells. The uptake media w a s therefore optimised to increase cell
viability, while still achieving high levels of uptake. H L 6 0 cells were not used in further
pinocytic loading experiments. The optimal uptake medium was found to be 10 m M
H E P E S , containing 0.5 M sucrose and 1 0 % P E G , adjusted to p H 7.4. It w a s found that
by maintaining a cell density in the hypotonic uptake buffer of not more than lOxlO 6
cells/200 u L optimal uptake and viability was achieved. Subsequent pinocytic loading of
Jurkat and U-937 cells was performed as described in section 6.B.2.I.

The efficacy of the pinocytic loading technique was confirmed by demonstrating uptake
by intact cells of 4,400 D a FITC-conjugated dextran (FITC-dex) or calcein (642 D a ) .
The resulting increase in fluorescence w a s detected by both confocal microscopy and
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flow cytometry. Figure 6.4 shows the increase in cell-associatedfluorescenceof Jurkat
and U-937 cells after pinocytic loading of FITC-dex. The consistently higher
fluorescence levels achieved in U-937 cells, compared with Jurkat cells, indicates that
the pinocytic loading process is more efficient in these cells.
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Figure 6.4: Flow cytometric overlay histograms showing the increase in green
fluorescence in cells that had been loaded with FITC-dex. Jurkat (A) and U-937 (B) cells
had been pinocytically loaded with (green profile) or without (black profile) 4,400 D a
FITC-dex. Confocal microscopy was used to confirm that FITC-dex taken up b y
pinocytic loading was released to the cytosol (see text and Fig 6.5).

The pinocytic uptake of fluorescent molecules into the cytosol of Jurkat and U-937
cells and its distribution within the cell was confirmed by confocal microscopy.
Hypertonic uptake of pinocytic vesicles was visualised by the presence of discrete
concentrated regions of green fluorescence within the cell whereas subsequent hypotonic
lysis of pinosomes was evidenced by a diffuse fluorescence throughout the cytosol.
(Figure 6.5).
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A

Figure 6.5: Scanning confocal laser microscopy images of U-937 cells pinocytically
loaded from a solution of 2.3 m g / m L calcein. Cells take up pinocytic vesicles containing
calcein, which appear as localised regions of intense green fluorescence, during the
pinocytic loading procedure (A). Following the loading step, cells were incubated briefly
in a mildly hypotonic buffer which caused bursting of the vesicles and release of calcein
into the cytosol. Calcein fluorescence became diffuse and evenly distributed throughout
the cytosol of cells after this treatment (B).
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6.C.2

Quantitation of Cytochrome c Uptake into Cells

After verification of pinocytic uptake of cytochrome c into cells it was necessary to
quantitify the incorporated cytochrome c in order to assess whether the amounts being
loaded were in the physiological range theoretically available should mitochondria
release their endogenous cytochrome c to the cytosol. Quantitation of cytochrome c
uptake was achieved as described in section 6.B.2.3.

The range of FITC-cyt c concentrations that gave a linear standard curve of fluorescence
emission at 520 nm was determined to be 0.25-10 ug/mL and the range of concentration
of FITC-cyt c in the pinocytic uptake solution that gave linear uptake characteristics
was found to be 250-1000 ug/mL. FITC-cyt c loading experiments were set up in
triplicate with both U-937 and Jurkat cells. Figure 6.6 shows the standard curve
prepared for quantitation of FITC-cyt c uptake into Jurkat cells while Figure 6.7 shows
the average fluorescence of triplicate samples of lOxlO6 cells pinocytically loaded with
FITC-cyt c. Similar curves were prepared for U-937 cells.
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Figure 6.6: Standard curve relating the fluorescence emission of a range of FITCcytochrome c solutions to their protein concentration. Serial dilutions of a standard
solution of FITC-cytochrome c were made into triplicate wells of a microtitre plate.
FITC w a s excited at 485 n m and emission read at 520 nm. Average background values
were subtracted prior to preparation of the standard curve. The values shown are means
of triplicate assays. Error bars representing S E in each case are too small to be visible.
Results are representative of 3 independent time courses.
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Figure 6.7: Plot showing thefluorescenceemission of Jurkat lysates prepared from
cells that had been pinocytically loaded from a range of concentrations of FITCcytochrome c. Triplicate samples of lOxlO 6 cells were loaded with FITC-cytochrome c
and lysed by multiple freeze-thawing. T h e cytosols were loaded into triplicate wells of
a microtitre plate. F I T C w a s excited at 485 n m and emission read at 520 nm. Average
background values were subtracted prior to graphing. T h e values shown are means of
triplicate assays. Error bars represent the S E in each case. Results are representative of
3 independent experiments.
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The estimated amounts of FITC-cyt c loaded per cell for U-937 and Jurkat are shown in
Table 6.2. The amount of FITC-cyt c loaded into Jurkat cells is less than that taken

by U-937 cells under the same conditions. This is in agreement with the differences i
fluorescence levels measured by flow cytometry (Figure 6.4). The amount of FITC-cyt
c taken into cells (by the pinocytic loading technique) from a hypotonic buffer

containing 1 mg/mL cytochrome c is less than the total amount of endogenous releasabl
cytochrome c estimated for human embryonic kidney 293 and MCF7 cells to be 40-100
fg/cell [Li, 1997a]. If it is assumed that the total amount of cytochrome c in Jurkat
U-937 cell falls within this range, then the amount loaded by the pinocytic loading

technique, as described in Section 6.B.2.1, is physiologically relevant and equates t

release of cytochrome c from less than one third of the total mitochondria in the cel

Table 6.2: Amounts of FITC-cytochrome c pinocytically loaded into cells
[FITC-cyt c] in uptake amount of FITC-cyt c in amount of FITC-cyt c in
solution (ug/mL)

Jurkat cells (fg/cell)

U-937 cells (fg/cell)

1000

12

16

750

9.6

11

500

6.1

8.6

250

1.99

3.4

6.C.3 Measurement of Apoptotic Changes after Introduction of
Cytochrome c into Cells
Following pinocytic loading of cytochrome c (or control treatments) into the cytosol
intact cells by pinocytic loading, a range of apoptotic events were analysed. These
included activation of caspase-3, -8 and -9-like enzymes, DNA fragmentation, PS

extemalisation, and mitochondrial depolarisation. Time course experiments were carrie
out on both U-937 and Jurkat cells to observe apoptotic changes over a period of four
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hours after pinocytic loading. The experiments were repeated numerous times and in
many cases measurements were made in triplicate.

6.C.3.1

Activation of Caspase-3

The timing of caspase-3-like activation after the introduction of cytochrome c into the
cytosol of Jurkat and U-937 cells was determined by fluorogenic assay (section
2.B.7.1). SDS-PAGE of cell lysates prepared from samples taken at hourly intervals
after pinocytic loading, followed by immunoblotting using anti-caspase-3 antibody
(Section 2.B.9) was used to confirm the specific identity of the activated enzyme as
caspase 3. Caspase-3 had been activated by the time of the first sampling after
pinocytic loading and the activity reached a maximum by 1-2 h in both cell types
(Figures 6.8 and 6.9). Activity declined by 3-4 hours in all time courses.
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Figure 6.8: Caspase-3-like activity in U-937 cell lysates following pinocytic loading of
cytochrome c (red), myoglobin (green) or no protein (blue), as a function of time.
Specific caspase-3-like activity was determined by subtracting the fluorescence values
obtained in the presence of D E V D . C H O from those in the presence of substrate only.
Each data point represents the m e a n of triplicate measurements. In each case, error bars
represent the SE, which in m a n y cases are too small to be visible. Samples of 2xl0 6 cells
were taken at each time point. The result shown is representative of 4 independent
experiments.
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Figure 6.9: Caspase-3-like activity in Jurkat cell lysates following pinocytic loading of
cytochrome c (red), myoglobin (green) or no protein (blue), as a function of time.
Specific caspase-3-like activity was determined by subtracting the fluorescence values
obtained in the presence of D E V D . C H O from those in the presence of substrate only.
Each data point represents the m e a n of triplicate measurements. In each case, error bars
represent the SE, which in m a n y cases are too small to be visible. Samples of lxlO 6 cells
were taken at each time point. The result shown is representative of 3 independent
experiments.

Activation of caspase-3 was specifically caused by the introduction of cytochrome c
into the cell cytosol. Fluorescence levels for lysates prepared from cells pinocytically
loaded with myoglobin or with no protein were at the level of untreated control cells (0
h). In the case of U-937 cells, fluorescence levels for controls stayed at the same level
that for untreated control cells throughout the time courses. For Jurkat cells, the
controls showed a slight increase in fluorescence over the course of 3 hours, suggesting
some level of non-specific activation of caspase-3 like enzymes. The level of activation
of caspase-3 in U-937 cells appeared to be approximately twice that induced in Jurkat
cells (after taking into account differences in the numbers of cells lysed in each case).
This may be due to the existence of higher levels of endogenous caspase-3 in U-937

cells, or to the successful loading of a larger amount of cytochrome c into U-937 cells (a
shown by Table 6.2), resulting in higher overall levels of activation.
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Immunoblotting for the presence of the 32 k D a procaspase-3 enzyme confirmed the
results of the fluorogenic assays. In U-937 cells, the proenzyme was detected in
untreated cell lysates, but was not visible in cell lysates sampled immediately after
loading of cytochrome c into cells, or in lysates from cells sampled over the following 3
hours (Figure 6.10). This confirms that caspase-3 was activated in U-937 cells

immediately following pinocytic loading of cytochrome c. In the case of Jurkat cells, the
intensity of the proenzyme band was starting to diminish by 1 hour after pinocytic
loading of cytochrome c, and was not detectable at 2 hours, although a faint band was
detected at 3 h (Figure 6.11). This confirms the lower initial levels of caspase-3
activation in Jurkat cells.
control 0 h
32 kDa

Figure 6.10: Immunoblot showing activation of caspase-3 in U-937 lysates following
pinocytic loading of cytochrome c. The presence of inactive procaspase-3 was detected
with an anti-caspase-3 antibody as described in Section 2.B.9. Activation of caspase-3,
as indicated by the disappearance of the proenzyme band present in untreated (control)
cells, occured immediately upon loading of cytochrome c into the cytosol of U-937
cells, as seen by the total loss of the proenzyme in the 0 h and later cell samples. The
result shown is representative of 4 independent experiments.
control Oh lh 2h 3h4h
32 kDa

Figure 6.11: Activation of caspase-3 as detected in Jurkat lysates following pinocytic
loading of cytochrome c. The presence of inactive procaspase-3 was detected with an
anti-caspase antibody as described in Section 2.B.9. Activation of caspase-3, as
indicated by the disappearance of the proenzyme band present in untreated (control)
cells, was detected 1 hour after pinocytic loading of cytochrome c, as shown by a
decrease in the amount of proenzyme detected at this time. The result shown is
representative of 2 independent experiments.
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6.C.3.2

Activation of Caspase-9- and Caspase-8-Iike E n z y m e s

The timing and extent of activation of caspase-8 and caspase-9-like enzymes after the
pinocytic loading of cytochrome c into Jurkat and U-937 cells was measured by
fluorogenic assay (section 2.B.7.1). Caspase-9-like activation was detected by cleavage
of the fluor AMC from the tetrapeptide substrate LEHD.AMC, while activation of
caspase-8-like enzymes was measured by fluorescence generated by cleavage of the
IETD.AMC substrate.

Caspase-9-like enzymes were activated in both U-937 (Figure 6.12) and Jurkat (Figure
6.13) cells immediately after pinocytic loading of cytochrome into the cytosol of cells.

The level of activation increased in both cell lines until 2 h after loading, after which

it diminished. In Jurkat cells, the fluorescence levels generated in lysates of cells loa
either with myoglobin or in the absence of protein were maintained at the level present
in untreated control cells throughout the time course (data not shown). This was

identical to the level shown for 0 h samples. In the case of U-937 cells, the fluorescence
level of lysates generated from cells loaded either with myoglobin or in the absence of

protein was higher than that present in untreated control cells, but was still significan
lower than the fluorescence levels generated by lysates from cells loaded with
cytochrome c. This indicates a low level of non-specific activation of caspase-9-like
enzymes in U-937 cells induced by the pinocytic loading process, but a much higher
level of activation induced specifically by cytosolic cytochrome c.
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Figure 6.12: Caspase-9-like activity in U-937 cell lysates following pinocytic loading
of cytochrome c (red), myoglobin (green) or no protein (blue), as a function of time.
Specific caspase-9-like activity w a s determined by subtracting thefluorescencevalues
obtained in the presence of L E H D . C H O from those in the presence of substrate only.
Each data point represents the m e a n of triplicate measurements. In each case, error bars
representing the S E are too small to be visible. Samples of 4x10 6 cells were taken at each
time point. Results shown are representative of 4 independent experiments.
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Figure 6.13: Caspase-9-like activity in Jurkat cell lysates following pinocytic loading
of cytochrome c (red), myoglobin (green) or no protein (blue), as a function of time.
Specific caspase-9-like activity w a s determined by subtracting thefluorescencevalues
obtained in the presence of L E H D . C H O from those in the presence of substrate only.
Each data point represents the m e a n of triplicate measurements. Error bars representing
the SE. are in some cases too small to be seen. Samples of 2x10 6 cells were taken at each
time point. Results shown are representative of 3 independent experiments.
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Pinocytic loading of cytochrome c specifically induced low level activtion of caspase-8like enzymes. In the case of U-937 cells, maximum fluorescence levels were reached by
the time of first sampling, indicating that caspase-8-like enzyme activation was rapid
(Figure 6.14). The levels of activated enzyme declined over the course of 3 h. The level
of activated caspase-8-like enzymes in U-937 cells pinocytically loaded with myoglobin
remained at the level of untreated control cells (0 h) throughout the 4 h time course,
however in the case of cells loaded without protein, a low level of caspase-8-like
activation, detected immediately after loading, was maintained over the course of 4 h.
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Figure 6.14: Caspase-8-like activity in U-937 cell lysates following pinocytic loading
of cytochrome c (red), myoglobin (green) or no protein (blue), as a function of time.
Specific caspase-8-like activity w a s determined by subtracting thefluorescencevalues
obtained in the presence of I E T D . C H O from those in the presence of substrate only.
Each data point represents the m e a n of triplicate measurements. In each case, error bars
represent the SE. In some cases the S E are too small to be seen. Samples of 4x10 6 cells
were taken at each time point. Results shown are representative of 3 independent
experiments.
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In Jurkat cells pinocytically loaded with cytochrome c, after an intial activation of
caspase-8-like enzymes, the level of activated enzymes increased gradually over the

course of 3 h, indicating a slower time course of activation in this cell type (Figure 6.15
In Jurkat cells pinocytically loaded with myoglobin, there was an intital activation of
caspase-8-like enzymes which declined almost to untreated cell levels (0 h) over the
course of 3 h, while in cells loaded in the absence of protein, the level of activated
caspase-8-like enzymes remained at a level slightly higher than that of untreated cells
throughout the time course.
4.5E+04
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Figure 6.15: Caspase-8-like activity in Jurkat cell lysates following pinocytic loading
of cytochrome c (red), myoglobin (green) or n o protein (blue), as a function of time.
Specific caspase-8-like activity w a s determined by subtracting thefluorescencevalues
obtained in the presence of I E T D . C H O from those in the presence of substrate only.
Each data point represents the m e a n of triplicate measurements. In each case, error bars
represent the SE, which in some cases are too small to be visible. Samples of 2xl0 6 cells
were taken at each time point. Results shown are representative of 2 independent
experiments
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6.C.3.3

Internucleosomal D N A Fragmentation

Internucleosomal DNA fragmentation has long been considered a "hallmark" of

apoptosis, resulting in the characteristic DNA ladder consisting of fragments that are
multiples of 180-200 base pairs in length. To determine the timing and extent of DNA
fragmentation resulting from pinocytic loading of cytochrome c, agarose gel
electrophoresis was performed on cell samples taken hourly during time course

experiments (as described in Section 2.B.10). Pinocytic loading of cytochrome c into U
937 cells induced internucleosomal DNA fragmentation by 1 hour after uptake (Figure
6.16). Faint laddering was detected in controls by 1 h, suggesting a low degree of
apoptosis induced in control cultures, but the degree of DNA degradation induced by
cytosolic cytochrome c was much more extensive.
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Figure 6.16: Ethidium bromide stained agarose gel of D N A extracted from U-937 cells
sampled at intervals of 0-4 h after pinocytic loading. Internucleosomal D N A
fragmentation wasfirstdetected by 1 h after cytochrome c loading whereas control cells
pinocytically loaded with myoglobin (myoglobin con) or in the absence of protein
(pinocytic con) showed evidence of low level D N A fragmentation after treatment.
Result is representative of 2 independent experiments. M = 100 bp D N A ladder.
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In the case of Jurkat cells, there was smearing of D N A at 1 h after cytochrome c uptake,
with obvious laddering by 2 h (Figure 6.17). There was faint laddering of DNA in
pinocytic control cells by 2 h and in myoglobin control cells by 3 h. This again
suggested a low degree of apoptosis induced in control cells, but not to the extent
induced by cytochrome c.

Figure 6.17: Ethidium bromide stained agarose gel of D N A extracted from Jurkat cells
sampled at intervals of 0-4 h after pinocytic loading. Smearing of D N A was first
detected at 1 h after loading of cytochrome c (cyt) with internucleosomal fragmentation
obvious by 2 h. Faint laddering was evident in cells loaded with myoglobin (myo) or in
the absence of protein (pin) by 2-3 h. Result is representative of 2 independent
experiments. M = 100 bp D N A ladder.

6.C.3.4

Exposure of P S at the Cell Surface

Phosphatidylserine is a lipid that is localised on the inner surface of the plasma
membrane in normal cells but flips out to become exposed at the cell surface of
apoptotic cells [Fadok, 1998]. PS exposure was detected by the binding of annexin VFITC which selectively binds to PS at the cell surface (Section 2.B.6.1). Dead cells,
which nonspecifically bind annexin V-FITC, were excluded from analysis after staining
with the membrane-impermeant dye propidium iodide (PI) (Fig. 6.18).
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Figure 6.18: Flow cytometry density plots showing analyses of U-937 cells stained
with annexin V-FITC and PI. Cells were treated by pinocytic uptake from 1 m g / m L
cytochrome c (A) or myoglobin (B) or in the absence of protein (C; pinocytic loading
control) and incubated in complete media for 4 h. B y 4 h the dead cell population
(Plhigh; R l ) reached 8 % in cytochrome c treated cells compared to 1.5% in myoglobin
controls and 1.8% in pinocytic loading controls.

When pinocytically loaded with cytochrome c, both Jurkat and U-937 cells exposed PS
at the cell surface. The percentage of U-937 cells with exposed PS was typically 1723% by the time of first sampling, 15 mins after pinocytic uptake of cytochrome c and
increased to 24-32% by 2-3 hours, after which the percentage cells with PS exposed
typically declined due to an increasing percentage of cells losing membrane integrity,
and therefore being excluded from analysis (Figure 6.19). The specificity of the

response to cytosolic cytochrome c is shown by the low percentages of control cells tha
had exposed PS. Untreated control cells typically had 5% of cells with exposed PS and
this increased only marginally in cells pinocytically loaded with myoglobin or in the
absence of added protein. The maximum percentage of cells induced in myoglobin
treated cells was 12% in one time course (Figure 6.19), but was typically at untreated
control cell levels throughout the time courses.
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Time (h)
Figure 6.19: Induction of PS exposure in U-937 cells pinocytically loaded with
cytochrome c. Line graph showing the percentages of U-937 cells with exposed PS as a
function of time. Cells were either left untreated (black line), or pinocytically loaded
from 1 m g / m L cytochrome c (red line) or 1 m g / m L myoglobin (green line) or in the
absence of protein (blue line). The percentages of cells with exposed P S for these
treatments w a s compared to that in untreated cells from the same culture, after
electronic exclusion of dead cells. Each data point represents the m e a n of three
independent measurements. In all cases, error bars representing S E are too small to be
visible. Results are representative of 4 independent time courses.

PS extemalisation also occurred in Jurkat cells in response to pinocytic loading of
cytochrome c (Figure 6.20). Typically 12-23% of Jurkat cells had exposed PS at the cell

surface by the time of first sampling, 15 mins after pinocytic loading, and this increas
to 24-40%) after 2-3 hours of subsequent culture. As in the case of U-937 cells, the

percentage of cells with exposed PS typically declined after this peak, due to exclusion
of cells that had lost membrane integrity. Jurkat cells were more affected by the
pinocytic loading technique than U-937 cells, with 10-16 % of cells that were
pinocytically loaded with myoglobin (or in the absence of protein) exposing PS over the
course of 4 h, compared to typically 6-7% in untreated control cultures.
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Figure 6.20: Induction of P S exposure in Jurkat cells pinocytically loaded with
cytochrome c. Line graph showing the percentages of Jurkat cells with exposed P S as a
function of time. Cells were either left untreated (black line), pinocytically loaded from
1 m g / m L cytochrome c (red line) or 1 m g / m L myoglobin (green line) or in the absence
of protein (blue line). The percentages of cells with exposed PS for these treatments was
compared to that in untreated cells from the same culture, after electronic exclusion of
dead cells. Each data point represents the m e a n of three independent measurements. In
m a n y cases, error bars representing S E are too small to be visible. Results are
representative of 5 independent time courses.

6.C.3.5

Loss of Mitochondrial M e m b r a n e Potential (A\|/mit)

A loss of A\|/rnit> as evidenced by a reduction in cell-associated D i O C 6 fluorescence,
resulted from the introduction of cytochrome c into the cytosol of both Jurkat and U937 cells. Cells with depolarised mitochondria appeared by the time of first sampling,
15 mins after pinocytic loading of cytochrome c, at a level of typically 17-18 % in U937 cells and increased to a level of 20-24% over the course of 3 hours (Figure 6.21).
The proportion of U-937 cells exhibiting mitochondrial depolarisation was quite
variable, however, and could reach a level of 55% over the course of 3 hours. The

specificity of cytochrome c as the causative agent of mitochondrial depolarisation in U937 cells is shown by the low numbers of cells with depolarised mitochondria in
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pinocytic loading controls and in myoglobin loaded cells. Typically these were only
slightly above that of untreated control cells from the same initial culture.
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Figure 6.21: Induction of mitochondrial depolarisation in U-937 cells pinocytically
loaded with cytochrome c. Line graph showing the percentages of U-937 cells with
depolarised mitochondria as a function of time. Cells were either left untreated (black
line), pinocytically loaded from 1 m g / m L cytochrome c (red line) or 1 m g / m L
myoglobin (green line) or in the absence of protein (blue line). Each data point
represents the mean of three independent measurements. Error bars representing the SE
are too small to be visible. Results are representative of those from 4 experiments.

The proportion of Jurkat cells with depolarised mitochondria was consistently lower
than for U-937 cells, reaching 12-17% by the time of first sampling, 15 mins after

pinocytic loading of cytochrome c, and persisting at a level of 18-20%) throughout th
time courses (Fig. 6.22). This may reflect the lower degree of uptake of cytochrome c
by Jurkat cells (Fig. 6.4). The levels of pinocytically loaded control cells with

depolarised mitochondria was typically approximately 10%>, which was higher than that

found in untreated control cultures. This suggested that Jurkat cells were marginally
more adversely affected by the pinocytic loading technique than U-937 cells.
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Figure 6.22: Induction of mitochondrial depolarisation in Jurkat cells by pinocytic
loading of cytochrome c. Line graph showing the percentages of Jurkat cells with
depolarised mitochondria as a function of time. Cells were either left untreated (black
line), pinocytically loaded from 1 m g / m L cytochrome c (red line) or 1 m g / m L
myoglobin (green line) or in the absence of protein (blue line). Each data point
represents the m e a n of three independent measurements. In each case, error bars
represent the SE, which in m a n y cases are too small to be visible. Results are
representative of those from 4 experiments.

6.C.3.6

Detection of P T and Loss of A\|/mjt by Confocal Microscopy

Calcein is a membrane-impermeable green fluorescent molecule that is normally
excluded from cells and from intracellular organelles such as mitochondria. The

technique of pinocytic loading was used to introduce calcein into cells which were then
imaged by scanning laser confocal microscopy. Confocal images (Figure 6.5) showed
that calcein was taken into the cell, as evidenced by concentrated areas of green

fluorescence which diffused throughout the cytosol after transfer of cells to a hypoton
medium, indicating bursting of pinocytic vesicles. Healthy Jurkat and U-937 cells were
loaded with calcein and then counterstained with TMRM to allow identification of
mitochondria (Figure 6.23). Mitochondria appeared as punctate areas of red
fluorescence which were unevenly distributed throughout the cell. Calcein was evenly
distributed throughout most of the cytosol, which contained "dark" areas of low-level
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green fluorescence. The "dark" areas were closely correlated with areas of T M R M
staining. This indicated that mitochondria in healthy cells were not staining with
calcein, as shown by overlays of the two colour images. There were areas within cells
that did not stain with calcein or TMRM, presumably indicating non-mitochondrial
organelles that also exclude calcein (Fig. 6.23).

Cells that were treated by simultaneous pinocytic uptake of calcein and cytochrome c
were counterstained with TMRM and examined by confocal microscopy approximately
2.5 h after loading. Both Jurkat and U-937 cells had obviously shrunken and there was a

decrease in intensity of calcein fluorescence relative to cells that were not treated wi
cytochrome c, which may indicate changes in the permeability of the plasma
membrane. Cells in which mitochondria retained intense red (TMRM) fluorescence,
also showed corresponding areas of low calcein fluorescence indicating that calcein was
being excluded from mitochondria. These cells had not yet lost AYmit (Figure 6.24). In
some cells TMRM staining was diffuse and of reduced intensity, indicating
depolarisation of mitochondria. In these cells calcein fluorescence appeared to be
homogenous throughout the cytosol. This suggests that entry of calcein into
mitochondria coincided with loss of ATmit (Fig. 6.24).

In late stage cells that exhibited the characteristic morphological changes associated
with apoptosis, including cell shrinkage, membrane blebbing and apoptotic body
formation, TMRM fluorescence was completely lost, indicating a loss of A\|fmit- Calcein
fluorescence in these cells was homogenously distributed, indicating that calcein had
entered into mitochondria (Figure 6.24). Although it appeared that calcein was entering
mitochondria, there was no evidence for the mitochondrial swelling that would be
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expected if H C P T were taking place in response to uptake of cytochrome c into Jurkat
and U-937 cells. However, under the staining conditions used, individual mitochondria
could not be visualised after release of TMRM and the entry of calcein.
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Figure 6.23: Confocal microscopy images of healthy Jurkat (A-C) and U-937 (D-F)
cells loaded with calcein and counterstained with 100 n M T M R M . (A, D ) Image of
cells showing calcein fluorescence only. (B, E) Image of cells showing T M R M
(mitochondrial) staining only. (C, F) Overlay images showing calcein (green) and
T M R M (orange) fluorescence. This result is representative of many independent
experiments. Numerous cells were scanned to ensure reproducibility.
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Figure 6.24: Confocal microscopy images of Jurkat (A-C) and U-937 (D-F) cells loaded
with calcein and cytochrome c, incubated for 2.5 h at 37°C, then counterstained with 100
n M T M R M . (A, D ) Image of cells showing calcein fluorescence only. (B, E) Image of
cells showing T M R M (mitochondrial) staining only. (C, F) Overlay image showing
calcein (green) and T M R M (orange) fluorescence. This result is representative of many
independent experiments. Numerous cells were scanned to ensure reproducibility.
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6.C.3.7

D e a d Cell Counts

There were low counts of non-viable cells, identified by PI assay, in control cell
cultures throughout the duration of the time courses. Typically there were 2-4% nonviable U-937 or Jurkat cells in untreated, pinocytic loading and myoglobin controls
throughout the 4 h time courses whereas in cultures treated by pinocytic uptake of
cytochrome c there was an increasing percentage of non-viable cells, reaching 8-9% by
4 hours.

6.C.3.8 Apoptotic Morphology
Cell cultures that had been treated by pinocytic uptake of cytochrome c were compared

with control cultures by light microscopy to assess the extent of morphological changes
induced by the various treatments. Cells treated with cytochrome c exhibited shrinkage,
blebbing of the cell membrane and budding to produce apoptotic bodies, all of which

are characteristic morphological changes associated with apoptotic cells. In the case of
pinocytic and myoglobin controls, there were relatively low numbers of cells that
exhibited these characteristics of apoptosis (data not shown). U-937 cells were seen to
develop these morphological changes much more rapidly than Jurkat cells.

Additional evidence of the degeneration of cells into apoptotic bodies was seen in the
progressive generation of low FSC/low SSC debris which was electronically excluded
from flow cytometry assays so that only cell-sized events were monitored. 1 hour after
pinocytic loading of cytochrome c, deterioration of cells into low FSC/low SSC debris

resulted in typically only 40-60% of all events falling within the "cell-sized" gate for
cytochrome c treated U-937 cells, whereas approximately 90% of untreated controls
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and 8 5 % of myoglobin and pinocytic controls were of normal cell-size, indicating rapid
apoptosis of U-937 cells that was specifically induced by cytochrome c. The
percentages of cells that had undergone apoptotic events, as reported for cells that had
exposed PS at the cell surface (Section 6.C.4.4) and for cells that had depolarised
mitochondria (Section 6.C.4.5) is therefore an underestimate. In the case of cytochrome
c-treated Jurkat cells, approximately 90% of events fell within the "cell-sized" gate
throughout the time courses, indicating a lower degree of cellular degradation to
apoptotic bodies from Jurkat cells.

6.C.4 Inhibition of Caspase Activation
The caspase-dependence of apoptotic changes induced by pinocytic loading of
cytochrome c was demonstrated by parallel loading of the caspase inhibitors zVAD.fmk
and DEVD.CHO. The concentrations of these inhibitors in the cytochrome c loading

solution which resulted in total inhibition of caspase-3 activity in Jurkat and U-937 ce
were initially determined to be 50 uM for the general caspase inhibitor zVAD.fmk and
100 uM for the caspase-3-like inhibitor DEVD.CHO. Attempts were made to optimise
the uptake of the caspase-9-like inhibitor LEHD.CHO and the caspase-8-like inhibitor
IETD.CHO, however uptake from loading solutions containing up to 500 uM inhibitor
resulted in poor levels of inhibition of the respective enzymes. Furthermore, at these
high concentrations, the specificity of caspase inhibition could not be assured as these

inhibitors were shown in a microplate assay to directly inhibit the activation of caspase
3 (data not shown). Attempts to selectively inhibit caspase-8 and caspase-9-like
activities by pinocytic uptake of the respective inhibitors was therefore abandoned.
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Figure 6.25 shows that the presence of cytosolic cytochrome c caused immediate
activation of caspase-3-like enzymes in Jurkat cells, with maximum activation
occurring 2 hours after pinocytic loading. The presence of either zVAD.fmk or
DEVD.CHO caused fluorescence levels to be reduced to that of untreated cells,
indicating complete inhibition of caspase-3-like activity. The presence of each of the

inhibitors also caused the complete inhibition of caspase-3-like activity in U-937 cells
(Figure 6.26).
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Figure 6.25: Fluorogenic assay for activation of caspase-3-like enzymes in Jurkat cells
pinocytically loaded in the absence of protein (blue), with cytochrome c alone (red), or
with cytochrome c and 50 u M z V A D . f m k (green) or 100 u M D E V D . C H O (It. blue).
The presence of each of the inhibitors reduced fluorescence levels to that of untreated
control cells (0 h), indicating a total inhibition of caspase-3-like activity. Each data
point represents the m e a n of triplicate measurements. Error bars represent the S E which
in m a n y cases are too small to be visible. Result shown is representative of 3
independent experiments.
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Figure.6.26: Fluorogenic assay for activation of caspase-3 in U-937 cells pinocytically
loaded in the absence of protein (blue), with cytochrome c alone (red), or with
cytochrome c and 50 u M z V A D . f m k (green) or 100 u M D E V D . C H O (It. blue). Each
data point represents the mean of triplicate measurements. Error bars representing the
S E are too small to be visible. Result shown is representative of 3 independent
experiments.

6.C.4.1

Effect of Caspase Inhibition on other Apoptotic Events Induced by

Pinocytic Loading of Cytochrome c
The effects of pinocytically co-loading zVAD.fmk and DEVD.CHO with cytochrome c
on cytochrome c-induced apoptosis were examined by flow cytometry and by agarose
gel electrophoresis.

6.C.4.1.1

Exposure of P S at the Cell Surface

In both Jurkat and U-937 cells, exposure of PS at the cell surface was almost
completely inhibited by the general caspase inhibitor zVAD.fmk. The caspase-3-like
inhibitor DEVD.CHO caused PS exposure in Jurkat cells to be reduced almost to
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background levels (Fig. 6.27) while in U-937 cells there was incomplete inhibition (Fig.
6.28).
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Figure 6.27: Inhibition of P S exposure in Jurkat cells pinocytically loaded in the
absence of protein (blue) or from 1 mg/ml cytochrome c alone (red) or together with 50
u M z V A D . f m k (green) or 100 u M D E V D . C H O (It. blue). The percentage of cells with
exposed P S was inhibited almost to control levels by the presence of either inhibitor.
Each data point represents the average of triplicate measurements. Error bars
representing the S E are in m a n y cases too small to be visible. Result is representative of
3 independent experiments.
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Figure 6.28: Inhibition of PS exposure in U-937 cells pinocytically loaded in the
absence of protein (blue) or from 1 mg/ml cytochrome c alone (red), or together with 50
u M zVAD.fmk (green) or 100 u M D E V D . C H O (It. blue). The percentage of cells with
exposed PS was inhibited to control levels by the presence of zVAD.fmk, whereas
D E V D . C H O gave incomplete inhibition. Each data point represents the average of
triplicate measurements. Error bars representing the S E are too small to be visible.
Results are representative of 2 independent experiments.

6.C.4.1.2

Loss of Mitochondrial M e m b r a n e Potential (A\|/mjt)

In both Jurkat and U-937 cells there was a substantial inhibition of mitochondrial
depolarisation by both caspase inhibitors zVAD.fmk and DEVD.CHO (Figures 6.29
and 6.30). The presence of zVAD.fmk inhibited mitochondrial depolarisation
reproducibly to background or near background levels. The inhibitory effects of
DEVD.CHO were slightly less potent than zVAD.fmk.
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Figure 6.29: Inhibition of loss of A\(/mit in Jurkat cells pinocytically loaded in the
absence of protein (blue) or from 1 mg/ml cytochrome c alone (red) or together with 50
u M z V A D . f m k (green) or 100 u M D E V D . C H O (It. blue). The percentages of cells with
depolarised mitochondria were reduced in the presence of either inhibitor. Each data
point represents the average of triplicate analyses. Error bars represent the S E which in
m a n y cases are too small to be visible. Results are representative of 2 independent
experiments.
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Figure 6.30: Inhibition of loss of A\|/mit in U-937 cells pinocytically loaded with
cytochrome c with or without z V A D . f m k or D E V D . C H O . Cells were pinocytically
loaded from 1 mg/ml cytochrome c alone (red) or together with 50 u M z V A D . f m k
(green) or 100 u M D E V D . C H O (It. blue), or in the absence of protein (blue). The
percentage of cells with depolarised mitochondria was reduced to control levels by the
presence of zVAD.fmk, whereas D E V D . C H O did not completely inhibit depolarisation.
Each data point represents the average of triplicate analyses. Error bars represent the SE
which in m a n y cases are too small to be visible. Results are representative of 2
independent experiments.
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6.C.4.1.3

Internucleosomal D N A Fragmentation

Cytochrome c-induced DNA fragmentation was inhibited by each of the caspase
inhibitors, zVAD.fmk and DEVD.CHO. The inhibitors delayed the appearance of DNA

laddering in Jurkat cells (Figure 6.31). In cells loaded with cytochrome c only, DNA

fragmentation was evident by 1 h after loading. The onset of fragmentation was dela
in the presence of zVAD.fmk, appearing as faint laddering in samples taken at 3 h,
not in 4 h samples. The presence of DEVD.CHO completely inhibited DNA
fragmentation, which was not detected even at 4 h after loading in the presence of
DEVD.CHO.
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Figure 6.31: Internucleosomal D N A fragmentation in Jurkat cells pinocytically loaded
with cytochrome c in the presence or absence of the caspase inhibitors zVAD.fmk and
D E V D . C H O . D N A fragmentation was evident by 1 h after uptake of cytochrome c
alone but was inhibited in the presence of both inhibitors. Results shown are
representative of 2 independent experiments.
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D N A laddering was evident in U-937 cells immediately after pinocytic loading of
cytochrome c (Fig. 6.32). DEVD.CHO and zVAD.fmk delayed the onset of cytochrome

c-induced DNA fragmentation from 0 h to 1 h after loading of cytochrome c. Thus the
inhibition of internucleosomal fragmentation by zVAD.fmk and DEVD.CHO was more
potent in Jurkat cells than in U-937 cells.
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Figure 6.32: Internucleosomal D N Afragmentationin U-937 cells pinocytically loaded
with cytochrome c in the presence or absence of the caspase inhibitors zVAD.fmk and
D E V D . C H O . D N A fragmentation was evident immediately after uptake of cytochrome
c alone but was delayed by D E V D . C H O or zVAD.fmk. Results are representative of 2
independent experiments.

6.C.4.1.4

Cell Shrinkage and Fragmentation

The complete degradation of cells into low FSC/SSC debris was also inhibited by the
caspase inhibitors zVAD.fmk and DEVD.CHO. U-937 cells loaded with cytochrome c

undergo shrinkage and fragmentation rapidly, with only 51% of flow cytometric even

falling with the "cell-sized' gate by 2 h after pinocytic loading. At the same tim
in the presence of zVAD.fmk, 95%> of events fell within this gate, while 62% of
cytochrome c loaded cells with DEVD.CHO were still "cell-sized". This indicates
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complete and partial inhibition, respectively, of cell shrinkage and degradation into
apoptotic bodies.

The loss of plasma membrane integrity that allows identification of dead cells by PI

staining is also inhibited by zVAD.fmk. In the case of U-937 cells, for example, ther
was an average of 16% of cytochrome c loaded cells stained brightly with PL This was
not inhibited by DEVD.CHO, but in the presence of zVAD.fmk, the percentage of dead
cells was reduced to background levels (l-2%>). These results indicate that the
morphological changes of apoptosis including cell shrinkage and fragmentation and

changes in the integrity of the plasma membrane are inhibited by the caspase inhibit
zVAD.fmk and DEVD.CHO.

211

6.D

DISCUSSION

The introduction of cytochrome c into the cytosol of cells by osmotic lysis of pinocytic
vesicles allowed transfer of cytochrome c into large numbers of cells. Typically 1050xl06 cells were treated and 12-16 fg (12-40%> of the cytochrome c estimated to be
present in 293 and MCF-7 cells by Li et al. [Li, 1997a]) was loaded per cell. Apoptosis
was induced in Jurkat and U-937 cells by the pinocytic uptake of cytochrome c, as
evidenced by morphological changes such as shrinkage, blebbing of the cell membrane
and apoptotic body formation as well as characteristic biochemical changes including
exposure of phosphatidylserine, fragmentation of DNA, depolarisation of mitochondria

and activation of caspases 3, 8 and 9. Control treatments, in which cells were loaded in
the absence of protein, induced either much lower levels of apoptosis or had no effect
when compared to loading of cytochrome c, indicating that the loading technique was

not detrimental to the cells. The lack of induction of apoptosis by pinocytic loading of
myoglobin, a protein with strong physical similarities to cytochrome c, indicates that
the apoptotic changes induced were specific to cytochrome c.

Release of cytochrome c from mitochondria to the cytosol has been implicated in many

cell types (including U-937 and Jurkat cells) as being a critical event in apoptosis. In
staurosporine and anti-Fas antibody-treated Jurkat cells (Section 4.C.1) and in
TNFa/CHX treated U-937 cells (Section 5.C), mitochondrial depolarisation was shown
to occur at about the same time as release of cytochrome c to the cytosol, and prior to
exposure of PS, activation of caspase-3 and internucleosomal DNA fragmentation.
Cytochrome c release was reported to occur in Jurkat cells treated with anti-Fas
antibody [Bossy-Wetzel, 1999; Ferrari, 1998; Eguchi, 1999], staurosporine [Ferrari,
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1998; Samali, 1999; Vander Heiden, 1997], nitric oxide [Ushmorov, 1999] and with
chemotherapeutic drugs including etoposide, mytomycin c and doxorubicin [Ferrari,

1998]. In U-937 cells, the release of cytochrome c was reported to be inducer-specific;
induction of apoptosis with staurosporine involved release of cytochrome c to the
cytosol, whereas induction with BMD188 did not [Tang, 1998].

This study demonstrated that in intact Jurkat and U-937 cells, caspase-3 was activated
rapidly after pinocytic loading of cytochrome c (by the time of first sampling 15 min
after pinocytic loading) and prior to internucleosomal DNA fragmentation which was
first observed 1-2 h later. This confirms the observation in cell-free models that

cytochrome c is required for activation of caspase-3 [Liu, 1996]. In cell-free systems,
release of cytochrome c to the cytosol leads to the formation of a tetramolecular
complex consisting of pro-caspase-9, cytochrome c, Apaf-1 and dATP which results in
the proteolytic activation of caspase-9 [Ellis, 1991; Li, 1997; Wilson, 1998]. This in
rum leads to cleavage and activation of caspase-3, followed by DNA fragmentation. The
apoptotic events induced by pinocytic loading of cytochrome c into the cytosol of U937 and Jurkat cells were consistent with these reports. Caspase-9-like activity was
initiated in both cell types rapidly after loading, as was caspase-3 activity followed
h later by internucleosomal DNA fragmentation.

The inhibition of caspase-3 activation by the caspase-3-like inhibitor DEVD.CHO and
the general caspase inhibitor zVAD.fmk led to inhibition of DNA fragmentation,

indicating that this process is caspase-dependent. The poor levels of inhibition achiev
by pinocytic uptake of the caspase inhibitors LEHD.CHO and IETD.CHO, as well as
their inherent lack of specificity [Garcia-Calvo, 1998] prevented them being used to
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determine the dependence of downstream events such as D N A fragmentation on the
activation of caspases-9 and -8. Caspase-8-like activity was rapidly activated after
pinocytic loading of cytochrome c in both U-937 and Jurkat cells.

Cytochrome c-loaded Jurkat and U-937 cells exposed phosphatidylserine at the cell
surface and underwent a collapse of the mitochondrial transmembrane potential. In both
cell types, the loss of A Y m i t was shown by confocal microscopy to be the result of a
high conductivity permeability transition ( H C P T ) , as evidenced by the loss of
mitochondrial T M R M fluorescence and the entry of calcein into mitochondria. The
inhibition of loss of A Y , ^ and exposure of P S at the cell surface by both z V A D . f m k
and D E V D . C H O indicate that both of these processes are caspase-dependent.

Exposure of PS at the cell surface following microinjection of cytochrome c has
previously been shown in a range of cells by Brustugun et al. [Brustugun, 1998].
Previous publications in which the effect, in intact cells, of introduced cytosolic
cytochrome c on the mitochondrial membrane potential was measured, include that of
Garland et al. [Garland, 1998]. They concluded from a qualitative single time point
measurement of AY m i t that introduction of cytochrome c into the cytosol of murine B o
and B 1 5 cells did not cause a loss of AWmii. Chang et al. also recently reported the
retention of mitochondrial transmembrane potential in N R K - 5 2 E (rat kidney epithelial)
cells induced to undergo apoptosis by microinjection of cytochrome c [Chang, 2000],
using Rhodamine 123 [Metivier, 1998] to measure AY mit . The techniques described in
both of these reports to measure A Y ^ t are likely to be suboptimal, and therefore m a y
not accurately indicate the state of mitochondrial polarisation in cells undergoing
apoptosis in response to microinjection of cytochrome c. In contrast, the results of the
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current work show that the introduction of cytochrome c into the cytosol of Jurkat and
U-937 cells leads to a loss of AY^t in at least 20-25% of cells within 2 h.

The loss of mitochondrial transmembrane potential in cells pinocytically loaded with
cytochrome c support the notion of the existence of a feedback loop, as suggested by
Reed [Reed, 1997]. Mitochondrial depolarisation has been shown in the current work to
occur prior to or at the same time as release of cytochrome c to the cytosol in U-937
cells treated with TNFa/CHX, (Section 5.C.1.4) and in Jurkat cells induced to undergo
apoptosis by staurosporine (Section 4.C.2.5.) or by ligation of anti-Fas antibody

(Section 4.C. 1.5). The release of cytochrome c may therefore be a result of PT in thes
systems. In the case of the Jurkat/staurosporine system, the fact that BA inhibited
cytochrome c release suggests that cytochrome c release was a result of PT (Section
4.C.2.5). Mitochondrial depolarisation may therefore occur upstream of cytochrome c

release in these cell types. Loss of AYmit occurred in Jurkat and U-937 cells following
pinocytic loading of cytochrome c ie. downstream of the presence of cytosolic
cytochrome c. It probably follows that pinocytic loading of cytochrome c into these
cells induces loss of AYm;t via a feedback mechanism.

In Jurkat and U-937 cells pinocytically loaded with cytochrome c, the inhibition of lo
of A*Fmit by DEVD.CHO and zVAD.fmk indicates that cytochrome c-induced loss of
A^mit is caspase-dependent. A number of studies have demonstrated that caspases can
induce PT in isolated mitochondria in vitro [Susin, 1997a; Marzo, 1998b]. A report by
Li et al. [Li, 1998] linked activation of caspase-8 in the Fas and TNFa pathways to
mitochondrial changes (including release of cytochrome c and loss of AWmit) via the
cleavage and translocation of cytosolic Bid to mitochondria [Li, 1998; Bossy-Wetzel,
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1999]. Caspases-6 and -7 have also been shown to initiate cytochrome c release from
mitochondria in vitro [Bossy-Wetzel, 1999]. The presence of caspase inhibitors was

found to inhibit cytochrome c release in Jurkat cells treated with anti-Fas antibody but
not with staurosporine, indicating an alternative mechanism for induction of cytochrome
c release in this system [Bossy-Wetzel, 1999]. Collectively, the available evidence
strongly suggests that, at least in some systems, cytosolic cytochrome c exerts a
caspase-dependent feed-back effect on mitochondria to induce PT and further
cytochrome c release, amplifying pro-apoptotic signals (Figure 6.1).

The activation of caspase-8 occured earlier than cytochrome c release in anti-Fas
antibody-treated Jurkat cells (Section 4.C.1) and is generally considered to be an
upstream signalling event due to the association of caspase-8 with cell death receptor
molecules including Fas and TNFR1. However, it has been shown that Jurkat cells
belong to a class of cells (type II) in which there is reduced DISC formation at the
cytosolic domain of the Fas receptor with a correspondingly lower level of caspase-8
activation at this early stage of apoptosis [Scaffidi, 1998]. Relatively low levels of
activated caspase-8 in this system were shown to mediate downstream apoptotic events

via induction of mitochondrial damage [Scaffidi, 1998]. Most of the caspase-8 activation
in these cells was reported to be Bcl-2-inhibitable and to occur downstream of
mitochondrial changes including loss of A¥mit and release of cytochrome c, [Scaffidi,
1998]. Caspase-8 (as well as caspases -3, -7 and -9) has been shown to be activated in
both receptor-mediated and chemical-induced apoptosis of Jurkat and U-937 cells
[Ferrari, 1998]. Caspase-8 can therefore be activated at the level of the DISC and/or
downstream of mitochondrial changes, possibly dependent on cytochrome c release.
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The addition of cytochrome c to a cytosolfractionin a cell-free system has been shown

to activate caspase-9 which in turn facilitated activation of caspase-8 (and caspases-2
3, -6, -7, and -10) [Slee, 1999]. Caspase-8 activation has been reported to be deficient
Apaf-1-[Yoshida, 1998] deficient mice and in the embryonic stem cells from caspase-9deficient mice, induced to undergo apoptosis by UV-irradiation [Hakem, 1998]. This
suggests that the Apaf-1 pathway, which requires cytochrome c, is necessary for
caspase-8 activation in some systems. These reports support the activation of caspase8 downstream of cytochrome c release, as was observed in Jurkat and U-937 cells after
pinocytic loading of cytochrome c. The inhibition of mitochondrial depolarisation by
zVAD.fmk suggests that activated caspase-8 and/or other caspases, may participate in a
feedback loop to cause loss of AYmit) followed by further release of cytochrome c.

The rapid initiation of apoptotic events after pinocytic loading of cytochrome suggests

that, in intact cells, release of mitochondrial cytochrome c to the cytosol induces rapi
apoptosis and may therefore be a critical event in the apoptosis of at least some cell
types. The presence of cytosolic cytochrome c was shown to be sufficient to induce

apoptosis in both cell types tested, including changes not previously directly linked t
the release of mitochondrial cytochrome c, such as ensuing loss of AYmit and activation
of caspase-3. The results presented for apoptotic changes induced after pinocytic
uptake of cytochrome c are compatible with the model for cytochrome c-induced
activation of caspase-9 and subsequent apoptosis proposed by Li et al. [Li, 1997b]. The
inhibition of PS exposure, loss of A*Fmit and DNA fragmentation by co-loading of the
capase inhibitors DEVD.CHO and zVAD.fmk suggests that, at least in Jurkat and U937 cells, the pathway/s leading from cytochrome c release to these events are caspasedependent.
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This study has extended the cell types in which the effects of introduced cytosolic
cytochrome c have been measured to include U-937 cells and Jurkat cells. Furthermore,

results presented here have demonstrated for the first time that in intact cells cytosoli
cytochrome c specifically induces activation of caspases-3, -8 and -9, and loss of A¥mit
associated with mitochondrial PT.
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Chapter 7

Use of CMX-Ros

to Measure Loss

of/Wmit in Apoptotic CeCCs is
IncompatiSCe with CeCC Fixation
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7A

INTRODUCTION

Disruption of the inner mitochondrial transmembrane potential (AYmit) has been shown
in m a n y systems to be a critical event in the sequence of morphological and
biochemical changes that constitute apoptosis [Kroemer, 1997b; Wilson, 1998]. The
loss of AYmit, which is thought to be caused by mitochondrial permeability transition
(PT) [Zoratti, 1995] appears to trigger degradation phase events in m a n y different cell
systems. Disruptions in AWmn can be monitored using a number of cationic lipophilic
fluorochromes including 3,3' dihexyloxacarbocyanine iodide (DiOCe) [Korchak, 1982],
5,5',6,6'-tetrachloro-l,l',3,3'tetraethylbenzimidazolcarbocyanine

iodide (JC-1)

[Cossarizza, 1996] and chloromethyl-X-rosamine ( C M X - R o s ) [Poot, 1997]. These
stains passively diffuse across the plasma membrane and accumulate in mitochondria in
response to the negatively charged mitochondrial matrix. The extent of dye uptake is
dependent upon the magnitude of AY m i t , such that a dissipation of AYmh results in a
decrease in cell-associated fluorescence that can be detected by flow cytometry.

The ability of dyes such as CMX-Ros to discriminate normal cells with fully polarised
mitochondria from those with reduced AYmit can be confirmed using carbonyl cyanide
m-chlorophenylhydrazone ( C C C P ) , an uncoupling agent that dissipates the proton
gradient across the inner mitochondrial membrane. Cells stained in the presence of
C C C P have a reduced cell-associated fluorescence w h e n compared with normallystained control cells (Fig. 3.1).

It was reported in murine thymocytes [Macho, 1996] that CMX-Ros can be successfully
used in 2-colour staining protocols that concurrently measure, for example, AYmit and
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D N A fragmentation (using the terminal d U T P nick end-labelling technique, T U N E L ) .
In the applications described, cells were first stained with CMX-Ros and then fixed
before proceeding with subsequent staining protocols. In this report, there were no
direct comparisons described between cells freshly stained with CMX-Ros and those
analysed after subsequent fixation, excepting the case of cells treated with CCCP
[Macho, 1996]. Thus the technique was not properly validated in this publication.

The aim of this section of work was to investigate the effect of paraformaldehyde
fixation on the cellular retention of CMX-Ros and the implications of this for the

subsequent analysis of changes in AYmitin cells undergoing apoptosis. Parts of the work
reported in this chapter have been published [Gilmore, 1999].
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7B

MATERIALS AND METHODS

This section contains specific experimental details of the work presented in Chapter 7,
excluding the details that were presented in Chapter 2 (Materials and Methods).

7B.1 Materials

Dexamethasone, etoposide, cycloheximide and carbonyl cyanide mchlorophenylhydrazone (CCCP) were obtained from Sigma (Sydney, Australia).
Tumour necrosis factor-alpha (TNFa) was a gift from Dr. Simon Easterbrook-Smith
(University of Sydney, Australia). Anti-Fas antibody was obtained from Immunotech
(Coulter, Australia).

7B.2 Methods
7B.2.1 Isolation of Thymocytes
Thymocytes were freshly isolated from 10 week old Balb/c mice and purified from red

blood cells using a hypotonic lysis technique. Cells were collected by centrifugati

(500 g, 5 min) and resuspended in 100 \iL of PBS. After the addition of 2 mL of O.lx
PBS, cells were incubated for 10 sec, then 2 mL of 2x PBS was added. Tubes were
topped up to 15 mL with lx PBS, pelleted by centrifugation and finally, cells were
washed in lx PBS, collected by centrifugation (500 g, 5 min) and resuspended in
growth media.
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7B.2.2

Induction of Apoptosis

Prior to induction of apoptosis, cells were harvested and resuspended in growth med
at a density of 1 x 106/mL. Apoptosis was induced by the addition of agents to the
growth medium for 3-6 h: thymocytes, 1 uM dexamethasone; HL60 cells, 20 ug/mL

etoposide; Jurkat cells, 100 ng/mL anti Fas antibody; U-937 cells, 10 ng/mL TNFa and
10 ug/mL cycloheximide.

7B.2.3 Measurement of Mitochondrial Transmembrane Potential
A 1 mM stock solution of CMX-Ros in DMSO was prepared prior to use and stored in

the dark at -20°C. A 4 mM stock solution of DiOC6 in ethanol was also prepared prior

to use and stored in the dark at 4°C. To determine AYmit, in each case lxlO6 cells w
incubated with either 100 nM CMX-Ros or 40 nM DiOC6 in growth medium for 15 min
at 37°C in the dark, placed on ice and assayed immediately by flow cytometry. For
subsequent fixation, cells were initially stained with 150 nM CMX-Ros as described
[Macho, 1996]. In some experiments, cells were stained with CMX-Ros in the presence
of 50 uM CCCP, which is known to reduce AYmit.

7.B.2.4 Fixation
CMX-Ros stained cells were pelleted by centrifugation (500 g, 5 min) washed in PBS,

resuspended in 4% paraformaldehyde in PBS and gently agitated on a horizontal shaker
for 15 min at room temperature in the dark. Flow cytometric analysis was performed

immediately after fixation and again after incubation in the dark at 4°C for extend
periods of time.
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7C

RESULTS

7C.1

Correlation of CMX-Ros Staining with A¥mit

One way to validiate that CMX-Ros can accurately measure changes in AYmu is to
demonstrate that agents that are known to affect A^t produce concomitant changes in

the level of fluorescence of CMX-Ros-stained cells. In all cases, cells that were stai
in the presence of the protonophore CCCP showed a reduced FL-3 fluorescence when
compared to control cells (Fig. 7.1). Cells treated to undergo apoptosis also showed

reduction in fluoresence when compared to control cells, suggesting that this decreas
due to a loss of A4W
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Figure 7.1: Flow cytometry overlay histogram of C M X - R o s stained thymocytes.
Freshly isolated thymocytes spontaneously undergo apoptosis as evidenced by the
presence of a population of untreated control cells (black line) having reduced cellassociated fluorescence levels. Cells induced to undergo apoptosis by treatment with
dexamethasone for 5 h (red line) showed an increase in the percentage of cells with
reduced fluorescence. Control cells co-incubated with 100 u M C C C P during staining
(green line) had reducedfluorescence,indicating that this reduction is caused by a loss
of AT mit . Cells were stained as described in Section 7.B.2.3. Data shown is
representative of m a n y independent experiments.
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7C.2

Correlation of C M X - R o s and D i O C 6 Staining Profiles

Analysis of the intensity of FL-3 fluorescence of freshly CMX-Ros-stained cells
allowed discrimination of cells with depolarised mitochondria from control cells with
fully polarised mitochondria. Using DiOC6, a greater change in fluorescence enabled

better resolution of cells with depolarised mitochondria from those with fully polarise
mitochondria (data not shown). Parallel staining in the same time course experiments
using CMX-Ros and DiOC6 showed that both dyes label the same populations of
freshly-stained cells, so that the indicated pattern of changes in ATmit for CMX-Ros-

stained cells closely correlated with that for DiOC6-stained cells. The results of a st
of etoposide-induced apoptosis in Jurkat cells comparing changes in A¥mit measured
with CMX-Ros and DiOC6 are shown in Fig. 7.2. Similar results were obtained in
studies of staurosporine-induced apoptosis of HL60 and Jurkat cells (data not shown).
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Figure 7.2: Line graph showing the percentage of Jurkat cells with depolarised
mitochondria as a function of time. Control cells (square symbols) or etoposide-treated
cells (triangular symbols) were treated for the indicated times (Section 7.B.2.2) and
stained with either C M X - R o s (red) or D i O C 6 (green) according to the method detailed
in Section 7.B.2.3. Data points represent the m e a n of triplicate assays from 4
independent time courses. Error bars representing the S E are too small to be visible.
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7.C.3

Loss of Resolution of A^F^ on Fixation

Flow cytometric analysis indicated that, immediately following paraformaldehyde
fixation, CMX-Ros stained cells showed a decrease in fluorescence of approximately

7 log units relative to freshly stained cells. The difference in relative fluoresce

of fully polarised and CCCP-treated cells decreased when CMX-Ros stained cells were
fixed, causing a loss of resolution of AVmith{gh from A¥mjtlow cells (Fig. 7.3). Re-

analysis of fixed samples at later times (after storage for 1-10 days in the dark a
showed further minor decreases in fluorescence intensity and resolution of ATmit10™
from A^mit1"^ populations on storage (data not shown).
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Figure 7.3: Flow cytometry overlay histograms of C M X - R o s stained Jurkat cells
showing the difference in fluorescence between control (black lines) and CCCP-treated
cells (red lines). Cells were either stained with C M X - R o s and analysed immediately (A)
or then fixed and analysed subsequently (B). The results shown are representative of
many independent experiments. Similar results were obtained with U-937 and H L 6 0
cells and with mouse thymocytes (data not shown).
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7.C.4

Changes in the Assignment of Cells to A f J 0 W or AxPmithi8h

Populations after Fixation
Resolution of populations of normal cells with fully polarised mitochondria from
apoptotic cells with depolarised mitochondria was possible immediately after staining
with CMX-Ros (Fig. 7.4). When the same cells were subsequently fixed with
paraformaldehyde there was a very substantial loss of resolution between normal and
apoptotic cells (Fig. 7.4).
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Figure 7.4: Flow cytometry overlay histograms of C M X - R o s stained cells showing the
difference in fluorescence between control cells (black lines) and cells induced to
undergo apoptosis (red lines). Cells were either stained with C M X - R o s and analysed
immediately (A, C, E and G ) or thenfixedbefore being immediately analysed (B, D, F
and H ) . The results are representative of many independent experiments. Cells were
induced to undergo apoptosis as described in Section 7.B.2.2 (HL60 cells for 5.5 h
(A,B); Jurkat cells for 3 h (B, C); U-937 cells for 3 h (C,D); thymocytes for 5 h (G, H)),
stained as in Section 7.B.2.2 and fixed as in Section 7.B.2.4. By setting "markers" as
shown in A and B, the percentages of cells with depolarised mitochondria in these
samples and in corresponding replicates were estimated using CellQuest software (see
Table 7.1).
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The extent of the decrease in resolution upon fixation is such that w h e n thefractionof
cells undergoing apoptosis with depolarised mitchondria is estimated by setting
"markers" on the overlay histograms (Section 2.B.4.1) and using the statistical

functions of CellQuest software, the values obtained for fixed cells are very differen
those obtained for the corresponding freshly stained cells (Table 7.1).

Table 7.1: Estimates of the percentages of cells with depolarised mitochondria, for
control cells and cells induced to undergo apoptosis, as determined from analyses of
CMX-Ros-stained cells before and after fixation.
% Cells with depolarised mitochondria
Induced to undergo apoptosis
Controls
Cell type
HL60
Jurkat
Thymocyte
U-937

Freshly stained
7.95 ± 0.24
7.82 ± 0.24
38.19 ±0.40
6.14 ±0.26

Fixed
2.02
1.31
3.13
1.79

±0.31
±0.18
±0.08
±0.12

Freshly stained

Fixed

53.89±1.19
51.01 ±0.66
81.15 ±0.44
80.96 ± 0.26

18.69 ±2.63
11.01 ±1.75
5.11 ±0.88
53.18 ±1.07

Values shown are means of three replicate determinations ± SE. The results shown are
representative of m a n y independent experiments. Data was analysed using CellQuest
software.
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7D

DISCUSSION

Cells that were treated to undergo apoptosis using a range of inducing agents displayed
a decrease in cell-associated fluorescence when stained with CMX-Ros. The assessment
of the low fluorescence population as having depolarised mitochondria was verified by
CCCP treatment of control cells, which resulted in a corresponding decrease in cellassociated fluorescence.

Parallel staining in the same time course experiments using CMX-Ros and the
established probe for AYmit, DiOC6 [Korchak, 1982], showed that both dyes label the

same populations of cells leading to similar statistics for the percentages of cells w
depolarised mitochondria. Others have reported close agreement between the pattern of
changes in ATm;t measured with CMX-Ros and DiOC6 [Castedo, 1996; Metivier, 1998],
suggesting that, in freshly stained cells, CMX-Ros can be used as a specific probe for
A^mit-

In agreement with an earlier study, which reported an 80% loss of fluorescence in

CMX-Ros stained cells following fixation [Poot, 1996], there was an initial decrease in
fluorescence intensity immediately after fixation, with small further decreases in

intensity on storage. Of greater consequence, there was a decrease in resolution betwe
cells originally defined as having A^mit11^*1 from those defined as A^mit1™ . The
experimental results show that when comparing CMX-Ros staining of untreated control
cells and cells exposed to CCCP (a proton-ionophore uncoupler which reduces ATmit)

before and after fixation, resolution between control and CCCP-treated cells is reduce
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following fixation. The post-fixation loss of resolution in this case is less substantial
than that seen comparing control and apoptotic cells. Using a range of models of
apoptosis, results obtained for cells freshly stained with CMX-Ros were compared with

those stained in the same way but subsequently fixed prior to analysis. The results sh
that analyses of CMX-Ros-stained cells that have been fixed, significantly
underestimates the proportion of cells with depolarised mitochondria. Fixation of
CMX-Ros stained cells apparently preserves some association of CMX-Ros with

mitochondria but the extent of this association cannot be taken as a true indication o

ATmit in the cells prior to fixation. Thus, in studies of apoptosis, the use of CMX-Ro
described [Kroemer, 1998; Bossy-Wetzel, 1998] would lead to errors in the

determination of the timing and extent of collapse of ATmit. The results are consistent

with CMX-Ros being a valid probe for ATmit in intact cells but only when the cells are
stained and analysed immediately.

The apparently better preservation of the difference in CMX-Ros staining between
untreated and CCCP-treated cells may be a reflection of the redox status of the cell
rather than being an accurate representation of ATmit- CMX-Ros reacts with

mitochondrial thiol groups and its retention during fixation is presumably due to this
interaction [Poot, 1996]. Exposure to CCCP induces an oxidative stress in cells which
leads to a decrease in the levels of reduced thiol groups within the cell. This would
reduce the fixability of CMX-Ros in CCCP-treated cells and artifactually enhance the
discrimination of CMX-Ros fluorescence between untreated and CCCP-treated cells
[Gilmore, 1999].
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8A.

INTRODUCTION

O n e of the hallmark features of cells undergoing apoptosis is a sudden and dramatic
reduction in cell size which has been well documented for a large range of cell types
and inducers of apoptosis [Lang, 1999; McCarthy, 1997; Bortner, 1996; Beauvais,
1995; Benson, 1996; Zamzami, 1995a]. This cell shrinkage is likely to be of
considerable physiological importance in facilitating the phagocytic disposal of the

corpse. Apoptotic cell shrinkage has received little attention and, consequently, lit
known about the mechanisms underlying this process or even (in many cases) its
sequential placement in the series of many events that take place within cells during
apoptosis.

Typically, volume regulation in eukaryote cells involves membrane transport
phenomena, specifically, K+ and Cl" transport via the Na+-K+ ATPase [Alberts, 1994].

The changes in cell size that occur during apoptosis can be extreme, with losses of 60

of volume and up to 90% of cell surface area possible [Sit, 1994; Beauvais, 1995]. The
scale of these changes may require the operation of processes additional to those
normally involved in cell volume regulation.

One mechanism that might be involved in effecting apoptotic cell shrinkage is the
export of ions, resulting in a loss of water by osmosis and a consequent reduction in
size. It has been shown that apoptotic shrinkage of human eosinophils is inhibited by
K+ channel blockers, leading to the suggestion that K+ export may be an important
mechanism of cell shrinkage during apoptosis [Beauvais, 1995]. Consistent with this
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suggestion, it has also been reported that during etoposide-induced apoptosis, murine L
cells show a reduction in the intracellular concentration of K+ [Barbiero, 1995].
During apoptosis, the permeability of the cell membrane is thought to increase. This
claim has followed from demonstrations that apoptotic cells can be stained with a

variety of fluorescent nuclear dyes to a level intermediate between that of healthy an
dead cells [Idziorek, 1995; Dive, 1992; Lyons, 1992; Philpott, 1996; Schmid, 1994;
Zamai, 1996]. The increase in permeability probably coincides with a decrease in the
density of packing of cell membrane phospholipids that also occurs during apoptosis
[Mower, 1994], although this remains to be established. Since the extent of osmotic
water loss following ion export would be inversely proportional to the ionic

permeability of the cell membrane, ion export would be more efficient in effecting cel
shrinkage prior to an increase in cell membrane permeability.

The production of reactive oxygen species (ROS) has also been implicated in apoptotic
cell shrinkage. A surge in ROS production preceded cell shrinkage during
dexamethasone-induced apoptosis of mouse splenocytes [Zamzami, 1995a]. In this
same system, if the surge in ROS was inhibited by rotenone or ruthenium red, or the

cells provided with the radical scavenger N-t-butyl-a-phenylnitrone, then cell shrinka
was inhibited [Zamzami, 1995a]. However, this is the only published report of an

investigation of the involvement of ROS in apoptotic cell shrinkage, and the mechanism
by which ROS might initiate cell shrinkage remains to be elucidated.

A final process that has been suggested as acting in apoptotic cell shrinkage is
exocytosis. It has been shown that during dexamethasone-induced apoptosis, CEMC7A cells initially lose volume by a process that is not associated with any change in
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cellular buoyant density, and that does not involve any changes in K + efflux or
intracellular K+ concentration [Benson, 1996]. In this case it was suggested that the
mechanism responsible for apoptotic cell shrinkage is exocytosis of all of the
components of the cytoplasm in equal ratio, such that the density of the cell remains
constant [Benson, 1996].

During apoptosis, cells dramatically reduce both their volume and surface area.
Therefore, even if K+ export is a common mechanism by which apoptotic cells lose
volume, it cannot account for the reduction in surface area, and other mechanisms must
be involved in effecting this process. Human Chang liver cells have been reported to
rapidly endocytose the large macromolecules neutral red and 2 x IO6 Da fluoresceinlabelled dextran (FITC-dex) during serum deprivation-induced "apoptotic rounding"
[Sit, 1994]. When examined by transmission electron microscopy, these cells showed

evidence of many endocytic invaginations and vesicles just inside the cell membrane. I
was suggested that apoptotic Chang liver cells rapidly engulf "bites" of the external
medium and the continual inwards passage of endocytic vesicles results in a reduction
of the cell surface area [Sit, 1994].

As a step towards better understanding the mechanisms involved in apoptotic cell
shrinkage, the occurrence of rapid endocytosis during apoptosis in a variety of cell
systems was investigated. Previous to this work, endocytosis had been reported in the
adherent human Chang liver cell line undergoing apoptosis [Sit, 1994], however, this
was the only cell system examined, and a detailed analysis of the relative timing of

changes taking place in the cells was not carried out. In the current work the chronol
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of cell shrinkage, changes in membrane permeability, and endocytosis in H L 6 0 cells
undergoing etoposide-induced apoptosis was investigated.

8B

MATERIALS AND METHODS

This section contains specific experimental details of the work presented in Chapter 8,
excluding the details that were presented in Chapter 2 (Materials and Methods).

8.B.1 Materials
Actinomycin D (Act D), 7-aminoactinomycin D (7AAD), bovine serum albumin
(BSA), colchicine, cytochalasin B, dexamethasone, fluorescein isothiocyanate (FITC),
FITC-labelled dextrans (FITC-dex; 4.4 x IO3, 1.45 x IO5 and 2 x IO6 Da), etoposide,
phycoerythrin (PE), propidium iodide (PI), quercetin, sodium azide, staurosporine,
horseradish peroxidase (HRP) and diaminobenzidine were all purchased from Sigma
Chemical Co. (Sydney, Australia). The membrane-impermeant green fluorescing
nuclear stain Sytox Green (SG) was purchased from Molecular Probes Inc. (Eugene,
OR, USA). Low melting temperature agarose was obtained from Promega (WI, USA)
while hydrogen peroxide, and sodium acetate were obtained from BDH (Dorset,
England). Propylene oxide, sodium cacodylate, glutaraldehyde and araldite502 were
obtained from ProSciTech (Thuringowa Central, Australia). Other general chemicals
were obtained from Ajax Chemicals (Sydney, Australia). FITC-labelled BSA was
prepared using standard methods as described for FITC-labelling of cytochrome c
(section 6.B.2.4).
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8B.2

Methods

8.B.2.1

Induction of Apoptosis

HL60 cells were induced to undergo apoptosis by incubation for various periods of t
with 20 ug/ml etoposide, 2 ug/mL Act D or 2 uM colchicine. Apoptosis was induced in

Jurkat cells by 16-20 hours incubation with 2 uM staurosporine and in K562 cells by

hour incubation with 100 uM quercetin, followed by a 1 hour incubation at 42°C and a
further 18 hour incubation with 100 uM quercetin [Wei, 1994]. Murine splenocytes
were induced to undergo apoptosis by 18 hours culture with 0.1 uM dexamethasone
[Perandones, 1993; Zamzami, 1995b].

8.B.2.2 Measurements of Endocytosis
To measure endocytosis, cells were incubated with a variety of large impermeant

molecules. Generally, approximately lxlO6 cells were pelleted by centrifugation (500
5 min), resuspended in 50 ul of phosphate buffered saline pH 7.4 (PBS) containing 1
mg/ml of 2xl06 Da fluorescein isothiocyanate-labelled dextran (FITC-dex) and
incubated, protected from light, at 37°C for 20 min. The cells were then chilled on
and washed 3 times by centrifugation (500 g, 5 min) with cold PBS, before being

resuspended in 0.5 ml of cold PBS and analysed by flow cytometry. In some cases cell
were treated the same way except that they were incubated with 1 mg/ml in PBS of
either phycoerythrin (an orange fluorescing 240 kDa algal protein), F1TC-BSA
(approximately 70 kDa), or 4.4 kDa or 145 kDa FITC-dex.
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Inhibitors of endocytosis were tested as follows. Cytochalasin B or sodium azide were
added, at 5 y,M and 15 mM, respectively, to cultures 1 hour before incubation with
FITC-dex. The inhibitors were also present at the same concentrations during the
incubation with FITC-dex. To test the effect of cold, cell pellets were chilled on ice
before resuspending them in cold 1 mg/ml FITC-dex in PBS and incubating them for 20
minutes on ice. The percentage inhibition was determined by comparison with control
cultures in which FITC-dex uptake was allowed to proceed at 37°C in the absence of
inhibitors.

8.B.2.3 Flow Cytometry
In all analyses, relative cell size was measured using the forward angle laser scatter
signal of the flow cytometer.

8.B.2.3.1 Nuclear Staining of Cells
7-aminoactinomycin D (7AAD) is a red fluorescing nuclear dye that can be used to
discriminate between populations of live, apoptotic and dead cells on the basis of
differences in membrane permeability [Schmid, 1994]. For each test, approximately
5xl05 cells were pelleted by centrifugation, resuspended in 50 ul of 20 ng/ml 7AAD in
PBS and incubated, protected from light, on ice for 20 mins. The suspensions were then
diluted to a total volume of 0.5 ml with cold PBS and analysed immediately by flow
cytometry. In some experiments, the nuclear dye Sytox Green (SG) was used similarly

to 7AAD, but at 1 jj.g/ml, to discriminate between viable, apoptotic and dead cells. In
other experiments, dead cells were discriminated by staining with propidium iodide
(PI). In these cases, PI was added at a final concentration of 0.1-1.0 ug/ml to cells
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suspended in 0.5 m l of P B S immediately prior to flow cytometric analysis. Owing to

the lack of an intact cell membrane, the nuclei of dead cells were strongly stained wit
PI and showed a bright orange fluorescence.

8.B.2.4 Preparation of Cells for Electron Microscopy
Transmission Electron Microscopy (TEM) is a routine technique for imaging the
process of endocytosis [Alberts, 1994] using readily detectable tracer molecules such
the 44 kDa protein horseradish peroxidase (HRP). HRP is added to the extracellular

fluid and is taken up by cells by the process of fluid phase endocytosis. Restriction o
the incubation time to 10-15 min allows transfer of HRP to early endosomes [Alberts,
1994]. The cells are then fixed and exposed to a HRP substrate, such as
diaminobenzidine. The product of the enzymatic reaction is then rendered electron

dense by fixation in osmium tetroxide and visualised (after dehydration, embedding and
sectioning of the sample) by TEM.

This technique was used to determine if the uptake of large molecules (such as HRP)
into apoptotic HL60 cells occurs by endocytosis. The cells were induced to undergo

apoptosis by treatment with etoposide for 28 h. At this time it was ascertained by flow
cytometry that 31% of cells were "apoptotic" by the criteria of having mid-range 7AAD

fluorescence, and also had increased green fluorescence, indicating uptake of FITC-dex

Aliquots of 1 Ox IO6 untreated control cells and cells treated with etoposide were pel
by centrifugation (500 g, 5 min) in 15 mL centrifuge tubes, and resuspended in 1 mL of
10 mg/mL HRP in culture media for 10 min at 37°C to enable uptake of the protein. The
cells were then placed on ice, topped up by the addition of 14 mL of ice-cold PBS,
pelleted by centrifugation and then washed twice with centrifugation (500 g, 5 min,
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4°C). The cells were fixed briefly in 2.5% glutaraldehyde in 0.1M sodium cacodylate
(NaCo), 6.8% sucrose for 15 min at room temperature (RT), then washed 3 times for 5
min each with Tris-buffered saline (TBS: 137 mM NaCl, 3.7 mM KC1, 25 mM Tris).
The suspended cells were mixed with an equal volume of low melting point agarose at

37°C in order to minimise cell loss throughout subsequent procedures. After allowing

set, the agarose block was sliced into thin sections (approximately 0.5 mm thick). Th
sections were incubated with 10 mg/mL diaminobenzidine in TBS containing 0.3%
hydrogen peroxide for 60 min at RT on an orbital rotator. After washing 3 times with
100 mM NaCo (pH 7.4) the agarose slices were fixed overnight in 2.5% glutaraldehyde
in 0.1 M NaCo, 6.8% sucrose at 4°C. The cells were post-fixed in 2% osmium tetroxide
in 0.1 M NaCo (pH 7.4) for 4 h at RT. After 2 rinses in 2% sodium acetate they were
stained for 1 h at RT with 2% uranyl acetate, then dehydrated in a graded series of

ethanol. After washing twice for 10 min with propylene oxide (PPO) the agarose blocks

were infiltrated with araldite resin overnight and then embedded in araldite resin a
cured at 60°C, initially for 1 h, and then after replacing the resin, for 48 h. The
were cut into sections 60-90 nm thick ("gold" sections) using a Leica Ultracut S
microtome, stained with uranyl acetate and lead citrate before observation using a
Phillips CM 120 TEM.

8.B.2.5 Fluorescence Microscopy
Fluorescence microscopy was performed using a Leitz DMIL fluorescence microscope
(Leica, Sydney, Australia) and photographs taken using 400 ASA Kodak color print
photographic film. For capturing images of endocytosis, apoptotic HL60 cells were
incubated with 10 mg/ml of 2 x IO6 Da FITC-dex in PBS for 1 hour, washed as above,
and then counter-stained with 0.1 ug/ml PI immediately prior to photography.
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8C

RESULTS

8C.1 Discrimination of Viable, Apoptotic and Dead Cells by 7 A A D
Staining of cultures of cells undergoing apoptosis with 7AAD allowed discrimination
between different cell populations (Fig. 8.1). In cultures of HL60 cells induced to
undergo apoptosis with etoposide and stained with 7AAD, "viable" cells show low red
fluorescence and high forward angle scatter (population 1 in Fig. 8.1). A second
population with low red fluorescence and a reduced forward angle scatter was also

detected (population 2 in Fig. 8.1), representing cells that had undergone apoptotic c
shrinkage but had not stained with 7AAD. Populations with intermediate red
fluorescence ("apoptotic"; population 3 in Fig. 8.1) and high red fluorescence (dead
cells; population 4 in Fig. 8.1) were also clearly detected.

Forward Angle Laser Scatter

•

Figure 8.1: Flow cytometry density plots showing red fluorescence versus forward
angle laser scatter for control untreated H L 6 0 cells (A) and H L 6 0 cells exposed to 20
ug/ml etoposide for 36 hours (B). Following treatment, cells were stained with 7 A A D
as described in section 8.B.2.3.1 and immediately analysed by flow cytometry. In (B),
four populations are discriminated, these are (1) large, 7AAD(-) cells, (2) shrunken
7AAD(-) cells, (3) shrunken cells with intermediate 7 A A D staining (which defines a
stage of apoptosis [Schmid, 1994]), and (4) dead cells. The results shown are
representative of m a n y independent experiments.
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The ability of 7 A A D to discriminate between these populations in cultures of Jurkat,
K562, and murine splenocytes undergoing apoptosis was confirmed (data not shown),
in agreement with the report that the method is broadly applicable to many different
systems of apoptosis [Philpott, 1996]

Apoptosis in etoposide-induced HL60 cells was confirmed by demonstrating condensed
and fragmented nuclei in cells stained with acridine orange and examined by
fluorescence microscopy, together with internucleosomal fragmentation of nuclear
DNA (ie DNA "ladders") by agarose gel electrophoresis (Section 3.C.1.3.2).

8.C.2 Uptake of Macromolecules by Apoptotic Cells
Using staining with 7AAD to discriminate between viable, apoptotic and dead cell
populations, two color flow cytometric analysis was used to test in a variety of
apoptotic systems whether the cells in any of these populations took up significant

amounts of 2x106 Da FITC-dex. In all cases tested, cells discriminated by staining with

7 A AD as "apoptotic" had taken up substantial quantities of FITC-dex relative to viabl
cells that had not stained with 7AAD (Figs. 8.2, 8.3. 8.4). In separate control
experiments, viable cells incubated with FITC-dex had little if any increase in green
fluorescence relative to the same cells incubated in PBS alone (data not shown). This
was as expected, since the 2xl06 Da FITC-dex molecule cannot penetrate intact cell
membranes, and the process of endocytosis in normally functioning cells should result

in internalisation of only small quantities of extracellular molecules in the time all

for uptake (20 min). Dead cells also showed substantial green fluorescence (Fig. 8.2A),
presumably due to non-specific binding of FITC-dex. The two color analyses indicated
that cells defined by staining with 7AAD as apoptotic were, relative to dead cells,
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excluding 7 A A D (1270 D a ) from the nucleus, yet relative to viable cells were taking up
substantial quantities of FITC-dex (2 x IO6 Da). In all cases tested, most if not all
stained to an intermediate level with 7AAD were also positive for FITC-dex uptake
(Figs. 8.2, 8.3), indicating a strong correlation between the phases of increased
membrane permeability and rapid uptake of macromolecules. Examination of apoptotic
cells by fluorescence microscopy indicated that FITC-dex was being internalised and

was not simply bound to the cell surface. HL60 cells, defined by intermediate staining
with 7AAD as apoptotic, internalised all other fluorescently-labelled macromolecules
tested, including, FITC-BSA, and 4.4 kDa and 145 kDa FITC-dex molecules (data not
shown) as well as the orange fluorescing 240 kDa algal protein phycoerythrin
(counterstained with the green fluorescent nuclear dye Sytox Green (SG)) (Fig. 8.2C).
Independent experiments carried out under the same conditions indicated that
intermediate staining with either 7AAD or the nuclear dye SG discriminated the same
population of apoptotic cells (data not shown).

Green Fluorescence

Green Fluorescence

Orange Fluorescence

Figure 8.2: (A) T w o colour flow cytometry density plot showing red fluorescence
( 7 A A D staining) versus green fluorescence (FITC-dex uptake) for H L 6 0 cells induced
to undergo apoptosis by a 36 hour incubation with 20 ug/ml etoposide, followed by
incubation with 2x10 6 D a FITC-dex and staining with 7 A A D as described in 8.B.2.2
and 8B.2.3.1. Three cell populations were clearly discriminated, (1) "viable", (2)
"apoptotic", and (3) dead. (B) Overlay of flow cytometry histograms showing the green
fluorescence of "apoptotic" (defined by intermediate 7 A A D staining; solid line) versus
"viable" cells (7AAD(-); dashed line) for the same H L 6 0 culture represented in (A). (C)
Overlay of flow cytometry histograms showing the orange fluorescence of "apoptotic"
(defined by intermediate staining with S G ; solid line) versus "viable" H L 6 0 cells (SG";
dashed line) incubated with P E and stained with S G as described in 8.B.2.3.1.
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T o ensure that the observed uptake of macromolecules by apoptotic cells was not an
inducer-specific phenomenon, HL60 cells were induced to undergo apoptosis by a
range of cytotoxic agents including the protein kinase inhibitor staurosporine, the

protein synthesis inhibitor Act D and the microtubule disrupting agent colchicine and
then stained with FITC-dex and 7AAD. In each case the population designated as
apoptotic cells on the basis of intermediate staining with 7AAD also exhibited a high
level of green fluorescence, indicating uptake of FITC-dex (Fig. 8.3).

Figure 8.3: T w o colour flow cytometry density plot showing redfluorescence(staining
with 7 A A D ) versus green fluorescence (FITC-dex uptake) for H L 6 0 cells induced to
undergo apoptosis by incubation with staurosporine (A) or actinomycin D (B) for 17 h
or by incubation with colchicine (C) for 21 h, followed by incubation with 2xl0 6 D a
FITC-dex and staining with 7 A A D as described in 8.B.2.2 and 8B.2.3.1. In all cases
cells that stained to an intermediate level with 7 A A D (apoptotic cells) also displayed
high levels of greenfluorescenceindicating uptake of FITC-dex.

To determine if the observed uptake of macromolecules by apoptotic cells was a cell
type-specific phenomenon, the uptake of FITC-dex by a range of other cell types that
had been induced to undergo apoptosis was measured. Jurkat cells were induced to
undergo apoptosis by treatment with staurosporine, K562 cells by treatment with

quercetin and incubation at 42°C (section 8.B.2.1) and murine splenocytes by overnigh
incubation with 0.1 uM dexamethasone. The cells were then stained with FITC-dex and
7AAD. In each case the population designated as apoptotic cells on the basis of
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intermediate staining with 7 A A D also exhibited a high level of green fluorescence,
indicating uptake of FITC-dex (Fig. 8.4).

Green Fluorescence

•

Figure 8.4: Overlays of flow cytometry histograms showing the green fluorescence of
apoptotic (defined by intermediate 7 A A D staining; solid lines) versus viable cells
(7AAD(-); dashed lines) incubated with 2 x IO 6 D a FITC-dex and stained with 7 A A D
as described in sections 8.B.2.2 and 8.B.2.3.I. (A) Jurkat cells induced to undergo
apoptosis by overnight incubation with 2 |ig/ml staurosporine, (B) murine splenocytes
induced to undergo apoptosis by overnight incubation with 0.1 u M dexamethasone, (C)
K 5 6 2 cells induced to undergo apoptosis by treatment with heat and quercetin (Section
8.B.2.1). Each overlay is representative of at least two independent experiments.

To confirm that the cells defined as apoptotic by these analyses still had an intact ce
membrane, the membrane-impermeant orange fluorescing nuclear stain PI, which is
widely employed in flow cytometry to discriminate dead cells was used. Owing to the
broad emission spectrum of PI and its overlap with that of 7 A AD, it was not possible
perform 3-color analysis. Therefore, similar experiments were carried out in which
HL60 cells induced to undergo apoptosis were either incubated with FITC-dex and then

stained with PI, or stained solely with 7AAD prior to flow cytometric analysis. Analysi
of cells that had been incubated with FITC-dex and then stained with PI showed three
cell populations discriminated on the basis of fluorescence (Fig. 8.5). One population
showed low green and orange fluorescence, representing the viable cells (population 1
in Fig. 8.5). A second population showed low to intermediate orange fluorescence and

high green fluorescence (population 2 in Fig. 8.5). Since it is known that under simila
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conditions to those used here apoptotic cells show intermediate staining with PI [Zamai,
1996], and we have already demonstrated that the apoptotic population defined by
intermediate staining with 7AAD takes up FITC-dex, it is very likely that this
population corresponds to the 7AAD-intermediate, FITC-dex-positive populations
detected in results already shown (Fig. 8.2A). This is confirmed by the demonstration

that the fraction of cells in population 2 (Fig. 8.5) is (within experimental variation
exact match for the fraction of cells discriminated as being in the 7AAD-interrnediate

population in the samples stained in parallel (Table 8.1). The final population showing

high green and orange fluorescence (population 3 in Fig. 8.5) represents dead cells, wit

the fraction of cells in this population matching the fraction of 7AAD-high cells in th

samples stained in parallel (Table 8.1). These results confirmed that the cells defined
intermediate staining with 7AAD had an intact cell membrane.
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Green Fluorescence
Figure 8.5 Flow cytometry density plot showing two colour analysis of a culture of
H L 6 0 cells induced to undergo apoptosis by exposure to 20 ug/ml etoposide for 24
hours, then incubated with 2xl0 6 D a FITC-dex and stained with PI as described in
Sections 8.B.2.2 and 8.B.2.3.I. Three populations are discriminated, these are (1) cells
showing low green and orange fluorescence, (2) cells showing low to intermediate
orange fluorescence and high green fluorescence, and (3) cells showing high green and
orange fluorescence. See also Table 1 for statistical analysis.
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Table 8.1: Data showing a comparison of the fraction of cells (in aliquots taken from
H L 6 0 cultures induced to undergo apoptosis as described in the Figure 8.5 legend) in
various sub-populations defined by fluorescence. Aliquots of cells were stained as
described in the Figure 8.5 legend, or stained with 7 A A D alone, and analysed by flow
cytometry. Thefractionof cells showing low staining with 7 A A D corresponded to that
represented by region 1 of Figure 8.5. Similarly, the fractions of cells with intermediate
and high staining with 7 A A D corresponded to those represented by regions 2 and 3,
respectively, in Figure 8.5. This indicates that cells defined as apoptotic by intermediate
staining with 7 A A D , relative to dead cells lacking an intact cell membrane, exclude
both of the small nuclear dyes 7 A A D and PI yet still take up large amounts of a 2 x IO6
D a macromolecule (FITC-dex).
Cell Population Defined
7AAD(-)
low green and orange fluorescence (region 1, Fig.8.5)
intermediate 7 A A D staining
low to intermediate orange fluorescence and high green
fluorescence (region 2, Fig.8.5)
high 7 A A D staining (dead cells)
high orange and green staining (region 3, Fig. 8.5)

8.C.3

M e a n % +/- S D
37.1+/-1.1
38.5+/-1.5
16.0+/-1.2
15.5+/-1.1
43.5+/-2.2
40.3+/-1.8

Fluorescence Microscopy of FITC-dex Uptake

In order to further investigate the uptake of macromolecules into apoptotic cells,

cultures of HL60 cells were induced to undergo apoptosis by treatment with etoposid
allowed to take up FITC-dex and then stained with PI. Fluorescence microscopy of

apoptotic cells incubated with FITC-dex showed that the internalised macromolecules

were not uniformly distributed throughout the cytoplasm, but rather were restricted
localised intracellular "granules", presumably representing membrane-surrounded
vesicles (Fig. 8.6).
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Figure 8.6: Photographs showing H L 6 0 cells induced to undergo apoptosis by
incubation with 20 ug/ml etoposide for 35 hours, then incubated with 10 mg/ml of 2 x
IO 6 D a FITC-dex in P B S , and stained with 0.5 ug/ml PI (Sections 8.B.2.2 and
8.B.2.3.1). (A) Bright field illumination. (B) The same field under fluorescence
illumination. "Healthy" cells (1) are visible as those that have not acquired either green
or orange fluorescence and have an intact plasma membrane w h e n viewed by bright
field microscopy. Apoptotic cells (2) are visible as those that have taken up FITC-dex
(showing green fluorescence) but have not stained with PI and therefore show no
orange fluorescence. Note that in these cells, FITC-dex appears to be localised within
small "granules" which are presumably intracellular vesicles. Dead cells (3) can be seen
as those that have stained with PI and show strongly orange fluorescent nuclei.
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8.C.4

Establishing that Apoptotic Cells Perform Rapid

Endocytosis
The exclusion of small nuclear dyes by the cell membrane, together with the localised
intracellular distribution of internalised FITC-dex, suggested that the uptake of
macromolecules by apoptotic cells may result from endocytosis. To further test this
hypothesis normal HL60 cells and cells that had been induced to undergo apoptosis for
28 h using etoposide were allowed to take up the 44 kDa protein HRP, fixed and
prepared for TEM imaging. Comparisons were made between the morphologies of

untreated control cells and apoptotic cells (Fig. 8.7, overleaf). Areas of electron de

material (corresponding to internalised HRP) were not readily apparent, perhaps due to
problems with sample preparation which forced the use of low EM voltages for sample
analysis. However, in agreement with the work of Sit et al. [Sit, 1994] TEM
micrographs of apoptotic cells (Fig 8.7B) showed the presence of large endocytic
channels and large endosomes containing extracellular debris, presumably HRP. These
channels and endosomes were not observed in untreated control HL60 cells (Fig. 8.7A).
Apoptotic HL60 cells also exhibited a high degree of vesicularisation with a large

proportion of the cytosol being occupied by vesicles (Fig. 8.7B), whereas the extent of

vesicularisation was much lower in untreated control cells (Fig. 8.7A). The presence of
characteristic endocytic morphologies in apoptotic cells supports the hypothesis that
apoptotic cells rapidly internalise macromolecules by endocytosis.
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Figure 8.7: T E M micrographs of a (A) healthy untreated H L 6 0 cell and a (B) H L 6 0
cell induced to undergo apoptosis by incubation in etoposide for 28 h. Red arrows point
to large endosomes containing extracellular material. Black arrows point to large
endocytic channels containing extracellular material. These characteristic endocytic
structures were observed in apoptotic H L 6 0 cells but not in normal untreated cells. The
blue arrows point to intracellular vesicles which were m u c h more prevalent in apoptotic
cells than in untreated cells. Magnification 8,000X (A), 18,000X (B).
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To further confirm these findings, the effects of several reported inhibitors of endocytic
processes [Ollinger, 1995; Takakura, 1995] on the uptake of FITC-dex by apoptotic

cells was examined. The results shown in Fig. 8.8 indicate that low temperature, azide
and cytochalasin B all produce significant inhibition of the uptake of FITC-dex by
apoptotic HL60 cells. Although it is not clear why none of the treatments tested
completely inhibited the uptake of FITC-dex by apoptotic HL60 cells, collectively the
results shown in Figs. 8.6, 8.7 and 8.8 indicate that the uptake of macromolecules by
apoptotic HL60 cells is due to a process of rapid endocytosis.

Cytochalasin B

Cold

Azide

0 10 20 30 40

% inhibition of FITC-Dx uptake

Figure 8.8: Bar graph showing for HL60 cells defined by intermediate staining with
7 A A D as apoptotic, the percentage inhibition of uptake of 2 x IO 6 D a FITC-dex by
treatment with cytochalasin B, cold or sodium azide (Section 8.B.2.2). The results
shown represent the means of the specified number of independent experiments. Error
bars represent the standard error of the mean in each case. H L 6 0 cells were incubated
with 20 jig/ml etoposide for 8 hours (cytochalasin B, n=6) or 16-24 hours (cold, n=3;
azide, n=4).
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8.C.5

Determining the Sequence of Changes in Cell Size,

Membrane Permeability, and Endocytosis in Apoptotic
HL60 Cells
In order to rigorously define the sequence of changes taking place in cell size,
membrane permeability and endocytosis in HL60 cells during apoptosis, preliminary
time course experiments were performed in which all of these parameters were
measured at intervals following the induction of apoptosis using etoposide. These
results were supplemented by more extensive time courses in which apoptosis was
induced in HL60 cells with either Act D or etoposide (completed by other students in

our laboratory in parallel time courses). Between 4 and 8 hours after the induction of

apoptosis, there was a rapid increase in the fraction of cells that had undergone cell
shrinkage. The percentage of cells that were defined by intermediate staining with

7AAD as apoptotic had begun to increase by 8 hours after induction (Figs. 8.9 and 8.10
but was considerably lower than the percentage of cells that had undergone cell
shrinkage, suggesting that the transition to a stage of "intermediate" membrane

permeability did not take place until after apoptotic cell shrinkage. This was confirm
by further analysis of the data, which showed that when the first cells stained to an
intermediate level with 7AAD appeared, they had all already undergone cell shrinkage
(Fig. 8.11).
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Figure 8.9: Plot showing, for cultures of HL60 cells induced to undergo apoptosis by
exposure to 20 ug/ml etoposide, the proportion of cells at various times that had
undergone apoptotic shrinkage (blue line), that were defined as apoptotic by
intermediate staining with 7 A A D (red line) and that had taken up 2 x IO 6 D a FITC-dex
(green line). The results were highly reproducible, those shown being representative of
m a n y independent experiments. Very similar results were obtained for cultures of H L 6 0
cells induced to undergo apoptosis by exposure to Act D (Fig. 8.10).

M o r e extensive time courses showed that most cell shrinkage occurred early in the
course of apoptosis, with approximately 50% of cells being affected at 8 h after
induction of apoptosis. The percentage of the total cell population that took up FITCdex and that underwent an increase in membrane permeability resulting in intermediate
staining with 7AAD increased at a slower rate, affecting approximately 75% of cells by
45 h after induction of apoptosis (Fig. 8.10). The results demonstrate that rapid
endocytosis persists after the increase in membrane permeability (Figs. 8.9 and 8.10).
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Figure 8.10: Plot showing, for cultures of H L 6 0 cells induced to undergo apoptosis by
exposure to 5 ug/ml actinomycin D, the proportion of cells at various points in time
after induction (i) having undergone apoptotic shrinkage (triangles), (ii) defined as
apoptotic by intermediate staining with 7 A A D (circles), and (iii) that have taken up 2 x
IO 6 D a FITC-dex (squares). Each data point shown represents the m e a n of three
replicate measurements, taken from a single experiment. The results were highly
reproducible with those shown being representative of m a n y independent experiments.
The error bars shown represent standard errors (SE) of the mean. In most cases the S E
are too small to be visible. (Results shown are those of Katrina Giles).

The data shown in Figs. 8.9 and 8.10 indicate that the proportion of cells taking up
FITC-dex was consistently lower than the corresponding fraction of cells that had
undergone cell shrinkage. Further analysis of the data confirmed that when the first
FITC-dex-positive cells appeared, they had all already undergone cell shrinkage (Fig.
8.12) ie. rapid endocytosis (as for the increased membrane permeability detected by
7AAD), begins after apoptotic cell shrinkage.
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shrunken cells that have
not taken up 7 A A D

shrunken and

Figure 8.11: 3-D flow cytometry plots showing changes through time in the cell size
(measured by forward angle laser scatter) and staining with 7 A A D (measured as red
fluorescence) in a culture of H L 6 0 cells induced to undergo apoptosis by incubation
with 20 ug/ml etoposide. After 8 h, substantial numbers of the cells had shrunken and
populations of small cells that stain to an intermediate level with 7 A A D began to
appear. Note that at all time points, there were no large cells detected that stained with
7 A A D . After 16 h, most of the cells had shrunken and m a n y small cells stained to an
intermediate or high level with 7 A A D were present. After 36 h virtually all events
detected by the flow cytometer were shrunken apoptotic cells (7AAD-intermediate) or
dead cells (7AAD-high). Each plot represents data acquired for 10,000 cells. The results
shown are representative of m a n y independent experiments. Similar results were
obtained for H L 6 0 cells induced to undergo apoptosis with actinomycin D (data not
shown).

256

shrunken cells that have
not taken up FITC-dex

shrunken and

Figure 8.12: 3-D flow cytometry plots showing changes through time in the cell size
(measured by forward angle laser scatter) and the uptake of 2 x 10 6 D a FITC-dex
(measured as green fluorescence) in a culture of H L 6 0 cells induced to undergo
apoptosis by incubation with 20 ug/ml etoposide. After 8 h, a population of shrunken
cells is apparent and a small fraction of these have taken up FITC-dex. After 16 h all
cells have shrunken and a substantial FITC-dex(+) population is evident. After 36 h
virtually all cells show uptake of FITC-dex. Note that there was no significant
population of large, FITC-dex(+) cells detected at any time point. Each plot represents
data acquired for 10,000 cells. The results shown are representative of m a n y
independent experiments. Similar results were obtained for H L 6 0 cells induced to
undergo apoptosis with actinomycin D (data not shown).
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The data in Figs. 8.9 and 8.10 show that the percentage of cells taking up FITC-dex is
higher than that of cells staining with 7AAD to an intermediate level. This suggested

that apoptotic HL60 cells may begin rapid endocytosis before undergoing an increase in
membrane permeability. The data analysis represented in Fig. 8.13 confirmed this,

indicating that about 8 hours after induction a small population of FITC-dex-positive,
7AAD-negative cells was detected. At this and at later time points, there was a
population of cells that were FITC-dex-positive and had either intermediate or high
level 7AAD staining (Fig. 8.13). All cells that were stained to these levels with 7AAD
had also taken up FITC-dex indicating that FITC-dex uptake occurred prior to changes
in membrane permeability.
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Figure 8.13: 3-D flow cytometry plots showing changes through time in the staining of
cells with 7 A A D (measured as redfluorescence)and uptake of FITC-dex (measured as
green fluorescence) in a culture of H L 6 0 cells induced to undergo apoptosis by
incubation with 20 ng/ml etoposide. After 8 h a small "shoulder" population of FITCDx(+), 7 A A D ( - ) cells was detected. After 16 h a discrete FITC-Dx(+), 7 A A D intermediate population was detected, and at longer exposures (such as at 36 h) this
population was substantial. Each plot represents data acquired for 10,000 cells. The
results shown are representative of m a n y independent experiments. Similar results were
obtained for H L 6 0 cells induced to undergo apoptosis with actinomycin D (data not
shown).
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In summary, the data in Figs. 8.9-8.13 indicate that the sequence of events during H L 6 0
cell apoptosis is:
(1) cell shrinkage,
(2) rapid endocytosis, and finally
(3) an increase in membrane permeability
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8D

DISCUSSION

The results presented here indicate that during apoptosis H L 6 0 cells pass through a
stage where the plasma membrane remains intact, restricting free access of small dyes

to the nucleus, yet has a greater permeability to these dyes than the membranes of nonapoptotic cells. Furthermore, this stage of apoptosis is at least approximately

coordinated in time with the behaviour of rapidly internalising macromolecules present

in the external medium into the cell, consistent with a process of rapid endocytosis. T
demonstration that during apoptosis of Jurkat, K-562 cells and murine splenocytes,
there is a correlation between increased staining with 7AAD (to an intermediate level)
and uptake of macromolecules, suggests that a coordination between an increase in cell
membrane permeability and rapid endocytosis may be a general feature of cells
undergoing apoptosis.

Rapid endocytosis and an increase in cell membrane permeability do not occur during
volume reduction but take place after the process is complete. These findings have
important implications concerning the mechanisms involved in apoptotic cell shrinkage.
A model in which following reduction of volume, apoptotic cells have an excess of
plasma membrane which is later reduced by synergy between endocytic and exocytic
processes would encompass these results. The results are compatible with the
occurrence of a stage of apoptosis in which shrunken cells have an excess of plasma
membrane. Apoptotic cells characteristically display membrane blebbing, which may

play an important physiological role in the recognition and disposal of the cell corps
vivo.
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O f two "cardinal features of apoptosis" [Kerr, 1991], fragmentation of nuclear D N A has

received far greater attention than apoptotic cell shrinkage. However, cell shrinkage i
of considerable physiological importance during apoptosis. The integrity of the cell
membrane is not maintained during necrosis, which culminates in the lysis of the cell

and the release of its total contents into the surrounding tissue spaces, often produci
harmful inflammatory response. In contrast, during apoptosis the integrity of the cell
membrane is maintained and the cell contents are compressed into a reduced volume.

This generally avoids any inflammatory response and probably also facilitates ingestion
of the cell corpse by macrophages or other phagocytic cells. Shrunken cells with
"ruffled" or "blebbed" cell membranes are regarded as having classical morphological

features of apoptosis [Kerr, 1995], yet little is known about the mechanisms responsible
for this morphology. It has been suggested that during apoptotic cell shrinkage, rapid
endocytosis might act as a mechanism to reduce the surface area of the plasma
membrane [Sit, 1994]. We used FITC-dex as a fluorescent tracer to test whether HL60,
Jurkat, and K562 cells, and murine splenocytes, performed rapid endocytosis during
apoptosis, and how this process was related in time to apoptotic cell shrinkage and
changes in membrane permeability.

The results (in combination with those of other research students working in our
laboratory) demonstrated that in all models of apoptosis tested, virtually all cells
discriminated as apoptotic on the basis of intermediate staining with 7AAD showed
significant uptake of 2 x IO6 Da FITC-dex. This suggested that there was a correlation
in time between the well documented increase in membrane permeability that takes
place during apoptosis and rapid endocytosis. An alternative explanation would be that
the increase in permeability is sufficient to allow macromolecules to cross the cell
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membrane by diffusion and enter the cytosol. However, this seems unlikely for several
reasons. Firstly, the size of internalised 2 x IO6 Da FITC-dex particles has been

estimated by electron microscopy to be 1-5 urn [Sit, 1991]. Holes of this size in the c
membrane would allow free access of most molecules to the cell interior (and the

nucleus). However, it was demonstrated that relative to dead cells, apoptotic cells tak
up 2 x IO6 Da FITC-dex exclude from the nucleus the small 1270 Da nuclear stain
7AAD. It was further shown that apoptotic HL60 cells taking up 2 x IO6 Da FITC-dex
also exclude the 668 Da molecule PI from the nucleus. Secondly, if FITC-dex was

simply diffusing into apoptotic cells, it would be expected to homogeneously distribute
throughout the cytosol. However, fluorescence microscopy revealed that FITC-dex was
internalised within small discrete "patches" which presumably contained intracellular
vesicles. TEM micrographs showed that classical features indicative of endocytosis

were present in cells undergoing apoptosis but not in normal untreated cells. Lastly, i
was demonstrated that known inhibitors of endocytosis, including sodium azide and
cytochalasin B significantly inhibited the uptake of FITC-dex. Therefore, the results
indicate that rapid endocytosis of macromolecules was detected in all models of
apoptosis tested. Taken together with the results reported for Chang liver cells [Sit,

1994] our results suggest that rapid endocytosis is a general feature of cells undergo
apoptosis.

With the aim of precisely defining the sequence of changes in cell size, membrane
permeability and endocytosis during apoptosis, a series of time course experiments was
carried out using HL60 cells induced to undergo apoptosis by treatment with either
etoposide or actinomycin D. Detailed analyses of these data indicate that during
apoptosis most HL60 cells began rapid endocytosis some time after cell shrinkage and
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that this is closely followed by an increase in the permeability of the cell membrane
(shown by a transition to intermediate staining with 7AAD). In the models of apoptosis

tested, essentially all cells showing intermediate staining with 7AAD and/or uptake of
FITC-dex were reduced in size compared to "viable" cells not stained with 7AAD. This
suggests that rapid endocytosis, and an increase in membrane permeability, are
generally activated during apoptosis following cell shrinkage. The fact that the

permeability of the cell membrane does not increase until after apoptotic cell shrinka

is consistent with a role for ion export in effecting osmotic water loss from the cell
cause a loss of cell volume. Apoptotic cell shrinkage has been correlated with a

decrease in intracellular levels of K+ [Bortner, 1999 ; Benson, 1996] as well as the l
of the organic osmolyte taurine [Lang, 1999]. These changes have been shown to
precede changes in the permeability of the plasma membrane [Benson, 1996; Lang,
1998]. The critical role of intracellular K+ levels in controlling cell volume changes
in regulating the activities of enzymes involved in apoptosis has recently been
demonstrated by Bortner et al. who have shown that maintenance of normal
intracellular K+ levels inhibits the activation of caspases and of the endoncleases
responsible for internucleosomal DNA fragmentation [Bortner, 1999; Hughes, 1999;
Hughes, 1997].

If we accept the hypothesis that ion export is responsible for the loss in cell volume

it follows that there must be an additional mechanism in place to reduce the surface a
of the plasma membrane following cell volume reduction. The same corollary is
required if we were to accept the hypothesis that cell volume reduction is achieved by
exocytosis of cellular contents, as proposed by Benson et al. [Benson, 1996]. It has

been shown that rapid endocytosis does not take place until after apoptotic volume los
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If rapid endocytosis acts as part of a mechanism to reduce cell surface area, then it

follows that in cell populations undergoing apoptosis there exists a transient populati
of shrunken cells with "loose" plasma membranes. This suggestion is supported by the
widely reported classical apoptotic morphology of shrunken cells with "ruffled" or
"blebbed" cell membranes [Cohen, 1993]. The delay after cell volume loss before
reduction of surface area may be physiologically important. The "looseness" of the
membrane may be important in facilitating the concentration of phosphatidylserine

(PS), exposed on the outer surface of the membrane during apoptosis, into foci initiall

on cell surface blebs, as described in [Casciola-Rosen, 1996]. Comparison of the timing
of PS exposure (Section 3.C.1.2) with that of shrinkage of etoposide-induced HL60
cells shows that the two events occur concurrently, both being initiated 4h after

induction of apoptosis. PS exposure has been implicated in the recognition of apoptotic

cells by phagocytes [Martin, 1994], so this process may aid disposal of the cell corpse
The excess cell membrane may also be important in facilitating formation of "apoptotic
bodies" [Cohen, 1993], small membrane-surrounded vesicles containing parcels of

intracellular contents. These provide still greater reduction in size of the individual
packets of cellular material to be phagocytosed, thereby further aiding safe disposal.

If rapid endocytosis acts to reduce the cell surface area following volume reduction

effected by either osmotic water loss or exocytosis, this would also act to increase th
volume held within the cell. The increase in volume produced by rapid endocytosis may
be counteracted to maintain the observed stably shrunken morphology of apoptotic cells

by osmotic water loss driven by the selective export of ions. The data demonstrates tha
once begun, apoptotic cells maintain a process of rapid endocytosis for an extended
time, probably until they cease all functions and are defined as dead. This ongoing
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endocytic activity would not be necessary to maintain cell size, and so m a y be
performing some other function(s) in apoptosis which remain to be elucidated. Taken

together with the results presented in Chapter 3, it can be seen that the cell shrinkag

that is recognised as one of the earliest morphological changes of apoptosis, is preced
in etoposde-induced HL60 cells by high molecular weight DNA fragmentation, release
of cytochrome c from mitochondria, activation of caspase-3 and internucleosomal DNA
fragmentation. Cell shrinkage is correlated in time with loss of AWma in this system,

with the exposure of PS at the cell surface, which functions together with cell shrink
to facilitate the disposal of the cell corpse.
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Concfusions
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In recent years there has been intense research interest focussed on elucidating the
molecular mechanisms involved in the regulation and execution of apoptosis. An
increased understanding of these mechanisms could provide the basis for the
development of improved therapeutics for the treatment of the wide range of human
diseases in which dysfunctions of apoptosis, resulting either in uncontrolled
proliferation or in inappropriate cell death, are implicated.

At the time of initiation of this project, caspases and the Bcl-2 family of proteins we

well known as important regulators of apoptosis. Also at this time, Kroemer's group had
proposed that PT, a well-known phenomenon in normal functioning mitochondria

[Zoratti, 1997], was the cause of the loss of ATmh that was shown by this group to occu
in many systems of apoptosis [Kroemer, 1995]. They later claimed that PT was the
integration point for all apoptotic signals and the trigger for all degradation phase
events, ie. that PT is the executioner of apoptosis [Kroemer, 1995].

A detailed understanding of the chronology of cellular events in apoptosis is required
order to gain insight into the mechanisms involved and to identify the critical

components of the execution phase. At the time of initiation of this project there were

very few reports providing a detailed chronology of apoptotic events, particularly with
respect to the recently implicated mitochondrial changes. The work described here has
provided a detailed chronology of the cellular events that occur in HL60 cells in
response to the apoptosis-inducing agents etoposide and staurosporine, in U-937 cells
response to the combination of TNFa and cylcloheximide, and in Jurkat cells in
response to staurosporine, anti-Fas antibody and etoposide.
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Characteristic morphological and biochemical changes of apoptosis including
shrinkage, membrane blebbing, chromatin condensation and fragmentation, high
molecular weight and internucleosomal DNA fragmentation, activation of caspases and
phosphatidylserine exposure were all shown to occur in the cell systems studied. The
loss of mitochondrial transmembrane potential was found to occur in all cell systems

studied, and the timing of this in relation to other apoptotic events was established.

use of BA as a specific inhibitor of PT allowed assessment of the role of PT as a trig
of the degradation phase events of apoptosis.

In order to investigate whether PT could be the mechanism for the release of
cytochrome c from mitochondria, the release of cytochrome c in each of the apoptotic
systems studied was measured and the timing of this in relation to mitochondrial

depolarisation was determined. This was further investigated by using BA to inhibit PT
and examining the effect of this inhibition on the release of cytochrome c.

Jurkat Cell Apoptosis
The chronology and timing of apoptotic events was found to be very similar for Jurkat
cells induced to undergo apoptosis by either staurosporine or anti-Fas antibody, with

loss of A^mit occurring at about the same time as release of cytochrome c and the earl
high molecular weight fragmentation of DNA. These events preceded activation of
caspase-3, and internucleosomal fragmentation of DNA (Fig. 9.1). Exposure of PS
appeared to be initiated slightly before loss of AYmit in the case of staurosporineinduced apoptosis of Jurkat cells, whereas in the case of anti-Fas antibody-induced

Jurkat cells, exposure of PS appeared to be delayed until after the onset of ATmit loss
Although the chronology of apoptotic events in Jurkat cells treated with anti-Fas
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antibody or with staurosporine was similar, the pathways involved in apoptosis in these
two systems may be markedly different with respect to the role of PT in triggering
degradation phase events. In the case of staurosporine-triggered apoptosis, the release
cytochrome c, activation of caspase-3 and degradation phase events including DNA
degradation and PS exposure were inhibited by BA, indicating that these events were
triggered by PT. When Jurkat cells were induced to undergo apoptosis by ligation of
anti-Fas antibody, although the loss of A^it preceded degradation phase events, the
lack of inhibition of these events by BA suggested that PT may not be responsible for
triggering degradative events (Table 9.1). An alternative explanation is that a BAinsensitive form of PT may trigger degradative events in this system, eg. activated
caspases have been shown to trigger loss of AYmit in vitro, via a mechanism that was not
inhibitable by BA [Susin, 1997a; Marzo, 1998b].

Recently it has become clear that there are two major programs of execution in
apoptosis, the cell surface death receptor pathway that proceeds primarily via caspase
activation and is substantially mitochondria-independent, and an alternative pathway in
which mitochrondrial dysfunction plays a more significant role [Budihardjo, 1999;

Scaffidi, 1998]. It is likely that different cell types and inducers of apoptosis act via
different pathways. The results detailed above, and the early activation of caspase-8
followed by later activation of caspase-3 measured in anti-Fas antibody-induced Jurkat
cells, are compatible with the mitochondria-independent model of apoptosis. In this
model, caspase 8 activation at the DISC results in downstream activation of caspase-3
and subsequent degradation phase events of apoptosis [Scaffidi, 1998]. In contrast, it

appears that in the Jurkat/staurosporine system, PT triggers the release of cytochrome c
and subsequent downstream events. Caspase activation is critical to both major
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pathways, resulting from the ligation of cell surface receptors or as a result of
cytochrome c release. Activated caspases may feed back to mitochondria leading to
amplification of the apoptotic process, as suggested by Reed [Reed, 1997]. Activation
of caspase-8 in the Fas and TNFa pathways has been linked to mitochondrial changes
including loss of A*Pmh [Li, 1998]. The caspase-dependent depolarisation of
mitochondria in U-937 and Jurkat cells induced to undergo apoptosis by the pinocytic

loading of cytochrome c, described in this work, is further evidence for the existence
a caspase-dependent feedback loop from cytochrome release to mitochondria to initiate

loss of ATmit, further cytochrome c release and subsequent amplification of the apopto
process.

HL60 Cell Apoptosis
Internucleosomal DNA fragmentation in HL60 cells occurred prior to loss of ATmit,

independently of the inducing agent used (ie. for etoposide or staurosporine) (Fig. 9.
This was a cell-type-specific phenomenon, since in Jurkat cells induced to undergo
apoptosis by either etoposide or staurosporine, a loss of ATmit occurred at about the
same time as internucleosomal DNA fragmentation. The demonstrations that in
etoposide-induced HL60-cells (i) cytochrome c release occurred prior to loss of AYmit

and (ii) cytochrome c release was not inhibited by BA, suggest that PT does not control
cytochrome c release in this system. The inhibition of PT in etoposide-treated HL60
cells did not inhibit caspase-3 activation, DNA fragmentation or PS exposure, again

indicating that PT is not the critical executioner for all systems of apoptosis (Table
The results reported here are compatible with the work of Wang et al. [Liu, 1996] and
other more recent reports demonstrating that in HL60 cells, the loss of A^mit does not
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play a role in controlling the onset of degradation-phase events or the release of ~
cytochrome c [Finucane, 1999b; Tang, 1998].

U-937 cell Apoptosis
In U-937 cells treated with TNFa and cycloheximide, loss of AVm« preceded release of
cytochrome c, activation of caspase-3 and subsequent degradation phase events (Fig.
9.1). The incomplete inhibition of loss of AYrait by BA in this system may reflect BAinsensitive induction of PT, or alternatively, may suggest that PT is not solely
responsible for the observed loss of AHW in these systems (Table 9.1). Activation of

caspases has been shown to initiate in vitro mitochondrial changes including release o
cytochrome c [Bossy-Wetzel, 1999] and PT [Susin, 1997a] via a mechanism that was
not BA-inhibitable.
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Models of Apoptosis
In HL60 cells induced to undergo apoptosis by either etoposide or staurosporine, the

observed chronology of events and the lack of effect of inhibition of PT on subsequent
degradation phase events is compatible with a model of apoptosis in which degradation
phase events are not triggered by PT (Model 2, Section 1.A.13). The
Jurkat/staurosporine system is compatible with a model in which PT is upstream of and
is the trigger for degradation phase events (Model 1, Section 1.A.13). The chronology

of events in Jurkat cells induced to undergo apoptosis by anti-Fas antibody binding an
in U-937 cells induced to undergo apoptosis by TNFa and cycloheximide are
compatible with a model in which PT is upstream of degradation phase events, however
in these systems, PT may not be be the trigger, or at least not the sole trigger of
degradation phase events. A definitive assessment of the compatibility of these cell
systems with either Model 1 or Model 2 therefore cannot be made based on the current

results. Collectively, the results suggest that a loss of ATmit is not a universal early

marker of apoptosis and that PT is not always a critical triggering event in apoptosis
(Table 9.1).
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Table 9.1: S u m m a r y of the role of P T in each of the cell systems studied

Cell System

Loss of AT mit re.
degradation phase
events

Effect of B A on
AYmit, and

Compatiblity with
theoretical model

degradation phase
events

HL60:
etoposide
staurosporine

later than
later than

no inhibition

Model 2
(Section LA. 13)

prior to
prior to

no inhibition
inhibition

Model 1 or Model 2
Model 1
(Section LA. 13)

prior to

partial inhibition

Model 1 or Model 2
(Section 1.A.13)

Jurkat
anti-Fas antibody
staurosporine

U-937
TNFa/CHX

The Role of Cytosolic Cytochrome c in Apoptosis

The pinocytic loading of cytochrome c into the cytosol of Jurkat and U-937 cell
mimicked the release of mitochondrial cytochrome during apoptosis, and allowed the
specific effects of cytochrome c to be monitored in large numbers of cells. The presence
of cytosolic cytochrome c was found to trigger the activation of caspase-3-, -8- and -9like enzymes, the loss of A^mit, exposure of PS and internucleosomal fragmentation of
D N A . These findings are compatible with the release of mitochondrial cytochrome c in
these cell types being a critical event in apoptosis. Pinocytic loading was found to be a
gentle technique for the efficient loading of macromolecules into large numbers of cells
with limited detrimental effect on cell viability. The technique therefore offers an
alternative to transfection, microinjection and electroporation for studies of proteins
thought to regulate apoptosis.
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The finding that introduction of cytochrome c into the cytosol leads to activation of
caspase-3- and -9-like enzymes and subsequently to DNA fragmentation, supports

previous reports that in cell-free systems release of cytochrome c leads to the formati
of a tetramolecular complex that results in activation of caspase-9, followed by
sequential activation of caspase-3 and DNA fragmentation [Li, 1997b]. This report

describes the first direct measurements of the activation of these enzymes specifically
induced by the introduction of cytochrome c into intact cells.

Mitochondrial depolarisation was specifically induced by pinocytic loading of
cytochrome c, and appeared to result from high conductivity PT. The loss of AYmit in

Jurkat and U-937 cells pinocytically loaded with cytochrome c provides the first direct
evidence for the operation of a cytochrome c feedback loop in intact cells undergoing
apoptosis. The inhibition of the loss of AYmit by the caspase inhibitors zVAD.fmk and
DEVD.CHO demonstrates that activation of caspase-3-like enzymes was directly or
indirectly responsible for the mitochondrial changes measured. Activated caspases have
been shown to cause loss of A^IVt in isolated mitochondria and in intact cell systems
[Li, 1998; Bossy-Wetzel, 1999; Marzo, 1998b; Susin, 1997a]. The current results
suggest that, in intact cells, activated caspases feed back to mitochondrial to elicit

although it is uncertain whether PT is elicited directly or via the proteolytic activat
of other molecules (eg. Bid). The inhibition of cytochrome c-induced PS exposure and
DNA fragmentation by zVAD.fmk and DEVD.CHO is evidence of the caspasedependence of the degradation-phase events of apoptosis, supporting the role of
caspases as effectors of apoptosis [Nicholson, 1999].
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The Role of Endocytosis in Apoptosis
An investigation into the role of endocytosis in apoptosis provided insight into a

potential mechanism involved in apoptotic cell shrinkage, a neglected area of apoptosis

research. It was shown, in a range of cell types including HL60, Jurkat, and K-562 cells,
and in murine splenocytes, that cells undergoing apoptosis rapidly take up
macromolecules which are localised in discrete patches in the cytoplasm, presumably

contained within intracellular vesicles and consistent with uptake via endocytosis. Thi
rapid endocytosis was shown to occur after cell shrinkage and prior to initial changes
membrane permeability. The timing of these events provides insight into the
mechanism for the dramatic reduction in surface area that occurs during apoptosis. The

observed rapid endocytosis is compatible with a model proposed by Sit et al. [Sit, 1994
in which rapid endocytosis facilitates reduction of the excess plasma membrane that
would result from a reduction in cell volume. The fact that the permeability of the cell

membrane does not increase until after apoptotic cell shrinkage is consistent with a ro
for ion export in effecting osmotic water loss from the cell to cause a loss of cell
volume [Bortner, 1999; Lang, 1998]. The observed shrinkage of etoposide-induced
HL60 cells, one of the "hallmark" morphological changes of apoptosis was preceded in
time by both high molecular weight and internucleosomal fragmentation of DNA. In

this system, cell shrinkage was also preceded by release of cytochrome c and activation
of caspase-3 and was correlated in time with loss of AYmit and PS exposure. The
changes in membrane permeability that allow increased staining of apoptotic cells with
nuclear dyes such as PI and 7AAD are late stage events, occurring well after other
degradation phase events including PS exposure, and are therefore not sensitive
indicators of the onset of apoptosis.
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Contributions of this W o r k
The use of insensitive detection techniques such as the flow cytometric DNA assay for
detection of DNA degradation, or the use of dyes such as Rhodamine 123 that are
insensitive to changes in A^t [Bemardi, 1999; Metivier, 1998] for measurement of

loss of mitochondrial membrane potential, can lead to errors in the establishment of the

relative timing of events, and hence to misinterpretation of the role of these events in
apoptosis. The assumption that the technique of CMX-Ros staining followed by fixation

of cells is applicable to the measurement of loss of AY^t during apoptosis is a further

example of the use of inappropriate techniques leading to flawed results. As part of the
current work, it was demonstrated that CMX-Ros fluorescence associated with fixed

cells cannot validly be used as an indication of AYrait prior to fixation [Gilmore, 1999]
It was shown that the use of CMX-Ros in multiple-parameter analysis of fixed cells to

quantify the numbers of apoptotic cells that have reduced AYmit would lead to errors in
the determination of the timing and extent of collapse of ATmit. CMX-Ros was therefore
shown to be a valid probe for ATmit in intact cells, but only when the cells are stained
and analysed immediately. In the current work, staining conditions to measure AYmit
were optimised and the decrease in fluorescence intensity of DiOC6-stained cells was

shown to reflect a loss of A"¥m[t. Cells were analysed in the staining solution, without
washing, allowing the equilibrium concentration of dye (which directly reflects the
electrochemical gradient following the Nernst equation) to be maintained during
analysis of A*Fmit.

In the current work, the method of PI staining of nuclei, in which the appearance of
hypodiploid nuclei is used as a marker for DNA loss, was shown to be an insensitive
detection method. Gel electrophoresis showed high molecular weight DNA
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fragmentation and internucleosomal fragmentation several hours before D N A loss was
detected by the PI assay. This may lead to inacurracies in the determination of the
chronology of apoptotic events in cases where this assay is used as the sole detection
method for DNA fragmentation. Using PFGE, high molecular weight fragmentation of
DNA was shown to occur universally in the cell systems studied, as an early event in
apoptosis, occurring up to several hours before the internucleosomal fragmentation that
is a "hallmark" of apoptosis. The results support earlier reports that high molecular
weight fragmentation of DNA is one of the earliest detectable events in apoptosis
[Weis, 1995; Brown, 1993]. Although high molecular weight DNA fragmentation was
detected prior to loss of A*Fmit, its dependence on PT was shown by the inhibition of
high molecular weight fragmentation afforded by BA in staurosporine-induced Jurkat
cells.

A detailed chronology of the cellular events in apoptosis, measured in intact cells, is

necessary to identify the critical components of the execution phase of apoptosis and to
allow the molecular mechanisms of apoptosis to be elucidated. At the time of initiation
of this work, two models were proposed to explain the role of mitochondria in the
execution phase of apoptosis (Section LA. 13). Many of the critical features of these

models were based on data acquired in cell-free studies and the physiological validity o

the models needed to be tested in intact cells. The work presented here has extended the
available data regarding the chronology of apoptotic events in a range of intact cell

systems and provided novel insights into the role of PT in apoptosis, including its role
in the release of cytochrome c from mitochondria, in these systems.
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It was shown that collapse of A Y m i t as a consequence of P T is not a universal early
marker for apoptosis and therefore that PT is not a critical element in the execution
phase of apoptosis in all cell systems. In etoposide-induced HL60 cells, BA-mediated
inhibition of PT did not inhibit the release of cytochrome c from mitochondria,
confirming that PT is not involved in the release of cytochrome c this system. The
release of cytochrome c in staurosporine-induced Jurkat cells occurs prior to the
degradation-phase events and is inhibited by BA, indicating that the release of
cytochrome c may be triggered by PT. BA-mediated inhibition of PT, cytochrome c
release and all other degradation-phase events is consistent with cytochrome c release
being a critical component of the apoptotic program in staurosporine-treated Jurkat
cells. A model of apoptosis in which PT is a critical triggering event in apoptosis
(Model 1: Section 1.A. 13) is therefore compatible with some cell systems eg. the
staurosporine-induced Jurkat system whereas a model of apoptosis in which release of
cytochrome c and subsequent events are independent of PT (Model 2, Section 1.A.13)
is compatible with other cell systems including the etoposide-induced HL60 system.
This suggests that neither model of apoptosis is universally applicable to all cell
systems, and that the role of mitochondria in apoptosis maybe cell- and inducing-agentspecific.

Although the model of PT-dependent apoptosis (Model 1, Section LA. 13) relies on the
PT-dependent release of pro-apoptotic proteins to cause the downstream activation of
caspase-3 which in turn leads to DNA fragmentation, there has been little previous

evidence from studies of intact cells that caspase-3 activation depends on PT. The dire
dependence of caspase-3 activation on PT was demonstrated here by the inhibition of
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caspase-3 activation that occurs in the presence of B A , w h e n Jurkat cells are induced to
undergo apoptosis with staurosporine.

The pinocytic loading of cytochrome c into Jurkat and U-937 cells enabled application

of this simple and relatively gentle technique to identify apoptotic events in intact ce
that are induced by cytosolic cytochrome c. This study demonstrated that in intact
Jurkat and U-937 cells, caspase-3 was activated rapidly after pinocytic loading of
cytochrome c and prior to internucleosomal DNA, confirming the observation in cellfree models that cytochrome c is required for activation of caspase-3. In cell-free
systems, release of cytochrome c to the cytosol has been shown to lead to the formation
of a tetramolecular complex which results in the proteolytic activation of caspase-9.

This study has shown for the first time in an intact cell system, that capase-9 is activ
as a direct result of the presence of cytosolic cytochrome c.

The demonstration that a caspase-dependent loss of AWmn, caused by HCPT, occurred
after pinocytic loading of cytochrome c into U-937 and Jurkat cells is evidence that
cytosolic cytochrome c exerts a caspase-dependent feed-back effect on mitochondria to
induce PT and further cytochrome c release, amplifying pro-apoptotic signals The
presence of cytosolic cytochrome c was shown to be sufficient to induce apoptosis in
both cell types tested, including changes not previously directly linked to the release
mitochondrial cytochrome c, such as ensuing loss of ATmit and activation of caspase-3.
The inhibition of PS exposure, loss of AYmk and DNA fragmentation by co-loading of
the capase inhibitors DEVD.CHO and zVAD.fmk suggested that, at least in Jurkat and
U-937 cells, the pathway/s leading from cytochrome c release to these events are
caspase-dependent.
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A great deal of progress has been m a d e in recent years leading to an improved
understanding of the molecular mechanisms of apoptosis. Future progress in this area,

including clarification of the role of mitochondria in apoptotic cell death, will further
elucidate the important regulators of the execution phase of apoptosis and identify
additional targets for therapeutic intervention into apoptosis-related diseases.
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